data_1k8o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k8o _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.842 0.353 . . . . 4.8799999999999999 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 2.1699999999999999 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 2.3399999999999999 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.4700000000000002 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.45 109.17 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.96 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.4399999999999999 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 5.0800000000000001 111.788 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.7000000000000002 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.98 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.98 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.79 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.8700000000000001 110.94 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.504 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 1.1399999999999999 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 2.0699999999999998 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 3.5800000000000001 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 1.1399999999999999 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.409 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.9199999999999999 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' A' ' 32' ' ' VAL . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 1.4099999999999999 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 2.3199999999999998 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.52000000000000002 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 1.0800000000000001 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 1.0800000000000001 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.6000000000000001 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 3.2999999999999998 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 1.3799999999999999 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' ILE . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 1.3700000000000001 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.496 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.8899999999999999 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.99 110.537 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 3.0299999999999998 111.411 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 4.2800000000000002 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 3.48 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5999999999999996 110.445 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.9700000000000002 111.494 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.9299999999999999 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.496 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.6899999999999999 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.6899999999999999 110.207 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.6699999999999999 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.8799999999999999 111.006 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 4.0199999999999996 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.20999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.72 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 HG12 ' CG2' ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.75 113.671 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 2.1299999999999999 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.8300000000000001 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 24' ' ' TRP . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.504 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.77 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.6499999999999999 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.8899999999999997 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 4.0599999999999996 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 2.0299999999999998 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 3.3300000000000001 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 1.0600000000000001 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 2.3799999999999999 111.979 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 1.1299999999999999 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.456 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 1.5800000000000001 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.5800000000000001 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.422 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.8599999999999999 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.4100000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.026 0.441 . . . . 4.8799999999999999 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.446 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 2.1699999999999999 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 2.3399999999999999 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.4700000000000002 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.45 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.96 111.313 -179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 12' ' ' ILE . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.4399999999999999 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 5.0800000000000001 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.7000000000000002 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.98 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.98 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CG1' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.79 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.428 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.8700000000000001 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' HG13 ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.455 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 2.0299999999999998 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.411 ' N ' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 1.1399999999999999 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 2.0699999999999998 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 3.5800000000000001 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 1.1399999999999999 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.9199999999999999 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 ' CG1' ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 1.4099999999999999 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 2.3199999999999998 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.52000000000000002 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 32' ' ' VAL . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 1.0800000000000001 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.443 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 1.0800000000000001 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.6000000000000001 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 3.2999999999999998 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 1.3799999999999999 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.436 HG22 ' CZ3' ' A' ' 24' ' ' TRP . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 1.3700000000000001 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.8899999999999999 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.99 111.565 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 3.0299999999999998 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 4.2800000000000002 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 3.48 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5999999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.9700000000000002 111.981 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.9299999999999999 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.6899999999999999 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.6899999999999999 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.6699999999999999 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.8799999999999999 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 4.0199999999999996 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.20999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.72 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 78' ' ' ILE . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.75 113.75 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 2.1299999999999999 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.534 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.8300000000000001 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.6599999999999999 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 19' ' ' VAL . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.77 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.6499999999999999 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.8899999999999997 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 HG23 HD11 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 4.0599999999999996 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 2.0299999999999998 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 3.3300000000000001 111.545 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 1.0600000000000001 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 2.3799999999999999 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG2' HD22 ' A' ' 61' ' ' LEU . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 1.1299999999999999 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 1.5800000000000001 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' CG1' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.5800000000000001 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.8599999999999999 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.4100000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.728 0.299 . . . . 4.8799999999999999 110.73 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.432 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 2.1699999999999999 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 2.3399999999999999 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.4700000000000002 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.45 109.732 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.96 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.4399999999999999 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 5.0800000000000001 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.7000000000000002 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.98 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.98 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.79 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.8700000000000001 109.934 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 2.0299999999999998 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.43 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 1.1399999999999999 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 HG12 ' NE1' ' A' ' 24' ' ' TRP . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 2.0699999999999998 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 111.346 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.543 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 1.1399999999999999 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.9199999999999999 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.4099999999999999 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HA ' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 2.3199999999999998 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.52000000000000002 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 1.0800000000000001 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.6000000000000001 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 3.2999999999999998 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 1.3799999999999999 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 1.3700000000000001 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.8899999999999999 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.99 110.518 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 3.0299999999999998 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 4.2800000000000002 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 3.48 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5999999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.9700000000000002 111.664 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.9299999999999999 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.6899999999999999 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.6899999999999999 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.6699999999999999 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.8799999999999999 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 4.0199999999999996 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.20999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.72 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' CG2' ' A' ' 78' ' ' ILE . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.75 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 2.1299999999999999 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.543 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.8300000000000001 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.6599999999999999 112.567 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.43 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.77 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.6499999999999999 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.8899999999999997 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.437 ' CG2' HD13 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 4.0599999999999996 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 2.0299999999999998 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 3.3300000000000001 111.292 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 1.0600000000000001 111.892 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 2.3799999999999999 111.89 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 1.1299999999999999 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.439 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 1.5800000000000001 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.5800000000000001 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.8599999999999999 110.581 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.4100000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.816 0.341 . . . . 4.8799999999999999 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 77' ' ' ASP . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 2.1699999999999999 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' CG2' ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 2.3399999999999999 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.4700000000000002 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.45 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.96 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.4399999999999999 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 5.0800000000000001 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 ' CD1' HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.7000000000000002 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.98 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.98 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.403 ' CG1' HG21 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.79 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.8700000000000001 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.481 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 2.0299999999999998 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.1399999999999999 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 2.0699999999999998 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 3.5800000000000001 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 1.1399999999999999 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.9199999999999999 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 1.4099999999999999 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 2.3199999999999998 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.52000000000000002 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 1.0800000000000001 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.436 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 1.0800000000000001 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.6000000000000001 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 3.2999999999999998 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.3799999999999999 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.443 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 1.3700000000000001 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.49 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.8899999999999999 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.99 111.023 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 3.0299999999999998 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 4.2800000000000002 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 3.48 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5999999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.9700000000000002 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.9299999999999999 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.6899999999999999 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.6899999999999999 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.6699999999999999 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.8799999999999999 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 4.0199999999999996 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.20999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.72 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 78' ' ' ILE . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.75 113.739 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 2.1299999999999999 112.707 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.8300000000000001 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.6599999999999999 112.184 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' O ' ' CG2' ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 19' ' ' VAL . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.77 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.6499999999999999 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.8899999999999997 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 4.0599999999999996 110.934 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 2.0299999999999998 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 3.3300000000000001 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 1.0600000000000001 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 2.3799999999999999 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 1.1299999999999999 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 1.5800000000000001 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.5800000000000001 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.8599999999999999 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.4100000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.027 0.441 . . . . 4.8799999999999999 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 2.1699999999999999 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 2.3399999999999999 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.411 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.4700000000000002 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.45 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.96 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.4399999999999999 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 5.0800000000000001 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD2' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.448 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.7000000000000002 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.98 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.98 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.448 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.79 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' O ' HD11 ' A' ' 16' ' ' ILE . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.8700000000000001 110.632 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 2.0299999999999998 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.444 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 1.1399999999999999 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.463 HG12 ' CE2' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 2.0699999999999998 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 3.5800000000000001 111.375 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 39' ' ' CYS . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.9199999999999999 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 1.4099999999999999 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 2.3199999999999998 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.52000000000000002 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 1.0800000000000001 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.451 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 1.0800000000000001 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.6000000000000001 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 3.2999999999999998 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 1.3799999999999999 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 1.3700000000000001 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.8899999999999999 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.99 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 3.0299999999999998 111.279 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 4.2800000000000002 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 3.48 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5999999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.9700000000000002 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.9299999999999999 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.6899999999999999 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.6899999999999999 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.6699999999999999 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.8799999999999999 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 4.0199999999999996 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.20999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.72 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 HG12 ' CG2' ' A' ' 78' ' ' ILE . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.75 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 2.1299999999999999 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 HD21 ' CZ3' ' A' ' 24' ' ' TRP . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.8300000000000001 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.6599999999999999 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.425 ' CB ' ' HB3' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 19' ' ' VAL . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.77 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.444 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.6499999999999999 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.8899999999999997 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 4.0599999999999996 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 2.0299999999999998 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 3.3300000000000001 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 1.0600000000000001 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 2.3799999999999999 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 1.1299999999999999 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 1.5800000000000001 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.5800000000000001 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.8599999999999999 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.4100000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.401 HD13 ' HD3' ' A' ' 53' ' ' ARG . 10.9 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 4.8799999999999999 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 2.1699999999999999 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 2.3399999999999999 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.4700000000000002 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.45 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.96 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.4399999999999999 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 5.0800000000000001 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.7000000000000002 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.98 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.98 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.79 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.8700000000000001 110.572 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.491 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 2.0299999999999998 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.444 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 1.1399999999999999 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.48 HG12 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 2.0699999999999998 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 3.5800000000000001 111.508 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.49 ' CZ3' HD21 ' A' ' 61' ' ' LEU . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 1.1399999999999999 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.9199999999999999 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 32' ' ' VAL . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 1.4099999999999999 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 2.3199999999999998 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.52000000000000002 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 32' ' ' VAL . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 1.0800000000000001 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 1.0800000000000001 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.6000000000000001 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 3.2999999999999998 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 1.3799999999999999 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 38' ' ' ILE . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 1.3700000000000001 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.8899999999999999 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 3.0299999999999998 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 4.2800000000000002 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 3.48 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.416 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5999999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.9700000000000002 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.9299999999999999 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.6899999999999999 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.6899999999999999 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.6699999999999999 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.8799999999999999 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 4.0199999999999996 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.20999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.72 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 78' ' ' ILE . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.75 114.006 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 2.1299999999999999 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 ' CZ3' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.8300000000000001 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 112.225 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.77 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.6499999999999999 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.8899999999999997 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 4.0599999999999996 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 2.0299999999999998 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 3.3300000000000001 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 1.0600000000000001 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 2.3799999999999999 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 1.1299999999999999 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.434 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 1.5800000000000001 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' CG1' ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.5800000000000001 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.416 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.8599999999999999 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.4100000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.831 0.348 . . . . 4.8799999999999999 111.141 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 2.1699999999999999 111.723 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 2.3399999999999999 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.4700000000000002 112.606 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.507 ' CE1' ' CD1' ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.45 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.96 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.4399999999999999 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 5.0800000000000001 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.7000000000000002 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.98 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.98 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.79 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.8700000000000001 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.446 HG23 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 1.1399999999999999 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.427 HG13 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.0699999999999998 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 3.5800000000000001 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.51 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 1.1399999999999999 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.9199999999999999 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG12 ' CG1' ' A' ' 32' ' ' VAL . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.4099999999999999 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 61' ' ' LEU . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 2.3199999999999998 111.226 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.52000000000000002 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 1.0800000000000001 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.454 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 1.0800000000000001 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.6000000000000001 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 3.2999999999999998 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 1.3799999999999999 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.438 ' CG2' HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 1.3700000000000001 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.99 111.132 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 3.0299999999999998 111.114 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 4.2800000000000002 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 3.48 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5999999999999996 110.608 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.9700000000000002 111.284 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.9299999999999999 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.6899999999999999 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.6899999999999999 110.545 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.6699999999999999 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.8799999999999999 111.077 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 4.0199999999999996 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.20999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.72 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CD1' ' HB ' ' A' ' 26' ' ' VAL . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.75 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' CE ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 2.1299999999999999 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.51 ' CD1' ' CZ3' ' A' ' 24' ' ' TRP . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.8300000000000001 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.6599999999999999 112.433 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.77 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.477 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.6499999999999999 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.8899999999999997 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HD13 ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 4.0599999999999996 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 2.0299999999999998 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 3.3300000000000001 111.451 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 1.0600000000000001 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 2.3799999999999999 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 61' ' ' LEU . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 1.1299999999999999 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 1.5800000000000001 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.461 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.5800000000000001 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.4100000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.831 0.348 . . . . 4.8799999999999999 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 77' ' ' ASP . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 2.1699999999999999 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 5' ' ' VAL . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 2.3399999999999999 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.4700000000000002 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.45 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.96 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.4399999999999999 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.433 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 5.0800000000000001 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.448 HD11 ' CG1' ' A' ' 19' ' ' VAL . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.7000000000000002 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.98 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.98 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.79 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.8700000000000001 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 70' ' ' TYR . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 2.0299999999999998 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.453 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 1.1399999999999999 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 2.0699999999999998 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 3.5800000000000001 111.583 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CZ3' HD11 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 1.1399999999999999 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.9199999999999999 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 1.4099999999999999 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 2.3199999999999998 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.52000000000000002 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 32' ' ' VAL . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 1.0800000000000001 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.448 ' N ' HG23 ' A' ' 31' ' ' THR . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 1.0800000000000001 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 3.2999999999999998 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 1.3799999999999999 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 ' HA ' HG12 ' A' ' 26' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 1.3700000000000001 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.8899999999999999 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HG3' ' CG2' ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.99 110.575 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 3.0299999999999998 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.2800000000000002 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 3.48 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5999999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.9700000000000002 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.9299999999999999 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.6899999999999999 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.6899999999999999 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.6699999999999999 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.8799999999999999 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 4.0199999999999996 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.436 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.20999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.72 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' GLY . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.75 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 2.1299999999999999 112.693 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.502 HD11 ' CZ3' ' A' ' 24' ' ' TRP . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.8300000000000001 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CG ' HD13 ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.6599999999999999 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.453 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.77 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' C ' ' HG ' ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.6499999999999999 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.418 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.8899999999999997 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 4.0599999999999996 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 2.0299999999999998 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 3.3300000000000001 111.593 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 1.0600000000000001 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 2.3799999999999999 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 1.1299999999999999 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 1.5800000000000001 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.5800000000000001 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.8599999999999999 110.494 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.4100000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.768 0.318 . . . . 4.8799999999999999 110.769 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 2.1699999999999999 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG2' ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 2.3399999999999999 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.4700000000000002 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.45 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.96 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.4399999999999999 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 5.0800000000000001 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.443 HD11 ' CG1' ' A' ' 19' ' ' VAL . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.7000000000000002 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.98 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.98 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 12' ' ' ILE . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.79 111.552 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.8700000000000001 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 12' ' ' ILE . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 2.0299999999999998 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 2.0699999999999998 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 3.5800000000000001 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.9199999999999999 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 32' ' ' VAL . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 1.4099999999999999 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 2.3199999999999998 111.351 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.52000000000000002 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 32' ' ' VAL . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 1.0800000000000001 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 1.0800000000000001 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.6000000000000001 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 3.2999999999999998 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 1.3799999999999999 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.44 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 1.3700000000000001 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.8899999999999999 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.99 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 3.0299999999999998 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 4.2800000000000002 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 3.48 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5999999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.443 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.9700000000000002 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.9299999999999999 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.6899999999999999 109.726 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.6699999999999999 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.8799999999999999 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 4.0199999999999996 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.20999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.72 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.75 113.905 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 2.1299999999999999 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CH2' ' A' ' 24' ' ' TRP . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.8300000000000001 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' CD2' ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.6599999999999999 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.77 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.6499999999999999 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.8899999999999997 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.425 HG13 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 4.0599999999999996 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 2.0299999999999998 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 3.3300000000000001 111.343 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 1.0600000000000001 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 2.3799999999999999 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 ' CG2' HD21 ' A' ' 61' ' ' LEU . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 1.1299999999999999 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.5800000000000001 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.8599999999999999 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.4100000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.856 0.36 . . . . 4.8799999999999999 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 2.3399999999999999 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.4700000000000002 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.49 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.45 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.96 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.4399999999999999 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 5.0800000000000001 110.958 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.7000000000000002 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.98 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.98 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.79 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.8700000000000001 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' N ' ' HG2' ' A' ' 17' ' ' ARG . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.479 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 2.0299999999999998 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 1.1399999999999999 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 24' ' ' TRP . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 2.0699999999999998 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 3.5800000000000001 111.074 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 65' ' ' LEU . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 1.1399999999999999 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.9199999999999999 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 58' ' ' ILE . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 1.4099999999999999 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 2.3199999999999998 111.481 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.52000000000000002 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.417 HG21 ' N ' ' A' ' 32' ' ' VAL . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 1.0800000000000001 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 1.0800000000000001 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 3.2999999999999998 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 1.3799999999999999 110.228 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 ' O ' ' CE3' ' A' ' 24' ' ' TRP . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 1.3700000000000001 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.496 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.8899999999999999 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.99 111.216 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 3.0299999999999998 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 4.2800000000000002 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 3.48 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5999999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.9700000000000002 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.9299999999999999 110.49 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.49 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.6899999999999999 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.6899999999999999 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.6699999999999999 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.8799999999999999 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 4.0199999999999996 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.20999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.72 111.487 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 78' ' ' ILE . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.75 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 2.1299999999999999 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.8300000000000001 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.6599999999999999 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 19' ' ' VAL . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.77 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.6499999999999999 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.4 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.8899999999999997 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 4.0599999999999996 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 2.0299999999999998 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 3.3300000000000001 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 1.0600000000000001 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 2.3799999999999999 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 1.1299999999999999 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 1.5800000000000001 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.5800000000000001 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.453 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.8599999999999999 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.4100000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.759 0.314 . . . . 4.8799999999999999 110.851 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.435 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 2.1699999999999999 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 2.3399999999999999 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.48 ' HG3' ' CB ' ' A' ' 74' ' ' PRO . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.4700000000000002 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.45 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.96 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.4399999999999999 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 5.0800000000000001 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.7000000000000002 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.98 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.98 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.79 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.8700000000000001 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 2.0299999999999998 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 1.1399999999999999 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 3.5800000000000001 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.489 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 1.1399999999999999 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.9199999999999999 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.473 ' CG1' ' CG1' ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.4099999999999999 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 2.3199999999999998 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.52000000000000002 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 1.0800000000000001 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' CG1' ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 1.0800000000000001 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.6000000000000001 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 3.2999999999999998 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 1.3799999999999999 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 1.3700000000000001 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.8899999999999999 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.99 111.246 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 3.0299999999999998 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 4.2800000000000002 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 3.48 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5999999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.9700000000000002 111.79 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.9299999999999999 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.6899999999999999 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.6899999999999999 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.6699999999999999 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.8799999999999999 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 4.0199999999999996 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.20999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.72 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.75 114.066 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 2.1299999999999999 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.473 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.8300000000000001 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.6599999999999999 112.41 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.77 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.6499999999999999 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.8899999999999997 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 4.0599999999999996 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 2.0299999999999998 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 3.3300000000000001 110.866 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 1.0600000000000001 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 2.3799999999999999 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 1.1299999999999999 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 1.5800000000000001 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.5800000000000001 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.4 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.8599999999999999 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.4100000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.772 0.32 . . . . 4.8799999999999999 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.421 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 2.1699999999999999 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 2.3399999999999999 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.545 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.4700000000000002 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.45 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.96 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.4399999999999999 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 5.0800000000000001 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.7000000000000002 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.98 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.98 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.79 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.8700000000000001 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.48 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 2.0299999999999998 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.451 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 1.1399999999999999 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.494 HG13 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 2.0699999999999998 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 3.5800000000000001 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.518 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 1.1399999999999999 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.9199999999999999 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 1.4099999999999999 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 2.3199999999999998 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.52000000000000002 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 1.0800000000000001 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 HG22 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 1.0800000000000001 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.6000000000000001 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 3.2999999999999998 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 1.3799999999999999 110.27 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.472 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.99 111.493 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 3.0299999999999998 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 4.2800000000000002 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.48 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5999999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.9700000000000002 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.9299999999999999 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.6899999999999999 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.6899999999999999 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.6699999999999999 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.8799999999999999 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 4.0199999999999996 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.20999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.72 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.497 ' CD1' ' CG2' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.75 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 2.1299999999999999 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.518 ' CD1' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.8300000000000001 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.6599999999999999 112.901 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.451 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.77 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.6499999999999999 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.8899999999999997 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 4.0599999999999996 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 2.0299999999999998 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 3.3300000000000001 111.924 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.545 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 1.0600000000000001 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 2.3799999999999999 110.809 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' CG2' ' CD2' ' A' ' 61' ' ' LEU . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 1.1299999999999999 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 1.5800000000000001 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.5800000000000001 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.8599999999999999 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.4100000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.853 0.359 . . . . 4.8799999999999999 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 2.1699999999999999 111.008 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 2.3399999999999999 108.019 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.4700000000000002 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.45 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.96 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 5.0800000000000001 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.7000000000000002 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.98 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.98 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.79 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.8700000000000001 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 68' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 12' ' ' ILE . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 2.0299999999999998 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 1.1399999999999999 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' NE1' ' A' ' 24' ' ' TRP . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 2.0699999999999998 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 3.5800000000000001 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.494 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 1.1399999999999999 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.9199999999999999 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 1.4099999999999999 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 2.3199999999999998 111.005 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.52000000000000002 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 1.0800000000000001 110.498 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG13 ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 1.0800000000000001 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.6000000000000001 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 3.2999999999999998 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 1.3799999999999999 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.459 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 1.3700000000000001 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.8899999999999999 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 48' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.99 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 3.0299999999999998 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 4.2800000000000002 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 3.48 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5999999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 41' ' ' VAL . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.9700000000000002 111.825 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.9299999999999999 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.6899999999999999 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.6899999999999999 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.6699999999999999 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.8799999999999999 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 4.0199999999999996 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.20999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.72 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.437 ' CD1' ' HB ' ' A' ' 26' ' ' VAL . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.75 113.528 -176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 2.1299999999999999 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD22 ' CH2' ' A' ' 24' ' ' TRP . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.8300000000000001 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.6599999999999999 112.504 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 18' ' ' GLU . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.77 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.6499999999999999 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.8899999999999997 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 4.0599999999999996 110.942 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 2.0299999999999998 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 3.3300000000000001 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 1.0600000000000001 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 2.3799999999999999 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' A' ' 61' ' ' LEU . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 1.1299999999999999 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 1.5800000000000001 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.5800000000000001 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.8599999999999999 110.253 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.4100000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.73 0.3 . . . . 4.8799999999999999 110.792 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' CG ' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 2.1699999999999999 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 78' ' ' ILE . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 2.3399999999999999 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.4700000000000002 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.45 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.96 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.497 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.4399999999999999 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 5.0800000000000001 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.7000000000000002 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.98 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.98 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.79 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.8700000000000001 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 68' ' ' ILE . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.497 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 2.0299999999999998 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 2.0699999999999998 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 3.5800000000000001 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 1.1399999999999999 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.9199999999999999 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 1.4099999999999999 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.3199999999999998 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.52000000000000002 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 1.0800000000000001 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 1.0800000000000001 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 110.245 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 3.2999999999999998 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 1.3799999999999999 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 1.3700000000000001 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.99 111.476 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 3.0299999999999998 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 4.2800000000000002 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 3.48 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5999999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.9700000000000002 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.9299999999999999 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.6899999999999999 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.6899999999999999 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.6699999999999999 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.8799999999999999 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 4.0199999999999996 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.20999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.72 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.47 HG12 ' CG2' ' A' ' 78' ' ' ILE . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.75 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 2.1299999999999999 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.497 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.8300000000000001 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.6599999999999999 112.194 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 18' ' ' GLU . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.77 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.6499999999999999 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.8899999999999997 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' CG2' HD12 ' A' ' 9' ' ' LEU . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 4.0599999999999996 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 2.0299999999999998 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 3.3300000000000001 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 1.0600000000000001 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 2.3799999999999999 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 1.1299999999999999 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.47 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.5800000000000001 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.5800000000000001 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.8599999999999999 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.4100000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.779 0.323 . . . . 4.8799999999999999 110.896 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.476 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 2.1699999999999999 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 2.3399999999999999 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.443 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.4700000000000002 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.45 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.4399999999999999 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 5.0800000000000001 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 HD11 ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.7000000000000002 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.98 112.651 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.98 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.445 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.79 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.8700000000000001 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CE2' ' A' ' 70' ' ' TYR . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 2.0299999999999998 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 1.1399999999999999 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 2.0699999999999998 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 3.5800000000000001 110.9 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 1.1399999999999999 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.421 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.9199999999999999 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 1.4099999999999999 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 2.3199999999999998 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.52000000000000002 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 32' ' ' VAL . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 1.0800000000000001 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.6000000000000001 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 3.2999999999999998 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.3799999999999999 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 1.3700000000000001 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.8899999999999999 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.99 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 3.0299999999999998 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 4.2800000000000002 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 3.48 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5999999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.9700000000000002 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.9299999999999999 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.6899999999999999 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.6899999999999999 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.6699999999999999 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.8799999999999999 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 4.0199999999999996 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.20999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.72 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.479 HG22 HD13 ' A' ' 58' ' ' ILE . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.75 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' CE ' ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 2.1299999999999999 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.524 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.8300000000000001 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.6599999999999999 112.213 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD2' ' N ' ' A' ' 64' ' ' ASN . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.77 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.6499999999999999 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.8899999999999997 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 4.0599999999999996 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 2.0299999999999998 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 3.3300000000000001 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 1.0600000000000001 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 2.3799999999999999 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 7' ' ' PHE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 1.1299999999999999 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' OD1' ' CG ' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.5800000000000001 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.5800000000000001 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.8599999999999999 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.4100000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.868 0.366 . . . . 4.8799999999999999 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 2.1699999999999999 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 2.3399999999999999 108.839 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.4700000000000002 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.45 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.96 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.4399999999999999 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 5.0800000000000001 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CG2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.7000000000000002 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.98 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' CG1' ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.98 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.79 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.8700000000000001 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' CB ' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 2.0299999999999998 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 3.5800000000000001 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 1.1399999999999999 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.9199999999999999 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG13 ' CG1' ' A' ' 32' ' ' VAL . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 1.4099999999999999 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.3199999999999998 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.52000000000000002 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 1.0800000000000001 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.453 ' CG1' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 1.0800000000000001 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.6000000000000001 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 3.2999999999999998 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 1.3799999999999999 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 1.3700000000000001 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.8899999999999999 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' LYS . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.99 111.056 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' NE2' ' HG2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 3.0299999999999998 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 4.2800000000000002 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 3.48 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5999999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.9700000000000002 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.9299999999999999 109.733 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.484 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.6899999999999999 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.6899999999999999 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.6699999999999999 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.8799999999999999 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 4.0199999999999996 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.20999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.72 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 78' ' ' ILE . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.75 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 2.1299999999999999 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.8300000000000001 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.6599999999999999 112.089 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.77 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.6499999999999999 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.8899999999999997 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 4.0599999999999996 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 2.0299999999999998 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 3.3300000000000001 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 8' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 1.0600000000000001 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 2.3799999999999999 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 75' ' ' LEU . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 1.1299999999999999 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 1.5800000000000001 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.461 ' HG2' ' CG1' ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.8599999999999999 111.104 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.4100000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.733 0.301 . . . . 4.8799999999999999 110.815 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 2.1699999999999999 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 2.3399999999999999 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.4700000000000002 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.45 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.96 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.459 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.4399999999999999 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 5.0800000000000001 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.7000000000000002 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.98 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.98 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.79 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.8700000000000001 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 2.0299999999999998 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 1.1399999999999999 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 HG11 ' NE1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 2.0699999999999998 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 3.5800000000000001 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 1.1399999999999999 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.9199999999999999 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 1.4099999999999999 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 2.3199999999999998 111.006 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' N ' HD13 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.52000000000000002 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 1.0800000000000001 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 1.0800000000000001 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.6000000000000001 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 3.2999999999999998 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 1.3799999999999999 110.55 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.452 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 1.3700000000000001 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.8899999999999999 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.99 111.725 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 3.0299999999999998 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 4.2800000000000002 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 3.48 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5999999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.9299999999999999 110.536 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.6899999999999999 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.6899999999999999 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.6699999999999999 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.8799999999999999 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 4.0199999999999996 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.20999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.72 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.75 113.973 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 2.1299999999999999 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.8300000000000001 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.6599999999999999 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.77 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.459 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.6499999999999999 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.8899999999999997 110.219 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 4.0599999999999996 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 2.0299999999999998 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 3.3300000000000001 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 1.0600000000000001 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 2.3799999999999999 111.275 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 1.1299999999999999 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 1.5800000000000001 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.5800000000000001 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.8599999999999999 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.4100000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 4.8799999999999999 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.456 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 2.1699999999999999 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 2.3399999999999999 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 2.8 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.4700000000000002 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' ' SG ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.45 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.96 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.4399999999999999 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 5.0800000000000001 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.7000000000000002 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.98 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.98 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.435 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.79 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.8700000000000001 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 2.0299999999999998 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.438 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.1399999999999999 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG1' ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 2.0699999999999998 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 3.5800000000000001 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.535 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 1.1399999999999999 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.9199999999999999 111.555 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 1.4099999999999999 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 2.3199999999999998 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.52000000000000002 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 1.0800000000000001 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 1.0800000000000001 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.6000000000000001 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 3.2999999999999998 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 1.3799999999999999 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.446 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 1.3700000000000001 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.498 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.8899999999999999 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.99 111.424 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.0299999999999998 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 4.2800000000000002 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 3.48 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5999999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.9700000000000002 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.9299999999999999 110.582 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.6899999999999999 111.541 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.6899999999999999 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.6699999999999999 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.8799999999999999 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 4.0199999999999996 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.20999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.72 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.486 HG12 ' CG2' ' A' ' 78' ' ' ILE . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 2.1299999999999999 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.8300000000000001 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.6599999999999999 112.365 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.438 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.77 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.6499999999999999 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.8899999999999997 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 9' ' ' LEU . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 4.0599999999999996 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 2.0299999999999998 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 3.3300000000000001 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 1.0600000000000001 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 2.3799999999999999 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 1.1299999999999999 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 1.5800000000000001 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.5800000000000001 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.8599999999999999 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.4100000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.602 0.239 . . . . 4.8799999999999999 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 2.1699999999999999 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 2.3399999999999999 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.4700000000000002 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CE1' HD11 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.45 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.96 112.47 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.4399999999999999 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 5.0800000000000001 112.1 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' HG23 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.7000000000000002 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.98 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.98 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' HG21 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.79 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.8700000000000001 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HD12 ' A' ' 12' ' ' ILE . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 2.0299999999999998 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.45 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 1.1399999999999999 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 ' CE2' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 2.0699999999999998 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 3.5800000000000001 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.557 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 1.1399999999999999 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.9199999999999999 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 1.4099999999999999 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 2.3199999999999998 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.52000000000000002 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 1.0800000000000001 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.467 ' CG1' ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 1.0800000000000001 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.6000000000000001 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 3.2999999999999998 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 1.3799999999999999 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 1.3700000000000001 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.99 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 3.0299999999999998 111.038 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 4.2800000000000002 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 3.48 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5999999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.9700000000000002 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.9299999999999999 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.6899999999999999 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.6899999999999999 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.6699999999999999 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.8799999999999999 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 4.0199999999999996 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.20999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.75 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 2.1299999999999999 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.557 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.8300000000000001 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.6599999999999999 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.77 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.6499999999999999 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.406 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.8899999999999997 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 4.0599999999999996 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 2.0299999999999998 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 3.3300000000000001 111.421 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 1.0600000000000001 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 2.3799999999999999 111.451 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 1.1299999999999999 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.454 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.5800000000000001 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.5800000000000001 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.8599999999999999 110.657 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.4100000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.847 0.356 . . . . 4.8799999999999999 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.471 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 2.1699999999999999 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 2.3399999999999999 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.4700000000000002 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 50' ' ' ILE . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.45 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.96 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.4399999999999999 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 5.0800000000000001 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.7000000000000002 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.98 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.98 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.44 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.79 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.8700000000000001 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 68' ' ' ILE . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 2.0299999999999998 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 1.1399999999999999 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 24' ' ' TRP . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 2.0699999999999998 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 3.5800000000000001 111.322 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.526 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 1.1399999999999999 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.9199999999999999 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 1.4099999999999999 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 2.3199999999999998 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.52000000000000002 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 32' ' ' VAL . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 1.0800000000000001 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.6000000000000001 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 3.2999999999999998 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 1.3799999999999999 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 1.3700000000000001 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.8899999999999999 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.99 110.954 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 3.0299999999999998 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 4.2800000000000002 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 3.48 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5999999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.9700000000000002 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.9299999999999999 110.246 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 7' ' ' PHE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.6899999999999999 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.6899999999999999 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.6699999999999999 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.8799999999999999 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 4.0199999999999996 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.20999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.72 111.633 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' CG2' ' A' ' 78' ' ' ILE . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.75 113.425 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 2.1299999999999999 113.361 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.8300000000000001 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.6599999999999999 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.77 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.6499999999999999 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.425 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.8899999999999997 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 4.0599999999999996 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 2.0299999999999998 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 3.3300000000000001 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 8' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 1.0600000000000001 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 2.3799999999999999 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 75' ' ' LEU . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 1.1299999999999999 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.448 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.471 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.5800000000000001 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.8599999999999999 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.4100000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ptm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.893 0.378 . . . . 5.9699999999999998 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 19.47 5.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 4.3499999999999996 112.487 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.6 153.64 43.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 4.8799999999999999 110.838 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.44 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 2.1699999999999999 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 2.3399999999999999 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.4700000000000002 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.45 109.17 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.96 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.4399999999999999 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 5.0800000000000001 111.788 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.7000000000000002 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.98 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.98 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.79 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.8700000000000001 110.94 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 2.0299999999999998 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.504 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 1.1399999999999999 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 2.0699999999999998 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 3.5800000000000001 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 1.1399999999999999 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.409 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.9199999999999999 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG11 ' CG1' ' A' ' 32' ' ' VAL . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 1.4099999999999999 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 2.3199999999999998 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.52000000000000002 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 1.0800000000000001 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 1.0800000000000001 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.6000000000000001 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 3.2999999999999998 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 1.3799999999999999 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 38' ' ' ILE . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 1.3700000000000001 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.496 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.8899999999999999 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.99 110.537 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 3.0299999999999998 111.411 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 4.2800000000000002 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 3.48 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5999999999999996 110.445 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.9700000000000002 111.494 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.9299999999999999 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.496 HD12 ' CZ ' ' A' ' 7' ' ' PHE . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.6899999999999999 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.6899999999999999 110.207 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.6699999999999999 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.8799999999999999 111.006 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 4.0199999999999996 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.20999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.72 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 HG12 ' CG2' ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.75 113.671 -177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 2.1299999999999999 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.8300000000000001 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 24' ' ' TRP . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.6599999999999999 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.504 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.77 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.6499999999999999 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.8899999999999997 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 4.0599999999999996 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 2.0299999999999998 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 3.3300000000000001 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 1.0600000000000001 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 2.3799999999999999 111.979 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 1.1299999999999999 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.456 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 1.5800000000000001 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.5800000000000001 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.422 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.8599999999999999 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.4100000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.87 122.68 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -53.54 -22.49 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 8.7100000000000009 111.246 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -40.36 -49.82 2.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.35 -0.386 . . . . 6.2300000000000004 112.005 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 tp -116.45 -28.17 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.288 . . . . 4.4699999999999998 111.102 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.234 -0.888 . . . . 7.79 110.814 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.776 0.322 . . . . 5.9699999999999998 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.63 13.74 23.34 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 4.3499999999999996 112.884 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -107.43 153.23 23.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.026 0.441 . . . . 4.8799999999999999 111.141 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 2.1699999999999999 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 2.3399999999999999 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.4700000000000002 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.45 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.96 111.313 -179.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 12' ' ' ILE . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.4399999999999999 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 5.0800000000000001 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.487 HG12 ' CD1' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.7000000000000002 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.98 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.98 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CG1' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.79 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.428 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.8700000000000001 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' HA ' HG13 ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.455 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 2.0299999999999998 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.411 ' N ' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 1.1399999999999999 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 2.0699999999999998 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 3.5800000000000001 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.534 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 1.1399999999999999 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.9199999999999999 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 ' CG1' ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 1.4099999999999999 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 2.3199999999999998 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.52000000000000002 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 32' ' ' VAL . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 1.0800000000000001 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.443 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 1.0800000000000001 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.6000000000000001 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 3.2999999999999998 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 1.3799999999999999 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.436 HG22 ' CZ3' ' A' ' 24' ' ' TRP . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 1.3700000000000001 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.8899999999999999 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.99 111.565 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 3.0299999999999998 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 4.2800000000000002 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 3.48 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5999999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.9700000000000002 111.981 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.9299999999999999 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.6899999999999999 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.6899999999999999 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.6699999999999999 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.8799999999999999 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 4.0199999999999996 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.20999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.72 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 78' ' ' ILE . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.75 113.75 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 2.1299999999999999 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.534 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.8300000000000001 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' HB ' ' A' ' 21' ' ' VAL . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.6599999999999999 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.422 HG23 ' N ' ' A' ' 19' ' ' VAL . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.77 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.6499999999999999 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.8899999999999997 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 HG23 HD11 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 4.0599999999999996 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 2.0299999999999998 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 3.3300000000000001 111.545 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 1.0600000000000001 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 2.3799999999999999 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG2' HD22 ' A' ' 61' ' ' LEU . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 1.1299999999999999 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 1.5800000000000001 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' HG2' ' CG1' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.5800000000000001 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.8599999999999999 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.4100000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.33 126.42 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.6 -32.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 8.7100000000000009 111.577 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -49.64 -45.24 48.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 6.2300000000000004 111.111 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.43 16.04 16.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 4.4699999999999998 111.406 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.215 -0.898 . . . . 7.79 110.937 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.854 0.359 . . . . 5.9699999999999998 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.94 67.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 4.3499999999999996 112.632 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -141.73 152.13 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 4.8799999999999999 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 2.1699999999999999 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 78' ' ' ILE . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 2.3399999999999999 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.4700000000000002 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.45 109.732 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.96 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.4399999999999999 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 5.0800000000000001 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 ' HB ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.7000000000000002 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.98 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.98 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.479 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.79 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.8700000000000001 109.934 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 2.0299999999999998 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.43 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 1.1399999999999999 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 HG12 ' NE1' ' A' ' 24' ' ' TRP . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 2.0699999999999998 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 3.5800000000000001 111.346 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.543 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 1.1399999999999999 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.9199999999999999 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 1.4099999999999999 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HA ' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 2.3199999999999998 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.52000000000000002 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 1.0800000000000001 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.6000000000000001 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 3.2999999999999998 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.406 ' O ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 1.3799999999999999 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 1.3700000000000001 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.8899999999999999 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.99 110.518 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 3.0299999999999998 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 4.2800000000000002 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 3.48 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5999999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.9700000000000002 111.664 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.9299999999999999 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.6899999999999999 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.6899999999999999 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.6699999999999999 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.8799999999999999 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 4.0199999999999996 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.20999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.72 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.439 HG12 ' CG2' ' A' ' 78' ' ' ILE . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.75 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 2.1299999999999999 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.543 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.8300000000000001 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.6599999999999999 112.567 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.43 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.77 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.6499999999999999 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.8899999999999997 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.437 ' CG2' HD13 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 4.0599999999999996 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 2.0299999999999998 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 3.3300000000000001 111.292 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 1.0600000000000001 111.892 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 2.3799999999999999 111.89 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 1.1299999999999999 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.439 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 1.5800000000000001 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.5800000000000001 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.8599999999999999 110.581 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.4100000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt -116.66 135.7 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -24.39 67.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 8.7100000000000009 111.239 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.95 -41.66 25.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 6.2300000000000004 111.331 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.01 -24.74 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 4.4699999999999998 111.14 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 7.79 110.979 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.826 0.346 . . . . 5.9699999999999998 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.25 19.07 34.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 4.3499999999999996 112.567 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.61 124.92 4.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 4.8799999999999999 110.861 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 77' ' ' ASP . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 2.1699999999999999 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' CG2' ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 2.3399999999999999 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.4700000000000002 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.45 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.96 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.4399999999999999 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 5.0800000000000001 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 ' CD1' HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.7000000000000002 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.98 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.98 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.403 ' CG1' HG21 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.79 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.8700000000000001 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 2.0299999999999998 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 1.1399999999999999 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 2.0699999999999998 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 3.5800000000000001 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.529 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 1.1399999999999999 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.9199999999999999 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 1.4099999999999999 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 2.3199999999999998 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.52000000000000002 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.439 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 1.0800000000000001 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.436 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 1.0800000000000001 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.6000000000000001 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 3.2999999999999998 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.3799999999999999 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.443 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 1.3700000000000001 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.49 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.8899999999999999 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.99 111.023 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 3.0299999999999998 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 4.2800000000000002 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 3.48 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5999999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.9700000000000002 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.9299999999999999 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.6899999999999999 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.6899999999999999 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.6699999999999999 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.8799999999999999 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 4.0199999999999996 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.20999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.72 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.444 HG12 ' CG2' ' A' ' 78' ' ' ILE . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.75 113.739 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 2.1299999999999999 112.707 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.8300000000000001 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.6599999999999999 112.184 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' O ' ' CG2' ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 19' ' ' VAL . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.77 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.6499999999999999 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.8899999999999997 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 4.0599999999999996 110.934 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 2.0299999999999998 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 3.3300000000000001 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 1.0600000000000001 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 2.3799999999999999 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 1.1299999999999999 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 1.5800000000000001 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.5800000000000001 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.425 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.8599999999999999 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.4100000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.86 145.09 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -24.51 40.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 8.7100000000000009 111.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.38 -40.77 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 6.2300000000000004 111.3 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.53 -23.68 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 4.4699999999999998 110.899 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.206 -0.902 . . . . 7.79 110.877 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.867 0.365 . . . . 5.9699999999999998 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.78 67.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.69 -0.767 . . . . 4.3499999999999996 112.827 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -132.33 126.2 32.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.027 0.441 . . . . 4.8799999999999999 110.97 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 2.1699999999999999 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 2.3399999999999999 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.413 ' O ' ' CD2' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.4700000000000002 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.45 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.96 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.4399999999999999 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 5.0800000000000001 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.424 ' OD2' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.448 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.7000000000000002 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.98 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.98 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.448 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.79 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' O ' HD11 ' A' ' 16' ' ' ILE . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.8700000000000001 110.632 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB2' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 2.0299999999999998 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.444 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 1.1399999999999999 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.463 HG12 ' CE2' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 2.0699999999999998 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 3.5800000000000001 111.375 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CH2' ' HB2' ' A' ' 39' ' ' CYS . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 1.1399999999999999 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.9199999999999999 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 1.4099999999999999 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 2.3199999999999998 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.52000000000000002 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 1.0800000000000001 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 1.0800000000000001 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.6000000000000001 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 3.2999999999999998 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 1.3799999999999999 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 1.3700000000000001 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.8899999999999999 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.99 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 3.0299999999999998 111.279 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 4.2800000000000002 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 3.48 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5999999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.9700000000000002 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.9299999999999999 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.6899999999999999 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.6899999999999999 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.6699999999999999 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.8799999999999999 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 4.0199999999999996 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.20999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.72 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 HG12 ' CG2' ' A' ' 78' ' ' ILE . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 1.0 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.75 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 2.1299999999999999 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 HD21 ' CZ3' ' A' ' 24' ' ' TRP . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.8300000000000001 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.6599999999999999 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' CB ' ' HB3' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG21 ' N ' ' A' ' 19' ' ' VAL . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.77 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.6499999999999999 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.8899999999999997 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 4.0599999999999996 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 2.0299999999999998 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 3.3300000000000001 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 1.0600000000000001 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 2.3799999999999999 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 1.1299999999999999 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.458 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 1.5800000000000001 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.5800000000000001 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.8599999999999999 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.4100000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.401 HD13 ' HD3' ' A' ' 53' ' ' ARG . 10.9 mt -117.13 121.61 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -22.21 23.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.04 -0.527 . . . . 8.7100000000000009 111.645 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -34.26 -44.11 0.18 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.389 0.515 . . . . 6.2300000000000004 112.389 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -117.46 -16.19 10.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 4.4699999999999998 111.435 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.727 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.801 0.334 . . . . 5.9699999999999998 111.347 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.28 14.59 27.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 4.3499999999999996 112.961 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -140.11 146.81 39.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.942 0.401 . . . . 4.8799999999999999 111.02 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 2.1699999999999999 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 2.3399999999999999 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.4700000000000002 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.482 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.45 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.96 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.4399999999999999 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 5.0800000000000001 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.7000000000000002 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.98 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.98 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.79 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.8700000000000001 110.572 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.491 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 2.0299999999999998 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.444 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 1.1399999999999999 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.48 HG12 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 2.0699999999999998 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 3.5800000000000001 111.508 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.49 ' CZ3' HD21 ' A' ' 61' ' ' LEU . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 1.1399999999999999 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.9199999999999999 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 32' ' ' VAL . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 1.4099999999999999 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 2.3199999999999998 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.52000000000000002 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.434 HG23 ' N ' ' A' ' 32' ' ' VAL . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 1.0800000000000001 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 1.0800000000000001 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.6000000000000001 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 3.2999999999999998 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 1.3799999999999999 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 38' ' ' ILE . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 1.3700000000000001 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.8899999999999999 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.99 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 3.0299999999999998 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 4.2800000000000002 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 3.48 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.416 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5999999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.9700000000000002 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.426 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.9299999999999999 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.6899999999999999 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.6899999999999999 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.6699999999999999 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.8799999999999999 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 4.0199999999999996 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.20999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.72 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.434 HG12 ' CG2' ' A' ' 78' ' ' ILE . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 1.0 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.75 114.006 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 2.1299999999999999 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD21 ' CZ3' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.8300000000000001 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.6599999999999999 112.225 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.77 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.6499999999999999 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.8899999999999997 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 4.0599999999999996 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 2.0299999999999998 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 3.3300000000000001 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 1.0600000000000001 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 2.3799999999999999 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 1.1299999999999999 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.434 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 1.5800000000000001 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG3' ' CG1' ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.5800000000000001 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.416 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.8599999999999999 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.4100000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -117.02 145.75 43.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -22.16 66.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 8.7100000000000009 111.724 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.26 -49.96 1.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.171 0.434 . . . . 6.2300000000000004 112.171 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.94 -25.25 5.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.565 -0.289 . . . . 4.4699999999999998 111.469 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.21 -0.9 . . . . 7.79 110.906 -179.622 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.873 0.368 . . . . 5.9699999999999998 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.18 -0.95 88.89 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.811 -0.709 . . . . 4.3499999999999996 113.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -82.45 153.06 25.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.047 0.423 . . . . 4.8799999999999999 111.141 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 2.1699999999999999 111.723 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 2.3399999999999999 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.4700000000000002 112.606 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.507 ' CE1' ' CD1' ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.45 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.96 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.477 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.4399999999999999 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 5.0800000000000001 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD2' ' CD1' ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.442 ' HB ' ' CD1' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.7000000000000002 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.98 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.98 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.79 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.8700000000000001 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 2.0299999999999998 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.446 HG23 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 1.1399999999999999 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.427 HG13 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 2.0699999999999998 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 3.5800000000000001 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.51 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 1.1399999999999999 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.9199999999999999 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG12 ' CG1' ' A' ' 32' ' ' VAL . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.4099999999999999 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 61' ' ' LEU . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 2.3199999999999998 111.226 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 60' ' ' LYS . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.52000000000000002 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 1.0800000000000001 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.454 ' CG1' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 1.0800000000000001 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.6000000000000001 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.41 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 3.2999999999999998 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 1.3799999999999999 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.438 ' CG2' HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 1.3700000000000001 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.8899999999999999 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.99 111.132 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 3.0299999999999998 111.114 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 4.2800000000000002 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 3.48 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5999999999999996 110.608 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.9700000000000002 111.284 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.9299999999999999 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.6899999999999999 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.6899999999999999 110.545 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.6699999999999999 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.8799999999999999 111.077 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 4.0199999999999996 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.20999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.72 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 ' CD1' ' HB ' ' A' ' 26' ' ' VAL . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.75 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' CE ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 2.1299999999999999 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.51 ' CD1' ' CZ3' ' A' ' 24' ' ' TRP . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.8300000000000001 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.447 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.6599999999999999 112.433 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.77 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.477 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.6499999999999999 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.8899999999999997 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HD13 ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 4.0599999999999996 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 2.0299999999999998 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 3.3300000000000001 111.451 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 1.0600000000000001 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 2.3799999999999999 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG22 ' CD2' ' A' ' 61' ' ' LEU . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 1.1299999999999999 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 1.5800000000000001 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.461 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.5800000000000001 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.8599999999999999 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.4100000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.62 145.08 49.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -57.87 -23.01 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 8.7100000000000009 111.236 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -42.1 -49.18 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 6.2300000000000004 111.819 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -110.47 -24.64 10.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.423 -0.353 . . . . 4.4699999999999998 110.934 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.243 -0.884 . . . . 7.79 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mmm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.796 0.332 . . . . 5.9699999999999998 111.261 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.79 6.98 73.97 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.975 -0.631 . . . . 4.3499999999999996 113.431 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.07 131.86 55.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.015 0.407 . . . . 4.8799999999999999 111.381 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 77' ' ' ASP . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 2.1699999999999999 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 5' ' ' VAL . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 2.3399999999999999 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.4700000000000002 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.45 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.96 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.4399999999999999 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.433 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 5.0800000000000001 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.448 HD11 ' CG1' ' A' ' 19' ' ' VAL . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.7000000000000002 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.98 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.98 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.79 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.8700000000000001 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.418 ' HG2' ' HB3' ' A' ' 70' ' ' TYR . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 2.0299999999999998 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.453 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 1.1399999999999999 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 2.0699999999999998 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 3.5800000000000001 111.583 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CZ3' HD11 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 1.1399999999999999 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.9199999999999999 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG12 ' CG1' ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 1.4099999999999999 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 2.3199999999999998 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.52000000000000002 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 32' ' ' VAL . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 1.0800000000000001 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.448 ' N ' HG23 ' A' ' 31' ' ' THR . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 1.0800000000000001 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.6000000000000001 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 3.2999999999999998 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 1.3799999999999999 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 ' HA ' HG12 ' A' ' 26' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 1.3700000000000001 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.8899999999999999 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HG3' ' CG2' ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.99 110.575 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 3.0299999999999998 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.2800000000000002 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 3.48 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5999999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.9700000000000002 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.441 ' CG2' ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.9299999999999999 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.6899999999999999 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.6899999999999999 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.6699999999999999 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.8799999999999999 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 4.0199999999999996 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.20999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.72 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' GLY . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.75 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 2.1299999999999999 112.693 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.502 HD11 ' CZ3' ' A' ' 24' ' ' TRP . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.8300000000000001 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.438 ' CG ' HD13 ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.6599999999999999 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.453 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.77 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' C ' ' HG ' ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.6499999999999999 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.418 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.8899999999999997 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 4.0599999999999996 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 2.0299999999999998 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 3.3300000000000001 111.593 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 1.0600000000000001 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 2.3799999999999999 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 1.1299999999999999 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 1.5800000000000001 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.5800000000000001 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.8599999999999999 110.494 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.4100000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.37 142.64 48.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 -26.0 24.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.696 0.284 . . . . 8.7100000000000009 111.558 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.14 -39.37 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 6.2300000000000004 111.557 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 -27.98 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 4.4699999999999998 111.355 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.227 -0.892 . . . . 7.79 111.012 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.7 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.785 0.326 . . . . 5.9699999999999998 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.24 18.96 4.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.639 -0.791 . . . . 4.3499999999999996 112.84 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 142.82 38.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 4.8799999999999999 110.769 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.416 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 2.1699999999999999 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG2' ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 2.3399999999999999 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.4700000000000002 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.45 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.96 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.4399999999999999 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 5.0800000000000001 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.443 HD11 ' CG1' ' A' ' 19' ' ' VAL . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.7000000000000002 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.98 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.98 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 12' ' ' ILE . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.79 111.552 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.8700000000000001 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 12' ' ' ILE . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 2.0299999999999998 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 1.1399999999999999 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.502 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 2.0699999999999998 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 3.5800000000000001 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 1.1399999999999999 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.9199999999999999 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.441 HG11 ' CG1' ' A' ' 32' ' ' VAL . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 1.4099999999999999 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 2.3199999999999998 111.351 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.52000000000000002 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 32' ' ' VAL . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 1.0800000000000001 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 1.0800000000000001 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.6000000000000001 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 3.2999999999999998 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 1.3799999999999999 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.44 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 1.3700000000000001 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.8899999999999999 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.443 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.99 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 3.0299999999999998 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 4.2800000000000002 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 3.48 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5999999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.443 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.9700000000000002 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.9299999999999999 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.6899999999999999 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.6899999999999999 109.726 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.6699999999999999 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.8799999999999999 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 4.0199999999999996 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.20999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.72 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.431 HG12 ' CG2' ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.75 113.905 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 2.1299999999999999 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD22 ' CH2' ' A' ' 24' ' ' TRP . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.8300000000000001 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' CD2' ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.6599999999999999 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.77 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.46 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.6499999999999999 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.8899999999999997 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.425 HG13 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 4.0599999999999996 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 2.0299999999999998 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 3.3300000000000001 111.343 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 1.0600000000000001 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 2.3799999999999999 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 ' CG2' HD21 ' A' ' 61' ' ' LEU . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 1.1299999999999999 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.431 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.5800000000000001 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.8599999999999999 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.4100000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.74 138.55 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.02 14.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 8.7100000000000009 111.211 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.44 -49.61 13.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 6.2300000000000004 111.487 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.04 8.44 3.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.524 -0.307 . . . . 4.4699999999999998 111.783 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 7.79 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.776 0.322 . . . . 5.9699999999999998 111.208 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.76 19.02 77.82 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.766 -0.731 . . . . 4.3499999999999996 112.74 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -98.02 153.18 18.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.856 0.36 . . . . 4.8799999999999999 111.045 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 2.1699999999999999 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 2.3399999999999999 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' O ' ' CD2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.4700000000000002 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.49 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.45 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.96 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.4399999999999999 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 5.0800000000000001 110.958 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.7000000000000002 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.98 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.98 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.79 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.8700000000000001 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' N ' ' HG2' ' A' ' 17' ' ' ARG . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.479 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 2.0299999999999998 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.438 HG21 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 1.1399999999999999 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG13 ' CD1' ' A' ' 24' ' ' TRP . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 2.0699999999999998 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 3.5800000000000001 111.074 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' HA ' HD21 ' A' ' 65' ' ' LEU . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 1.1399999999999999 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.9199999999999999 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 58' ' ' ILE . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 1.4099999999999999 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 2.3199999999999998 111.481 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.52000000000000002 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.417 HG21 ' N ' ' A' ' 32' ' ' VAL . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 1.0800000000000001 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG12 ' CD1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 1.0800000000000001 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.6000000000000001 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 3.2999999999999998 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 1.3799999999999999 110.228 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' O ' ' CE3' ' A' ' 24' ' ' TRP . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 1.3700000000000001 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.496 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.8899999999999999 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.99 111.216 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 3.0299999999999998 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 4.2800000000000002 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 3.48 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5999999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.9700000000000002 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.9299999999999999 110.49 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.49 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.6899999999999999 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.6899999999999999 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.6699999999999999 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.8799999999999999 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 4.0199999999999996 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.20999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.72 111.487 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.453 HG12 ' CG2' ' A' ' 78' ' ' ILE . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 1.0 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.75 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 2.1299999999999999 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.8300000000000001 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 23' ' ' GLU . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.6599999999999999 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.419 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 19' ' ' VAL . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.77 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.6499999999999999 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.4 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.8899999999999997 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 4.0599999999999996 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 2.0299999999999998 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 3.3300000000000001 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 1.0600000000000001 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 2.3799999999999999 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 1.1299999999999999 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 1.5800000000000001 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.5800000000000001 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.453 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.8599999999999999 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.4100000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.6 145.57 47.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -77.77 -21.51 51.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.014 -0.539 . . . . 8.7100000000000009 111.497 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -39.93 -49.39 2.44 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.549 0.574 . . . . 6.2300000000000004 112.549 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 -21.26 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.608 0.242 . . . . 4.4699999999999998 111.622 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 86' ' ' LEU . 10.1 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 7.79 111.359 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.745 0.307 . . . . 5.9699999999999998 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 14.7 7.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 4.3499999999999996 112.825 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -129.82 153.41 48.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 4.8799999999999999 110.851 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.435 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 2.1699999999999999 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 2.3399999999999999 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.48 ' HG3' ' CB ' ' A' ' 74' ' ' PRO . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.4700000000000002 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.45 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.96 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.4399999999999999 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 5.0800000000000001 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.7000000000000002 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.98 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.98 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.79 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.8700000000000001 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 2.0299999999999998 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 1.1399999999999999 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 2.0699999999999998 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 3.5800000000000001 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.489 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 1.1399999999999999 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.9199999999999999 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.473 ' CG1' ' CG1' ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 1.4099999999999999 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 2.3199999999999998 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.52000000000000002 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 1.0800000000000001 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' CG1' ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 1.0800000000000001 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.6000000000000001 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 3.2999999999999998 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 1.3799999999999999 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 1.3700000000000001 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.8899999999999999 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.99 111.246 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 3.0299999999999998 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' HD3' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 4.2800000000000002 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' CB ' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 3.48 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5999999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.9700000000000002 111.79 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.9299999999999999 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.6899999999999999 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.6899999999999999 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.6699999999999999 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.8799999999999999 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 4.0199999999999996 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.20999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.72 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLY . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.75 114.066 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 2.1299999999999999 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.473 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.8300000000000001 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.6599999999999999 112.41 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' CD1' HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.77 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.6499999999999999 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.8899999999999997 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 4.0599999999999996 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 2.0299999999999998 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 3.3300000000000001 110.866 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 1.0600000000000001 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 2.3799999999999999 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 1.1299999999999999 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 1.5800000000000001 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.5800000000000001 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.4 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.8599999999999999 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.4100000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.59 133.79 55.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.17 -22.78 67.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 8.7100000000000009 111.259 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.04 -49.18 8.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.405 -0.361 . . . . 6.2300000000000004 111.658 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 6' ' ' GLN . 1.2 mp -110.84 -21.79 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 4.4699999999999998 111.083 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.909 . . . . 7.79 111.015 -179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.749 0.309 . . . . 5.9699999999999998 111.297 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.99 -4.56 18.66 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.745 -0.741 . . . . 4.3499999999999996 113.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -105.67 153.34 21.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.0 0.4 . . . . 4.8799999999999999 110.925 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 2.1699999999999999 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 2.3399999999999999 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.545 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.4700000000000002 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.45 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.96 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.4399999999999999 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 5.0800000000000001 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.456 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.7000000000000002 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.98 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.98 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.79 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.8700000000000001 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 2.0299999999999998 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.451 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 1.1399999999999999 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.494 HG13 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 2.0699999999999998 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 3.5800000000000001 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.518 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 1.1399999999999999 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.9199999999999999 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 1.4099999999999999 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 2.3199999999999998 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.52000000000000002 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 1.0800000000000001 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG22 ' CG1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 1.0800000000000001 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.6000000000000001 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 3.2999999999999998 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 1.3799999999999999 110.27 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 ' HA ' ' CG2' ' A' ' 26' ' ' VAL . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.472 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.8899999999999999 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.99 111.493 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 3.0299999999999998 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 4.2800000000000002 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 3.48 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5999999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.9700000000000002 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.9299999999999999 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.6899999999999999 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.415 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.6899999999999999 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.6699999999999999 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.8799999999999999 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 4.0199999999999996 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.20999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.72 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.497 ' CD1' ' CG2' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.75 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 2.1299999999999999 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 ' CD1' ' CZ3' ' A' ' 24' ' ' TRP . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.8300000000000001 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.6599999999999999 112.901 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.451 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.77 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.6499999999999999 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.481 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.8899999999999997 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 4.0599999999999996 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 2.0299999999999998 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 3.3300000000000001 111.924 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.545 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 1.0600000000000001 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 2.3799999999999999 110.809 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' CG2' ' CD2' ' A' ' 61' ' ' LEU . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 1.1299999999999999 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 1.5800000000000001 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.5800000000000001 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.8599999999999999 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.4100000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp -123.27 135.01 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.16 -22.92 18.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 8.7100000000000009 111.226 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -49.39 61.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 6.2300000000000004 111.263 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -28.15 6.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.513 -0.312 . . . . 4.4699999999999998 111.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.932 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.86 0.362 . . . . 5.9699999999999998 111.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.59 4.64 81.43 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.065 -0.516 . . . . 4.3499999999999996 113.597 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -91.1 152.02 20.78 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 122.563 -0.375 . . . . 4.8799999999999999 111.194 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 2.1699999999999999 111.008 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 2.3399999999999999 108.019 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.4700000000000002 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.45 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.96 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 69' ' ' ALA . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 5.0800000000000001 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' CD1' HD12 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.7000000000000002 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.98 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.98 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.79 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.8700000000000001 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 68' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' A' ' 12' ' ' ILE . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 2.0299999999999998 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 1.1399999999999999 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 HG12 ' NE1' ' A' ' 24' ' ' TRP . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 2.0699999999999998 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 3.5800000000000001 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.494 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 1.1399999999999999 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.9199999999999999 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 1.4099999999999999 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 2.3199999999999998 111.005 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.52000000000000002 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 1.0800000000000001 110.498 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG13 ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 1.0800000000000001 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.6000000000000001 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 3.2999999999999998 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 1.3799999999999999 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.459 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 1.3700000000000001 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.8899999999999999 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG23 ' HB ' ' A' ' 48' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.99 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 3.0299999999999998 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 4.2800000000000002 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 3.48 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5999999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' HB ' HG23 ' A' ' 41' ' ' VAL . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.9700000000000002 111.825 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.9299999999999999 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.6899999999999999 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.6899999999999999 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.6699999999999999 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.8799999999999999 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 4.0199999999999996 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.20999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.72 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.437 ' CD1' ' HB ' ' A' ' 26' ' ' VAL . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.75 113.528 -176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 2.1299999999999999 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD22 ' CH2' ' A' ' 24' ' ' TRP . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.8300000000000001 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.6599999999999999 112.504 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 18' ' ' GLU . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.77 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.468 ' HB3' ' CD2' ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.6499999999999999 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.8899999999999997 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 4.0599999999999996 110.942 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 2.0299999999999998 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 3.3300000000000001 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 1.0600000000000001 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 2.3799999999999999 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' CG2' HD21 ' A' ' 61' ' ' LEU . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 1.1299999999999999 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 1.5800000000000001 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.44 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.5800000000000001 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.8599999999999999 110.253 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.4100000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.81 135.47 54.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -49.87 -43.6 49.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.949 0.722 . . . . 8.7100000000000009 112.949 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.58 -47.38 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.491 0.552 . . . . 6.2300000000000004 112.491 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.54 -23.71 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.798 -0.361 . . . . 4.4699999999999998 111.828 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.556 -0.735 . . . . 7.79 110.761 179.453 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.856 0.36 . . . . 5.9699999999999998 111.113 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.54 18.94 5.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 4.3499999999999996 112.6 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.2 153.14 48.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 4.8799999999999999 110.792 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' CG ' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 2.1699999999999999 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 78' ' ' ILE . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 2.3399999999999999 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.4700000000000002 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.45 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.96 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.4399999999999999 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 5.0800000000000001 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.7000000000000002 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' CD1' ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.98 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.98 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.79 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.8700000000000001 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HB2' HG23 ' A' ' 68' ' ' ILE . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.497 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 2.0299999999999998 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 2.0699999999999998 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 3.5800000000000001 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 1.1399999999999999 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.9199999999999999 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 1.4099999999999999 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' HA ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.3199999999999998 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.52000000000000002 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 1.0800000000000001 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 1.0800000000000001 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.6000000000000001 110.245 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 3.2999999999999998 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 1.3799999999999999 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 1.3700000000000001 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.488 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.8899999999999999 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.99 111.476 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 3.0299999999999998 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 4.2800000000000002 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 3.48 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5999999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.9700000000000002 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.9299999999999999 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.6899999999999999 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.6899999999999999 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.6699999999999999 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.8799999999999999 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 4.0199999999999996 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.20999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.72 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.47 HG12 ' CG2' ' A' ' 78' ' ' ILE . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 1.0 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.75 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 2.1299999999999999 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.497 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.8300000000000001 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.6599999999999999 112.194 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 18' ' ' GLU . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.77 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.6499999999999999 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.8899999999999997 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' CG2' HD12 ' A' ' 9' ' ' LEU . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 4.0599999999999996 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 2.0299999999999998 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 3.3300000000000001 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 1.0600000000000001 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HG ' ' CD1' ' A' ' 63' ' ' TYR . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 2.3799999999999999 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 1.1299999999999999 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.47 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 1.5800000000000001 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.5800000000000001 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.8599999999999999 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.4100000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -114.24 133.68 55.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -54.86 -22.73 15.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 8.7100000000000009 111.173 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.2 -46.12 5.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.476 -0.329 . . . . 6.2300000000000004 111.573 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.65 -25.53 11.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 4.4699999999999998 110.915 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.27 -0.872 . . . . 7.79 110.928 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 5.9699999999999998 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.71 -6.94 26.0 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.797 -0.716 . . . . 4.3499999999999996 112.922 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -86.37 140.53 29.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.779 0.323 . . . . 4.8799999999999999 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.476 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 2.1699999999999999 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 2.3399999999999999 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.443 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.4700000000000002 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.45 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.96 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.4399999999999999 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 5.0800000000000001 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 HD11 ' CD1' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.7000000000000002 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.98 112.651 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.98 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.445 HD13 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.79 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.8700000000000001 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CE2' ' A' ' 70' ' ' TYR . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 2.0299999999999998 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 1.1399999999999999 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.521 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 2.0699999999999998 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 3.5800000000000001 110.9 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 1.1399999999999999 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.421 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.9199999999999999 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 1.4099999999999999 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 2.3199999999999998 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.52000000000000002 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.425 HG21 ' N ' ' A' ' 32' ' ' VAL . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 1.0800000000000001 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 1.0800000000000001 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.6000000000000001 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 3.2999999999999998 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 1.3799999999999999 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 1.3700000000000001 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.8899999999999999 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.99 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 3.0299999999999998 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 4.2800000000000002 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 3.48 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5999999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.9700000000000002 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.9299999999999999 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.6899999999999999 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.6899999999999999 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.6699999999999999 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.8799999999999999 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 4.0199999999999996 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.20999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.72 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.479 HG22 HD13 ' A' ' 58' ' ' ILE . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.75 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' CE ' ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 2.1299999999999999 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.524 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.8300000000000001 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.493 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.6599999999999999 112.213 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.449 ' OD2' ' N ' ' A' ' 64' ' ' ASN . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 69' ' ' ALA . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.77 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.6499999999999999 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.8899999999999997 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 4.0599999999999996 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 2.0299999999999998 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 3.3300000000000001 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 1.0600000000000001 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 2.3799999999999999 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 7' ' ' PHE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 1.1299999999999999 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' OD1' ' CG ' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.5800000000000001 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.5800000000000001 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.8599999999999999 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.4100000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.55 134.19 53.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -22.92 9.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 8.7100000000000009 111.061 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.73 -49.41 10.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.36 -0.382 . . . . 6.2300000000000004 111.567 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.85 -28.32 5.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.512 -0.313 . . . . 4.4699999999999998 111.289 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.269 -0.872 . . . . 7.79 110.902 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.831 0.348 . . . . 5.9699999999999998 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 19.13 11.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 4.3499999999999996 112.639 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -139.64 142.03 37.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 4.8799999999999999 110.863 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 2.1699999999999999 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 2.3399999999999999 108.839 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.4700000000000002 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.484 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.45 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.96 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.4399999999999999 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 5.0800000000000001 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.444 ' CG2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.7000000000000002 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.98 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HG3' ' CG1' ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.98 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.79 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.8700000000000001 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' CB ' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 2.0299999999999998 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 ' CG1' ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 2.0699999999999998 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 3.5800000000000001 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.524 ' CD1' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 1.1399999999999999 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.9199999999999999 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG13 ' CG1' ' A' ' 32' ' ' VAL . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 1.4099999999999999 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 30' ' ' ASP . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 2.3199999999999998 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.52000000000000002 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 1.0800000000000001 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.453 ' CG1' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 1.0800000000000001 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.6000000000000001 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 3.2999999999999998 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 1.3799999999999999 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 38' ' ' ILE . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 1.3700000000000001 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.8899999999999999 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' LYS . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.99 111.056 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' NE2' ' HG2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 3.0299999999999998 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 4.2800000000000002 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 3.48 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5999999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.9700000000000002 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.9299999999999999 109.733 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.484 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.6899999999999999 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.6899999999999999 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.6699999999999999 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.8799999999999999 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 4.0199999999999996 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.453 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.20999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.72 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 78' ' ' ILE . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.75 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 2.1299999999999999 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.8300000000000001 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.6599999999999999 112.089 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.77 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.6499999999999999 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.8899999999999997 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' CG1' ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 4.0599999999999996 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 2.0299999999999998 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 3.3300000000000001 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 8' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 1.0600000000000001 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 2.3799999999999999 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 75' ' ' LEU . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 1.1299999999999999 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 1.5800000000000001 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.461 ' HG2' ' CG1' ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.5800000000000001 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.8599999999999999 111.104 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.4100000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.56 135.27 53.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -61.02 -22.66 64.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 8.7100000000000009 111.154 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.86 -46.32 3.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.34 -0.391 . . . . 6.2300000000000004 111.737 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 tp -104.13 -27.87 11.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 4.4699999999999998 111.045 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.914 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.836 0.351 . . . . 5.9699999999999998 111.242 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.67 -7.2 22.27 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.717 -0.754 . . . . 4.3499999999999996 112.973 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -93.75 153.24 18.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.821 0.31 . . . . 4.8799999999999999 110.815 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.412 ' CG1' ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 2.1699999999999999 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 2.3399999999999999 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.436 ' HG3' ' CB ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.4700000000000002 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.47 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.45 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.96 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.459 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.4399999999999999 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 5.0800000000000001 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.48 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.7000000000000002 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.98 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.98 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.79 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.8700000000000001 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 2.0299999999999998 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.441 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 1.1399999999999999 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 HG11 ' NE1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 2.0699999999999998 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 3.5800000000000001 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 1.1399999999999999 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.9199999999999999 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 1.4099999999999999 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 2.3199999999999998 111.006 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' N ' HD13 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.52000000000000002 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 1.0800000000000001 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' CD1' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 1.0800000000000001 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.6000000000000001 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 3.2999999999999998 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 1.3799999999999999 110.55 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.452 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 1.3700000000000001 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.8899999999999999 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.99 111.725 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 3.0299999999999998 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 4.2800000000000002 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 3.48 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5999999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.9700000000000002 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.9299999999999999 110.536 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.47 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.6899999999999999 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.6899999999999999 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.6699999999999999 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.8799999999999999 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 4.0199999999999996 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' CG2' ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.20999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.72 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.75 113.973 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 2.1299999999999999 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.8300000000000001 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.6599999999999999 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.77 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.6499999999999999 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.8899999999999997 110.219 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 4.0599999999999996 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 2.0299999999999998 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' NZ ' ' O ' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 3.3300000000000001 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' O ' ' NZ ' ' A' ' 73' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 1.0600000000000001 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 2.3799999999999999 111.275 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 1.1299999999999999 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' HB2' ' HE3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 1.5800000000000001 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.5800000000000001 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.8599999999999999 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.4100000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.57 142.49 50.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -22.39 50.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 8.7100000000000009 111.299 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.27 -49.45 0.95 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.221 0.452 . . . . 6.2300000000000004 112.221 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 mt -121.04 -28.08 4.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.402 -0.363 . . . . 4.4699999999999998 111.64 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.285 -0.864 . . . . 7.79 110.853 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.858 0.361 . . . . 5.9699999999999998 111.097 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.13 27.12 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.722 -0.751 . . . . 4.3499999999999996 112.705 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -128.08 153.61 46.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.791 0.329 . . . . 4.8799999999999999 110.986 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.456 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 2.1699999999999999 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 2.3399999999999999 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 2.8 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.4700000000000002 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CE1' ' SG ' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.45 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.96 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.4399999999999999 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 5.0800000000000001 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.7000000000000002 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.98 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.98 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.435 ' CD1' ' HB ' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.79 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.8700000000000001 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CB ' HG23 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' CD2' ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 2.0299999999999998 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.438 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 1.1399999999999999 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.475 ' CG1' ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 2.0699999999999998 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 3.5800000000000001 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.535 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 1.1399999999999999 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.9199999999999999 111.555 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 1.4099999999999999 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 2.3199999999999998 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.52000000000000002 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 1.0800000000000001 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' CG1' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 1.0800000000000001 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.6000000000000001 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 3.2999999999999998 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 1.3799999999999999 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.446 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 1.3700000000000001 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.498 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.8899999999999999 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.99 111.424 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 3.0299999999999998 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 4.2800000000000002 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 3.48 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5999999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.9700000000000002 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.9299999999999999 110.582 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.6899999999999999 111.541 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.6899999999999999 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.6699999999999999 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.8799999999999999 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 4.0199999999999996 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.20999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.72 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.486 HG12 ' CG2' ' A' ' 78' ' ' ILE . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.75 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 2.1299999999999999 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.8300000000000001 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.437 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.6599999999999999 112.365 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.427 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.438 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.77 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.473 ' HA ' ' CE2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.6499999999999999 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.8899999999999997 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 9' ' ' LEU . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 4.0599999999999996 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 2.0299999999999998 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 3.3300000000000001 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 1.0600000000000001 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 2.3799999999999999 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 7' ' ' PHE . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 1.1299999999999999 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 5' ' ' VAL . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 1.5800000000000001 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.5800000000000001 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.8599999999999999 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.4100000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -104.9 146.7 28.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -17.83 -48.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.341 1.608 . . . . 8.7100000000000009 115.341 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.44 -57.71 2.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.167 -1.013 . . . . 6.2300000000000004 113.718 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.5 tp -141.13 -31.73 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.867 0.691 . . . . 4.4699999999999998 112.867 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.432 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.2 -0.905 . . . . 7.79 110.402 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.349 . . . . 5.9699999999999998 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.01 6.39 10.1 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.804 -0.712 . . . . 4.3499999999999996 112.939 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.18 146.98 30.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.934 0.367 . . . . 4.8799999999999999 110.472 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.43 ' CG1' ' HG2' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 2.1699999999999999 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 2.3399999999999999 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.4700000000000002 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CE1' HD11 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.45 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 74' ' ' PRO . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.96 112.47 -177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.4399999999999999 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 5.0800000000000001 112.1 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' HG23 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.474 ' CG2' ' N ' ' A' ' 13' ' ' GLY . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.7000000000000002 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.98 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.98 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 ' CG1' HG21 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.79 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.8700000000000001 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.417 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HD12 ' A' ' 12' ' ' ILE . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 2.0299999999999998 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.45 HG22 ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 1.1399999999999999 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.471 HG11 ' CE2' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 2.0699999999999998 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 3.5800000000000001 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.557 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 1.1399999999999999 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.9199999999999999 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' CG2' ' CD1' ' A' ' 58' ' ' ILE . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 1.4099999999999999 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 2.3199999999999998 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.52000000000000002 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 1.0800000000000001 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.467 ' CG1' ' CG1' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 1.0800000000000001 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.6000000000000001 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 3.2999999999999998 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 1.3799999999999999 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.431 HG12 ' CG1' ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 1.3700000000000001 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.8899999999999999 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 48' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.99 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 3.0299999999999998 111.038 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 4.2800000000000002 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 3.48 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5999999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.9700000000000002 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.9299999999999999 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.6899999999999999 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.6899999999999999 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.6699999999999999 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.8799999999999999 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 4.0199999999999996 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.20999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.75 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 2.1299999999999999 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.557 ' CD2' ' CH2' ' A' ' 24' ' ' TRP . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.8300000000000001 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.6599999999999999 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 ' CD1' HG22 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.77 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.438 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.6499999999999999 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.406 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.8899999999999997 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 4.0599999999999996 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 2.0299999999999998 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 3.3300000000000001 111.421 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 1.0600000000000001 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 2.3799999999999999 111.451 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLN . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 1.1299999999999999 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.454 ' CG2' HG12 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.5800000000000001 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.5800000000000001 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.8599999999999999 110.657 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.4100000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.71 145.38 44.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -65.61 -21.7 66.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 8.7100000000000009 111.598 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -30.02 -49.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.929 0.714 . . . . 6.2300000000000004 112.929 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -27.75 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 4.4699999999999998 110.859 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.174 -0.917 . . . . 7.79 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.677 0.275 . . . . 5.9699999999999998 111.348 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.55 58.09 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.667 -0.778 . . . . 4.3499999999999996 113.07 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -86.85 153.3 21.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.847 0.356 . . . . 4.8799999999999999 111.023 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.471 ' CG1' ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 2.1699999999999999 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 2.3399999999999999 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.4700000000000002 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 50' ' ' ILE . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.45 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.96 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HB2' ' CB ' ' A' ' 69' ' ' ALA . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.4399999999999999 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 5.0800000000000001 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.7000000000000002 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.98 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.98 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.44 HD12 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.79 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.8700000000000001 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 68' ' ' ILE . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 2.0299999999999998 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.446 ' OG1' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 1.1399999999999999 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 24' ' ' TRP . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 2.0699999999999998 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 3.5800000000000001 111.322 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.526 ' CZ3' ' CD2' ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 1.1399999999999999 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.9199999999999999 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 38' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 1.4099999999999999 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 2.3199999999999998 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.52000000000000002 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.437 HG22 ' N ' ' A' ' 32' ' ' VAL . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 31' ' ' THR . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 1.0800000000000001 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.6000000000000001 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 3.2999999999999998 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 1.3799999999999999 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 ' HA ' ' CG1' ' A' ' 26' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 1.3700000000000001 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.502 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.8899999999999999 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.99 110.954 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 3.0299999999999998 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 4.2800000000000002 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 3.48 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5999999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.9700000000000002 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.9299999999999999 110.246 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 7' ' ' PHE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.6899999999999999 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.6899999999999999 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.6699999999999999 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.8799999999999999 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 4.0199999999999996 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.20999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.72 111.633 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' CG2' ' A' ' 78' ' ' ILE . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.75 113.425 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 2.1299999999999999 113.361 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.8300000000000001 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.6599999999999999 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' CD1' ' OG1' ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.77 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.6499999999999999 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.425 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.8899999999999997 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 4.0599999999999996 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 2.0299999999999998 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 3.3300000000000001 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 8' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 1.0600000000000001 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 2.3799999999999999 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 75' ' ' LEU . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 1.1299999999999999 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.448 ' CG2' HG12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 1.5800000000000001 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.471 ' CG ' ' CG1' ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.5800000000000001 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.8599999999999999 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.4100000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.6 tp -105.62 147.99 27.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -17.55 -47.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.264 1.579 . . . . 8.7100000000000009 115.264 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 83' ' ' LEU . 72.6 m-20 -108.7 -57.06 2.19 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.383 -0.927 . . . . 6.2300000000000004 113.257 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.0 tp -141.25 -31.3 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.014 0.746 . . . . 4.4699999999999998 113.014 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB3' HG22 ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.85 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.842 0.353 . . . . 4.4699999999999998 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 1.79 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.2599999999999998 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.29 109.17 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.4199999999999999 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.969 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.2400000000000002 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.432 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 4.4900000000000002 111.788 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.854 ' OD2' HG21 ' A' ' 41' ' ' VAL . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.871 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.29 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.8399999999999999 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.8100000000000001 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.871 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.54 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.83 ' HG2' HD12 ' A' ' 16' ' ' ILE . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.4000000000000004 110.94 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.969 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 1.51 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.718 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 0.68999999999999995 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.848 HG11 ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.3899999999999999 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 2.9500000000000002 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.848 ' CD1' HG11 ' A' ' 21' ' ' VAL . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 0.82999999999999996 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' C ' HG13 ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.72 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 38' ' ' ILE . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 1.8899999999999999 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 61' ' ' LEU . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.45000000000000001 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.31 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.4199999999999999 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 2.52 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 32' ' ' VAL . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.46999999999999997 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.29 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' OD2' ' A' ' 11' ' ' ASP . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.3500000000000001 110.537 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' SER . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 2.6000000000000001 111.411 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 3.6499999999999999 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 2.8300000000000001 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5199999999999996 110.445 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.768 HG21 ' OD1' ' A' ' 11' ' ' ASP . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.5 111.494 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.46 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 39' ' ' CYS . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.01 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.207 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.3600000000000001 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.2300000000000004 111.006 -178.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 3.8799999999999999 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' THR . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.17999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.1100000000000001 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 0.38 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.1400000000000001 113.671 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 1.3500000000000001 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.1399999999999999 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.0600000000000001 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.3799999999999999 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.1600000000000001 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 3.6099999999999999 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 1.8700000000000001 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 2.96 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 0.91000000000000003 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 1.8400000000000001 111.979 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 60' ' ' LYS . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 0.46999999999999997 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.85999999999999999 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.74 ' HG3' HG12 ' A' ' 4' ' ' VAL . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.443 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.3900000000000001 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.1000000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.026 0.441 . . . . 4.4699999999999998 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.781 HG12 ' CG ' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 1.5700000000000001 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 1.79 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.2599999999999998 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.29 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.4199999999999999 111.313 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.052 HD12 HG23 ' A' ' 71' ' ' VAL . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.2400000000000002 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 4.4900000000000002 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.682 ' C ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.29 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.8399999999999999 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.8100000000000001 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.54 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.4000000000000004 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.848 HG12 HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 1.51 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.792 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 0.68999999999999995 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 1.3899999999999999 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 2.9500000000000002 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.858 ' CD1' HG11 ' A' ' 21' ' ' VAL . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.82999999999999996 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.72 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 0.5 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 1.8899999999999999 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.45000000000000001 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 0.31 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.28000000000000003 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.4199999999999999 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 2.52 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 32' ' ' VAL . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 0.46999999999999997 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.29 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.3500000000000001 111.565 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 2.6000000000000001 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 3.6499999999999999 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 2.8300000000000001 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5199999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' SER . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.5 111.981 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.46 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.01 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.04 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.3600000000000001 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.2300000000000004 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 3.8799999999999999 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 31' ' ' THR . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.17999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.1100000000000001 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.734 HD13 HG21 ' A' ' 26' ' ' VAL . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 0.38 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.1400000000000001 113.75 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 1.3500000000000001 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD22 ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.1399999999999999 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 24' ' ' TRP . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.0600000000000001 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 20' ' ' THR . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.3799999999999999 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 1.043 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.1600000000000001 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.6500000000000004 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.052 HG23 HD12 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 3.6099999999999999 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 1.8700000000000001 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 2.96 111.545 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 0.91000000000000003 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 0.46999999999999997 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.641 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.781 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.3899999999999999 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.1000000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.728 0.299 . . . . 4.4699999999999998 110.73 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.887 HG12 ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' ILE . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 1.79 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.2599999999999998 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.602 ' CE2' HD21 ' A' ' 75' ' ' LEU . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.29 109.732 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.4199999999999999 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.2400000000000002 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 4.4900000000000002 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 12' ' ' ILE . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.29 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.8399999999999999 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.8100000000000001 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.54 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.543 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.4000000000000004 109.934 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 1.51 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 0.68999999999999995 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 41' ' ' VAL . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 1.3899999999999999 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 65' ' ' LEU . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 2.9500000000000002 111.346 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.777 ' CD1' HG11 ' A' ' 21' ' ' VAL . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 0.82999999999999996 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.72 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG23 ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 0.5 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 1.8899999999999999 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.45000000000000001 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.31 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 0.28000000000000003 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.4199999999999999 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 2.52 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 0.93999999999999995 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.893 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 0.46999999999999997 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.29 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 21' ' ' VAL . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.3500000000000001 110.518 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 2.6000000000000001 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 3.6499999999999999 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 2.8300000000000001 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5199999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' ASP . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.5 111.664 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.46 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.01 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.04 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.3600000000000001 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 3.8799999999999999 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.17999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 31' ' ' THR . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.1100000000000001 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' A' ' 26' ' ' VAL . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.1400000000000001 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.1399999999999999 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.0600000000000001 112.567 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.3799999999999999 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.1600000000000001 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.6500000000000004 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.889 HG22 HD12 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 3.6099999999999999 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 1.8700000000000001 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 2.96 111.292 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 0.91000000000000003 111.892 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 1.8400000000000001 111.89 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 HD11 ' A' ' 78' ' ' ILE . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 0.46999999999999997 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.721 HD11 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.85999999999999999 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.887 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.3899999999999999 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.495 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.3900000000000001 110.581 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.1000000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.816 0.341 . . . . 4.4699999999999998 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.782 HG12 ' CG ' ' A' ' 79' ' ' GLU . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 1.79 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.2599999999999998 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.632 ' CE2' HD21 ' A' ' 75' ' ' LEU . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.29 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.4199999999999999 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 12' ' ' ILE . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 4.4900000000000002 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.29 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.8399999999999999 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.8100000000000001 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.54 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.4000000000000004 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.023 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 1.51 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.819 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 0.68999999999999995 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 2.9500000000000002 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CD1' HG11 ' A' ' 21' ' ' VAL . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.421 ' C ' HG13 ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.72 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 0.5 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 1.8899999999999999 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.45000000000000001 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 0.31 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.28000000000000003 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.4199999999999999 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 2.52 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.93999999999999995 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 0.46999999999999997 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.29 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.3500000000000001 111.023 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 2.6000000000000001 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 3.6499999999999999 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 2.8300000000000001 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.5 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.46 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.509 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.01 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.3600000000000001 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.2300000000000004 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 3.8799999999999999 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.17999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.1100000000000001 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 26' ' ' VAL . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 0.38 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.1400000000000001 113.739 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 112.707 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.1399999999999999 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.0600000000000001 112.184 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.819 HD13 HG23 ' A' ' 20' ' ' THR . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.3799999999999999 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.629 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.1600000000000001 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.6500000000000004 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.662 HG22 HD12 ' A' ' 9' ' ' LEU . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 3.6099999999999999 110.934 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 1.8700000000000001 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 2.96 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 0.91000000000000003 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.632 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 1.8400000000000001 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' LYS . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 0.46999999999999997 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 76' ' ' VAL . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.85999999999999999 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.782 ' CG ' HG12 ' A' ' 4' ' ' VAL . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.3899999999999999 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.1000000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.027 0.441 . . . . 4.4699999999999998 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 1.5700000000000001 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 1.79 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.2599999999999998 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.542 ' CE1' HD11 ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.29 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.4199999999999999 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.019 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.2400000000000002 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 4.4900000000000002 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.872 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.29 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.8399999999999999 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.8100000000000001 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.872 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.54 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.4000000000000004 110.632 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.019 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 1.51 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 0.68999999999999995 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' CD1' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 1.3899999999999999 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 2.9500000000000002 111.375 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.812 ' CD1' HG11 ' A' ' 21' ' ' VAL . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.82999999999999996 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.72 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG21 HG23 ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.5 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.8899999999999999 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' N ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.45000000000000001 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.31 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.4199999999999999 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 2.52 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.93999999999999995 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 32' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 0.46999999999999997 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.29 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 21' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.3500000000000001 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 2.6000000000000001 111.279 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 3.6499999999999999 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 2.8300000000000001 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5199999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.5 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.46 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.542 HD11 ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.01 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.2300000000000004 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 3.8799999999999999 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.17999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.1100000000000001 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 26' ' ' VAL . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 0.38 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.687 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 1.3500000000000001 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.1399999999999999 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.0600000000000001 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.3799999999999999 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.1600000000000001 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.6500000000000004 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 3.6099999999999999 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 1.8700000000000001 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 2.96 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.91000000000000003 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 0.46999999999999997 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 0.85999999999999999 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.902 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.3899999999999999 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.3900000000000001 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.1000000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 27.6 mt-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 4.4699999999999998 111.02 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' OG1' ' A' ' 80' ' ' THR . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 1.79 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.2599999999999998 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.29 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.027 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.2400000000000002 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' ILE . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.947 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.29 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.8399999999999999 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.8100000000000001 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.823 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.54 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 16' ' ' ILE . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.4000000000000004 110.572 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.027 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 1.51 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.906 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 0.68999999999999995 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.3899999999999999 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 2.9500000000000002 111.508 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.753 ' CD1' HG11 ' A' ' 21' ' ' VAL . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 0.82999999999999996 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.72 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.947 HG21 HG23 ' A' ' 38' ' ' ILE . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.5 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 1.8899999999999999 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.31 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.906 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 0.28000000000000003 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.4199999999999999 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 2.52 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.93999999999999995 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.947 HG23 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.46999999999999997 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.29 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.3500000000000001 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 2.6000000000000001 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 3.6499999999999999 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 2.8300000000000001 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.439 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5199999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.5 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.46 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.01 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.04 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.3600000000000001 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.2300000000000004 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 3.8799999999999999 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.1100000000000001 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.556 HD11 HG13 ' A' ' 32' ' ' VAL . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 0.38 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.1400000000000001 114.006 -176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 1.3500000000000001 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.1399999999999999 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.462 ' CD1' HD13 ' A' ' 75' ' ' LEU . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.0600000000000001 112.225 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 20' ' ' THR . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.906 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.3799999999999999 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.6500000000000004 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 3.6099999999999999 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 1.8700000000000001 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 2.96 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 0.91000000000000003 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 1.8400000000000001 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 78' ' ' ILE . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 0.46999999999999997 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.85999999999999999 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.3899999999999999 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.605 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.3900000000000001 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.1000000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 81' ' ' GLU . 3.4 mp . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.831 0.348 . . . . 4.4699999999999998 111.141 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.56 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 1.5700000000000001 111.723 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 1.79 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.2599999999999998 112.606 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.4199999999999999 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.0 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.2400000000000002 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 4.4900000000000002 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.703 ' CG ' HD13 ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.946 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.29 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.8399999999999999 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.8100000000000001 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.946 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.54 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.4000000000000004 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.0 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 1.51 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.939 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 0.68999999999999995 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 1.3899999999999999 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 2.9500000000000002 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.753 ' NE1' HG11 ' A' ' 21' ' ' VAL . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 0.82999999999999996 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.72 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.83 HG23 HD11 ' A' ' 61' ' ' LEU . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.5 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 111.226 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.45000000000000001 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.31 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.728 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 2.52 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.93999999999999995 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.772 HG23 HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.46999999999999997 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.29 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 21' ' ' VAL . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.3500000000000001 111.132 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 2.6000000000000001 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8300000000000001 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5199999999999996 110.608 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.5 111.284 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.46 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.01 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.04 110.545 179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.3600000000000001 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.2300000000000004 111.077 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 3.8799999999999999 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.17999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.1100000000000001 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.683 ' CG1' HG23 ' A' ' 78' ' ' ILE . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 0.38 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.1400000000000001 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 1.3500000000000001 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 26' ' ' VAL . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.1399999999999999 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 24' ' ' TRP . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.0600000000000001 112.433 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' THR . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.939 HD13 HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.3799999999999999 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.1600000000000001 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.6500000000000004 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 3.6099999999999999 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 1.8700000000000001 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 2.96 111.451 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 0.91000000000000003 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 1.8400000000000001 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 0.46999999999999997 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.694 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 0.85999999999999999 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.56 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.3899999999999999 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.3900000000000001 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.831 0.348 . . . . 4.4699999999999998 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 79' ' ' GLU . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.5700000000000001 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' A' ' 80' ' ' THR . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 1.79 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.2599999999999998 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.29 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.4199999999999999 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.07 HD11 HD13 ' A' ' 12' ' ' ILE . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.2400000000000002 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.651 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 4.4900000000000002 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.07 HD13 HD11 ' A' ' 9' ' ' LEU . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.29 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.8399999999999999 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.8100000000000001 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.54 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.4000000000000004 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB3' HG22 ' A' ' 68' ' ' ILE . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.026 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 1.51 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 0.68999999999999995 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.677 HG11 ' NE1' ' A' ' 24' ' ' TRP . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 1.3899999999999999 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 2.9500000000000002 111.583 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.859 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.82999999999999996 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.72 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.919 HG11 HG13 ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.5 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.45000000000000001 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.31 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 0.28000000000000003 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.4199999999999999 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 2.52 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 0.93999999999999995 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 32' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 0.46999999999999997 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.29 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 21' ' ' VAL . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.3500000000000001 110.575 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 2.6000000000000001 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 3.6499999999999999 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 2.8300000000000001 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5199999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.5 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.46 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.01 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.04 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.2300000000000004 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 3.8799999999999999 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.17999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.1100000000000001 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 26' ' ' VAL . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 0.38 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.1400000000000001 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 1.3500000000000001 112.693 -178.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 27' ' ' LYS . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.1399999999999999 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.0600000000000001 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.874 HD13 HG23 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.3799999999999999 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.1600000000000001 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.6500000000000004 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 3.6099999999999999 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 1.8700000000000001 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 74' ' ' PRO . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 2.96 111.593 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 0.91000000000000003 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 1.8400000000000001 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 78' ' ' ILE . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.46999999999999997 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.671 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.85999999999999999 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.864 ' HG2' HG12 ' A' ' 4' ' ' VAL . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.3899999999999999 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.3900000000000001 110.494 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.1000000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.768 0.318 . . . . 4.4699999999999998 110.769 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.91 HG12 ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 1.5700000000000001 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG21 ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 1.79 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.2599999999999998 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.29 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.4199999999999999 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.134 HD11 HD13 ' A' ' 12' ' ' ILE . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.2400000000000002 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 4.4900000000000002 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.134 HD13 HD11 ' A' ' 9' ' ' LEU . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.29 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.8399999999999999 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.8100000000000001 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.54 111.552 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.4000000000000004 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 68' ' ' ILE . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.93 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 1.51 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.716 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 0.68999999999999995 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.811 HG11 ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 1.3899999999999999 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.588 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 2.9500000000000002 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CD1' HG11 ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.82999999999999996 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' C ' HG13 ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.72 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 38' ' ' ILE . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 0.5 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 61' ' ' LEU . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 1.8899999999999999 111.351 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.31 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.876 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.28000000000000003 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.4199999999999999 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 2.52 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.93999999999999995 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 0.46999999999999997 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.29 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 21' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.3500000000000001 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 2.6000000000000001 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 3.6499999999999999 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 2.8300000000000001 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.5 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.46 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.01 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.04 109.726 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.583 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.3600000000000001 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.2300000000000004 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 3.8799999999999999 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' THR . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.17999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.1100000000000001 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.559 ' CG1' HG23 ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.1400000000000001 113.905 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 1.3500000000000001 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.889 HD11 HG23 ' A' ' 26' ' ' VAL . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.1399999999999999 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.0600000000000001 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.1600000000000001 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.6500000000000004 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG11 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 3.6099999999999999 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 1.8700000000000001 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 2.96 111.343 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 0.91000000000000003 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 1.8400000000000001 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG13 HD11 ' A' ' 78' ' ' ILE . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 0.46999999999999997 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 0.85999999999999999 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.91 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.3899999999999999 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.498 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.3900000000000001 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 83' ' ' LEU . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.792 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.5700000000000001 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 1.79 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.2599999999999998 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.29 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.4199999999999999 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.2400000000000002 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 4.4900000000000002 110.958 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' HB3' HD13 ' A' ' 12' ' ' ILE . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.932 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.29 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.8399999999999999 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.8100000000000001 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.72 HD11 ' CG2' ' A' ' 12' ' ' ILE . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.54 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.4000000000000004 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 68' ' ' ILE . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 1.51 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.807 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 0.68999999999999995 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 41' ' ' VAL . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 1.3899999999999999 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.639 ' O ' HD23 ' A' ' 65' ' ' LEU . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 2.9500000000000002 111.074 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 0.82999999999999996 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.72 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 32' ' ' VAL . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 0.5 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 1.8899999999999999 111.481 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.45000000000000001 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.31 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 0.28000000000000003 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.4199999999999999 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 2.52 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.93999999999999995 110.228 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG12 HG11 ' A' ' 32' ' ' VAL . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 0.46999999999999997 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.29 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' VAL . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.3500000000000001 111.216 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 2.6000000000000001 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 3.6499999999999999 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 2.8300000000000001 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5199999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.5 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 40' ' ' GLU . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.49 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.01 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.04 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.3600000000000001 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.2300000000000004 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 3.8799999999999999 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' THR . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.17999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.1100000000000001 111.487 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 26' ' ' VAL . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 0.38 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.1400000000000001 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 1.3500000000000001 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.631 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.1399999999999999 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.0600000000000001 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.807 HD13 HG23 ' A' ' 20' ' ' THR . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.3799999999999999 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.1600000000000001 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.6500000000000004 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.932 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 3.6099999999999999 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 1.8700000000000001 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 2.96 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 0.91000000000000003 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 1.8400000000000001 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 78' ' ' ILE . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 0.46999999999999997 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.792 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.3899999999999999 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.3900000000000001 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.1000000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.759 0.314 . . . . 4.4699999999999998 110.851 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.831 HG12 ' CG ' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.5700000000000001 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 1.79 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' A' ' 74' ' ' PRO . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.2599999999999998 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.29 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.4199999999999999 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.006 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.2400000000000002 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.4900000000000002 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.865 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.29 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.8399999999999999 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 71' ' ' VAL . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.8100000000000001 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.865 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.54 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.4000000000000004 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.006 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 1.51 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.905 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.68999999999999995 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG11 ' NE1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 1.3899999999999999 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 2.9500000000000002 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.867 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.82999999999999996 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.059 HG11 HG13 ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.5 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.8899999999999999 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.45000000000000001 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 0.31 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.059 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 0.28000000000000003 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 2.52 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' VAL . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.93999999999999995 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.95 HG12 HG11 ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.29 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 21' ' ' VAL . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.3500000000000001 111.246 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 2.6000000000000001 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 19' ' ' VAL . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 3.6499999999999999 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.8300000000000001 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5199999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 ' OD2' ' A' ' 11' ' ' ASP . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.5 111.79 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.46 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.01 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.04 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.3600000000000001 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.2300000000000004 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 3.8799999999999999 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.17999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.1100000000000001 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 32' ' ' VAL . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 0.38 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.1400000000000001 114.066 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.857 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 1.3500000000000001 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.867 HD22 ' CH2' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.1399999999999999 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 112.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.3799999999999999 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.1600000000000001 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.6500000000000004 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 3.6099999999999999 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 1.8700000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 2.96 110.866 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 0.91000000000000003 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 1.8400000000000001 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 0.46999999999999997 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.831 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.3899999999999999 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.3900000000000001 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.1000000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.772 0.32 . . . . 4.4699999999999998 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.783 HG12 ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 1.5700000000000001 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 1.79 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.2599999999999998 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.29 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.4199999999999999 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.02 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.2400000000000002 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 9' ' ' LEU . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 4.4900000000000002 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.29 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.8399999999999999 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.8100000000000001 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.54 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.4000000000000004 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.687 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.02 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 1.51 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.766 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 0.68999999999999995 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.832 HG11 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 1.3899999999999999 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 2.9500000000000002 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.842 ' CZ3' HD13 ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.82999999999999996 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.72 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.007 HG11 HG13 ' A' ' 32' ' ' VAL . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.5 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 1.8899999999999999 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.45000000000000001 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.31 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.007 HG13 HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.28000000000000003 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.4199999999999999 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 2.52 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.77 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.93999999999999995 110.27 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 78' ' ' ILE . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 0.46999999999999997 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.29 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.3500000000000001 111.493 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 2.6000000000000001 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 3.6499999999999999 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5199999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.5 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.46 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.01 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.04 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.3600000000000001 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.2300000000000004 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 3.8799999999999999 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 31' ' ' THR . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.1100000000000001 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 ' HB ' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 0.38 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.1400000000000001 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.864 ' C ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 1.3500000000000001 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG2' ' A' ' 58' ' ' ILE . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.1399999999999999 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.654 ' CD1' HD13 ' A' ' 75' ' ' LEU . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 112.901 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 20' ' ' THR . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.766 HD13 HG23 ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.3799999999999999 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.6500000000000004 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 3.6099999999999999 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 1.8700000000000001 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 2.96 111.924 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 0.91000000000000003 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 1.8400000000000001 110.809 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 78' ' ' ILE . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 0.46999999999999997 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.754 HG23 HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.85999999999999999 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.783 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.3899999999999999 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.3900000000000001 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.1000000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.853 0.359 . . . . 4.4699999999999998 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.706 HG12 ' CG ' ' A' ' 79' ' ' GLU . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 1.5700000000000001 111.008 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 78' ' ' ILE . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 1.79 108.019 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.2599999999999998 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.29 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.4199999999999999 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.089 HD11 HD12 ' A' ' 12' ' ' ILE . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.2400000000000002 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.489 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 4.4900000000000002 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.29 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.8399999999999999 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.8100000000000001 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.54 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.4000000000000004 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 1.51 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.876 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 0.68999999999999995 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.726 ' HA ' HG12 ' A' ' 41' ' ' VAL . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 1.3899999999999999 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 2.9500000000000002 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 0.82999999999999996 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.72 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 1.034 HG23 HD11 ' A' ' 61' ' ' LEU . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 0.5 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 1.8899999999999999 111.005 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 60' ' ' LYS . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.45000000000000001 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.498 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 0.28000000000000003 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 2.52 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 0.93999999999999995 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 0.46999999999999997 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 21' ' ' VAL . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.29 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 21' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.3500000000000001 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 2.6000000000000001 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 3.6499999999999999 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.8300000000000001 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5199999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.5 111.825 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.46 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.01 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.04 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.3600000000000001 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.2300000000000004 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 3.8799999999999999 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.17999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.1100000000000001 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.556 ' CG1' HG23 ' A' ' 78' ' ' ILE . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 0.38 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.1400000000000001 113.528 -176.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD11 HG23 ' A' ' 26' ' ' VAL . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.1399999999999999 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.0600000000000001 112.504 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.876 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.3799999999999999 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.1600000000000001 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.6500000000000004 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 12' ' ' ILE . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 3.6099999999999999 110.942 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 1.8700000000000001 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 2.96 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 0.91000000000000003 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 1.8400000000000001 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 HD11 ' A' ' 78' ' ' ILE . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 0.46999999999999997 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.71 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 0.85999999999999999 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.706 ' CG ' HG12 ' A' ' 4' ' ' VAL . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.3899999999999999 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.429 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.3900000000000001 110.253 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.1000000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.73 0.3 . . . . 4.4699999999999998 110.792 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.876 HG12 ' HG3' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 1.5700000000000001 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 1.79 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.2599999999999998 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.29 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.4199999999999999 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.986 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 4.4900000000000002 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.436 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.29 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.482 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.8399999999999999 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.8100000000000001 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.953 HD11 ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.54 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.4000000000000004 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 1.51 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.85 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 0.68999999999999995 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.786 HG11 ' NE1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 1.3899999999999999 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.786 ' NE1' HG11 ' A' ' 21' ' ' VAL . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.82999999999999996 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.72 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.5 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 1.8899999999999999 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.45000000000000001 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 0.31 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 0.28000000000000003 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 110.245 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 2.52 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 32' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.29 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.3500000000000001 111.476 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 2.6000000000000001 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 3.6499999999999999 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.8300000000000001 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5199999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.5 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.46 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.01 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.04 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.3600000000000001 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.2300000000000004 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 3.8799999999999999 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.17999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.1100000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.77 HD12 ' HB ' ' A' ' 26' ' ' VAL . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 0.38 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.1400000000000001 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 1.3500000000000001 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 26' ' ' VAL . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.1399999999999999 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.0600000000000001 112.194 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 20' ' ' THR . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.1600000000000001 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.6500000000000004 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.916 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 3.6099999999999999 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 1.8700000000000001 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 2.96 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 0.91000000000000003 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.8400000000000001 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 0.46999999999999997 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.904 HD11 HG13 ' A' ' 76' ' ' VAL . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.876 ' HG3' HG12 ' A' ' 4' ' ' VAL . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.3899999999999999 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.1000000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 83' ' ' LEU . 22.6 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.779 0.323 . . . . 4.4699999999999998 110.896 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG12 ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 1.79 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.2599999999999998 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.29 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.015 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.2400000000000002 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 4.4900000000000002 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.901 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.29 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 71' ' ' VAL . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.8399999999999999 112.651 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.8100000000000001 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.54 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.4000000000000004 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.015 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 1.51 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 0.68999999999999995 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.3899999999999999 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 2.9500000000000002 110.9 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.846 ' CD1' HG11 ' A' ' 21' ' ' VAL . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 0.82999999999999996 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.428 ' C ' HG13 ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.72 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 58' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 0.5 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 1.8899999999999999 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.45000000000000001 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 56' ' ' GLY . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.31 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.881 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.28000000000000003 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.4199999999999999 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 2.52 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.93999999999999995 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.881 HG12 HG11 ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 0.46999999999999997 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.29 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.3500000000000001 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 2.6000000000000001 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 3.6499999999999999 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 2.8300000000000001 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5199999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.5 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.46 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.501 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.01 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.04 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.3600000000000001 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.2300000000000004 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 3.8799999999999999 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.17999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.1100000000000001 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 0.38 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.1400000000000001 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 1.3500000000000001 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.1399999999999999 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.518 ' HD2' HD22 ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 112.213 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.513 ' C ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.686 HD13 ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.3799999999999999 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.1600000000000001 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.6500000000000004 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 3.6099999999999999 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 1.8700000000000001 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 2.96 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 0.91000000000000003 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 1.8400000000000001 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG13 HD11 ' A' ' 78' ' ' ILE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 0.46999999999999997 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 0.85999999999999999 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.909 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.3899999999999999 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.3900000000000001 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.1000000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.868 0.366 . . . . 4.4699999999999998 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.2599999999999998 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.29 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.4199999999999999 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.974 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.2400000000000002 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 4.4900000000000002 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 12' ' ' ILE . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.816 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.29 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.8399999999999999 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.8100000000000001 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.816 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.54 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HB2' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 1.51 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.469 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 0.68999999999999995 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.901 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 1.3899999999999999 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 2.9500000000000002 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HA ' HD21 ' A' ' 65' ' ' LEU . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.901 ' CD1' HG11 ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.82999999999999996 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.72 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.722 ' HB ' HD12 ' A' ' 58' ' ' ILE . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.5 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.45000000000000001 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.31 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.28000000000000003 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 2.52 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 0.93999999999999995 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 32' ' ' VAL . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 49' ' ' THR . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.3500000000000001 111.056 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 2.6000000000000001 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 3.6499999999999999 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 2.8300000000000001 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5199999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.5 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.46 109.733 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.01 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.04 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.3600000000000001 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.2300000000000004 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 3.8799999999999999 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.17999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.1100000000000001 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.722 HD12 ' HB ' ' A' ' 26' ' ' VAL . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 0.38 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.1400000000000001 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.1399999999999999 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 23' ' ' GLU . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.0600000000000001 112.089 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 18' ' ' GLU . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.3799999999999999 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.1600000000000001 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.6500000000000004 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 3.6099999999999999 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 1.8700000000000001 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 2.96 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 0.91000000000000003 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 1.8400000000000001 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 0.46999999999999997 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.85999999999999999 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.3899999999999999 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.474 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 111.104 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.1000000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.733 0.301 . . . . 4.4699999999999998 110.815 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.79 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.2599999999999998 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.29 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.4199999999999999 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.013 HD11 HD13 ' A' ' 12' ' ' ILE . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.812 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 4.4900000000000002 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.013 HD13 HD11 ' A' ' 9' ' ' LEU . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.29 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.8399999999999999 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.8100000000000001 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.54 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.595 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.4000000000000004 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.627 ' HB3' HG22 ' A' ' 68' ' ' ILE . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 1.51 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.97 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 0.68999999999999995 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 1.3899999999999999 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 2.9500000000000002 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CH2' HD22 ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.82999999999999996 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.72 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 0.5 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' LEU . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.8899999999999999 111.006 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.45000000000000001 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 0.31 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 0.28000000000000003 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.4199999999999999 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 2.52 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.93999999999999995 110.55 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.838 HG23 HG21 ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 0.46999999999999997 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.29 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.919 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 21' ' ' VAL . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.3500000000000001 111.725 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 2.6000000000000001 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 3.6499999999999999 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 2.8300000000000001 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5199999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.5 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 40' ' ' GLU . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.536 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.471 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.01 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.04 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.3600000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.2300000000000004 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 3.8799999999999999 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.17999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.1100000000000001 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 26' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 0.38 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.1400000000000001 113.973 -177.18 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 1.3500000000000001 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 HD22 ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.0600000000000001 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.97 HD13 HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.3799999999999999 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.1600000000000001 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.6500000000000004 110.219 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 3.6099999999999999 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 1.8700000000000001 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 2.96 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 0.91000000000000003 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 76' ' ' VAL . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 1.8400000000000001 111.275 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 0.46999999999999997 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.58 HG23 HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.85999999999999999 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.3899999999999999 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.3900000000000001 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.1000000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 4.4699999999999998 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.894 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.5700000000000001 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 1.79 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 15.6 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.2599999999999998 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.29 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.4199999999999999 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.01 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.2400000000000002 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 4.4900000000000002 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 12' ' ' ILE . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.908 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.29 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.8399999999999999 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.8100000000000001 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.904 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.54 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.4000000000000004 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.732 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.01 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 1.51 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.68999999999999995 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 1.3899999999999999 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 2.9500000000000002 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.812 ' NE1' HG11 ' A' ' 21' ' ' VAL . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.82999999999999996 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' C ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.72 111.555 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 58' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.5 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.45000000000000001 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.31 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.872 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 0.28000000000000003 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.4199999999999999 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 2.52 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.93999999999999995 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.872 HG12 HG11 ' A' ' 32' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 0.46999999999999997 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.29 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 111.424 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 2.6000000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 3.6499999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 2.8300000000000001 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5199999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.5 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 40' ' ' GLU . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.46 110.582 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.419 HG13 ' CE2' ' A' ' 7' ' ' PHE . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.01 111.541 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.04 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.3600000000000001 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.2300000000000004 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 3.8799999999999999 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.17999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.1100000000000001 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 26' ' ' VAL . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 0.38 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.1400000000000001 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.938 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 1.3500000000000001 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.665 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.1399999999999999 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.0600000000000001 112.365 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.3799999999999999 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.1600000000000001 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CA ' ' HG2' ' A' ' 18' ' ' GLU . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.6500000000000004 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 12' ' ' ILE . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 3.6099999999999999 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 1.8700000000000001 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 2.96 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 0.91000000000000003 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 0.46999999999999997 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 HG12 ' A' ' 58' ' ' ILE . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 0.85999999999999999 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.894 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.3899999999999999 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.1000000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.602 0.239 . . . . 4.4699999999999998 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' CG ' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 1.5700000000000001 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 1.79 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.2599999999999998 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.29 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.4199999999999999 112.47 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.923 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.2400000000000002 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 4.4900000000000002 112.1 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.474 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.892 HD12 HD11 ' A' ' 9' ' ' LEU . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.29 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.8399999999999999 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.8100000000000001 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG1' HG23 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.54 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.4000000000000004 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 12' ' ' ILE . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.923 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 1.51 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.932 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 0.68999999999999995 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.751 HG11 ' NE1' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 1.3899999999999999 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 2.9500000000000002 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.751 ' NE1' HG11 ' A' ' 21' ' ' VAL . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.82999999999999996 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.72 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.954 HG11 HG13 ' A' ' 32' ' ' VAL . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.5 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.45000000000000001 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 0.31 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.954 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.28000000000000003 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 2.52 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.93999999999999995 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.887 HG12 HG11 ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.46999999999999997 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.29 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 21' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.3500000000000001 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 111.038 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 3.6499999999999999 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 2.8300000000000001 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5199999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG21 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.5 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.01 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.04 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.3600000000000001 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.2300000000000004 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 3.8799999999999999 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.616 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.17999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.1100000000000001 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.38 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 1.3500000000000001 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 28' ' ' GLU . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.932 HD13 HG23 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.3799999999999999 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.1600000000000001 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.6500000000000004 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 12' ' ' ILE . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 3.6099999999999999 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 1.8700000000000001 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 2.96 111.421 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 0.91000000000000003 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 69' ' ' ALA . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.451 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 0.46999999999999997 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 0.85999999999999999 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.902 ' CG ' HG12 ' A' ' 4' ' ' VAL . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.3899999999999999 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HG21 ' A' ' 5' ' ' VAL . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.3900000000000001 110.657 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.1000000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.847 0.356 . . . . 4.4699999999999998 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.835 HG12 ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 1.5700000000000001 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 1.79 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.2599999999999998 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HD2' HD21 ' A' ' 75' ' ' LEU . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.29 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HA ' HD13 ' A' ' 75' ' ' LEU . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.4199999999999999 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.917 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.2400000000000002 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 4.4900000000000002 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.638 ' HB2' HD13 ' A' ' 12' ' ' ILE . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.971 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.29 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.8399999999999999 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.8100000000000001 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.795 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.54 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.4000000000000004 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB2' HG21 ' A' ' 68' ' ' ILE . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.917 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 1.51 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 0.68999999999999995 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 41' ' ' VAL . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 1.3899999999999999 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.745 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 2.9500000000000002 111.322 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.725 ' CZ3' HD22 ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 0.82999999999999996 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.72 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.778 ' HB ' HD12 ' A' ' 58' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 0.5 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 1.8899999999999999 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.45000000000000001 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.949 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 0.28000000000000003 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 2.52 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.93999999999999995 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.949 HG12 HG11 ' A' ' 32' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.46999999999999997 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.29 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.675 ' CG ' HG22 ' A' ' 49' ' ' THR . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 21' ' ' VAL . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.3500000000000001 110.954 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 2.6000000000000001 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 3.6499999999999999 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 2.8300000000000001 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5199999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.5 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.675 HG22 ' CG ' ' A' ' 40' ' ' GLU . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.46 110.246 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' ILE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.01 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.04 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.3600000000000001 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 3.8799999999999999 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 31' ' ' THR . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.17999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.1100000000000001 111.633 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.778 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 0.38 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.1400000000000001 113.425 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.793 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 1.3500000000000001 113.361 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.725 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.1399999999999999 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 22' ' ' LYS . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.3799999999999999 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.1600000000000001 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.6500000000000004 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 3.6099999999999999 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 1.8700000000000001 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 2.96 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 0.91000000000000003 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 1.8400000000000001 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 0.46999999999999997 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.784 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 0.85999999999999999 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.835 ' CG ' HG12 ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.3899999999999999 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.59 ' OG1' HG21 ' A' ' 5' ' ' VAL . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 110.782 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.1000000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 83' ' ' LEU . 2.6 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ptm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.893 0.378 . . . . 5.6799999999999997 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 19.47 5.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 4.1100000000000003 112.487 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.6 153.64 43.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 4.4699999999999998 110.838 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 1.79 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.2599999999999998 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.29 109.17 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.4199999999999999 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.969 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.2400000000000002 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.432 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 4.4900000000000002 111.788 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.854 ' OD2' HG21 ' A' ' 41' ' ' VAL . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.871 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.29 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.8399999999999999 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.8100000000000001 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.871 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.54 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.83 ' HG2' HD12 ' A' ' 16' ' ' ILE . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.4000000000000004 110.94 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.969 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 1.51 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.718 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 0.68999999999999995 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.848 HG11 ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.3899999999999999 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 2.9500000000000002 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.848 ' CD1' HG11 ' A' ' 21' ' ' VAL . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 0.82999999999999996 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' C ' HG13 ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.72 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 38' ' ' ILE . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 1.8899999999999999 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 61' ' ' LEU . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.45000000000000001 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.31 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.4199999999999999 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 2.52 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 32' ' ' VAL . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.46999999999999997 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.29 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' OD2' ' A' ' 11' ' ' ASP . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.3500000000000001 110.537 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' SER . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 2.6000000000000001 111.411 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 3.6499999999999999 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 2.8300000000000001 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5199999999999996 110.445 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.768 HG21 ' OD1' ' A' ' 11' ' ' ASP . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.5 111.494 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.46 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 39' ' ' CYS . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.01 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.207 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.3600000000000001 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.2300000000000004 111.006 -178.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 3.8799999999999999 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' THR . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.17999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.1100000000000001 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 0.38 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.1400000000000001 113.671 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 1.3500000000000001 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.1399999999999999 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.0600000000000001 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.3799999999999999 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.1600000000000001 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 3.6099999999999999 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 1.8700000000000001 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 2.96 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 0.91000000000000003 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 1.8400000000000001 111.979 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 60' ' ' LYS . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 0.46999999999999997 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.85999999999999999 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.74 ' HG3' HG12 ' A' ' 4' ' ' VAL . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.443 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.3900000000000001 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.1000000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -123.87 122.68 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -53.54 -22.49 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 8.3300000000000001 111.246 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' HB2' HD23 ' A' ' 83' ' ' LEU . 3.1 t0 -40.36 -49.82 2.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.35 -0.386 . . . . 6.2300000000000004 112.005 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 tp -116.45 -28.17 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.288 . . . . 4.3899999999999997 111.102 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.234 -0.888 . . . . 7.79 110.814 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.776 0.322 . . . . 5.6799999999999997 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.63 13.74 23.34 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 4.1100000000000003 112.884 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -107.43 153.23 23.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.026 0.441 . . . . 4.4699999999999998 111.141 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.781 HG12 ' CG ' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 1.5700000000000001 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 1.79 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.2599999999999998 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.29 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.4199999999999999 111.313 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.052 HD12 HG23 ' A' ' 71' ' ' VAL . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.2400000000000002 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 4.4900000000000002 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.682 ' C ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.29 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.8399999999999999 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.8100000000000001 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.54 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.4000000000000004 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.848 HG12 HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 1.51 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.792 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 0.68999999999999995 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 1.3899999999999999 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 2.9500000000000002 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.858 ' CD1' HG11 ' A' ' 21' ' ' VAL . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.82999999999999996 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.72 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 0.5 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 1.8899999999999999 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.45000000000000001 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 0.31 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.28000000000000003 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.4199999999999999 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 2.52 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 32' ' ' VAL . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 0.46999999999999997 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.29 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.3500000000000001 111.565 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 2.6000000000000001 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 3.6499999999999999 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 2.8300000000000001 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5199999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' SER . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.5 111.981 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.46 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.01 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.04 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.3600000000000001 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.2300000000000004 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 3.8799999999999999 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 31' ' ' THR . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.17999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.1100000000000001 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.734 HD13 HG21 ' A' ' 26' ' ' VAL . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 0.38 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.1400000000000001 113.75 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 1.3500000000000001 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD22 ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.1399999999999999 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 24' ' ' TRP . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.0600000000000001 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 20' ' ' THR . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.3799999999999999 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 1.043 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.1600000000000001 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.6500000000000004 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.052 HG23 HD12 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 3.6099999999999999 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 1.8700000000000001 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 2.96 111.545 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 0.91000000000000003 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 0.46999999999999997 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.641 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.781 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.3899999999999999 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.1000000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.33 126.42 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.6 -32.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 8.3300000000000001 111.577 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -49.64 -45.24 48.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 6.2300000000000004 111.111 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.43 16.04 16.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 111.406 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.215 -0.898 . . . . 7.79 110.937 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.854 0.359 . . . . 5.6799999999999997 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.94 67.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 4.1100000000000003 112.632 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -141.73 152.13 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 4.4699999999999998 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.887 HG12 ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' HD13 ' A' ' 86' ' ' LEU . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 1.79 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.565 ' O ' HD11 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.2599999999999998 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' CE2' HD21 ' A' ' 75' ' ' LEU . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.29 109.732 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.4199999999999999 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.2400000000000002 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 4.4900000000000002 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 12' ' ' ILE . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.29 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.8399999999999999 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.8100000000000001 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.54 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.4000000000000004 109.934 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 1.51 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 0.68999999999999995 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 41' ' ' VAL . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 1.3899999999999999 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 65' ' ' LEU . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 2.9500000000000002 111.346 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.777 ' CD1' HG11 ' A' ' 21' ' ' VAL . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 0.82999999999999996 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.72 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG23 ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 0.5 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 1.8899999999999999 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.45000000000000001 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.31 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 0.28000000000000003 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.4199999999999999 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 2.52 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 0.93999999999999995 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.893 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 0.46999999999999997 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.29 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 21' ' ' VAL . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.3500000000000001 110.518 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 2.6000000000000001 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 3.6499999999999999 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 2.8300000000000001 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5199999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' ASP . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.5 111.664 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.46 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.01 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.04 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.3600000000000001 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 3.8799999999999999 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.17999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 31' ' ' THR . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.1100000000000001 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' A' ' 26' ' ' VAL . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.1400000000000001 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.1399999999999999 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.0600000000000001 112.567 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.3799999999999999 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.1600000000000001 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.6500000000000004 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.889 HG22 HD12 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 3.6099999999999999 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 1.8700000000000001 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 2.96 111.292 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 0.91000000000000003 111.892 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 1.8400000000000001 111.89 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 HD11 ' A' ' 78' ' ' ILE . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 0.46999999999999997 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.721 HD11 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.85999999999999999 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.887 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.3899999999999999 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.495 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.3900000000000001 110.581 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.1000000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt -116.66 135.7 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -24.39 67.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 8.3300000000000001 111.239 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.95 -41.66 25.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 6.2300000000000004 111.331 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -95.01 -24.74 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 4.3899999999999997 111.14 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 7.79 110.979 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.826 0.346 . . . . 5.6799999999999997 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.25 19.07 34.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 4.1100000000000003 112.567 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.61 124.92 4.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 4.4699999999999998 110.861 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.782 HG12 ' CG ' ' A' ' 79' ' ' GLU . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 1.79 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.2599999999999998 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.632 ' CE2' HD21 ' A' ' 75' ' ' LEU . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.29 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.4199999999999999 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 12' ' ' ILE . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 4.4900000000000002 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.29 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.8399999999999999 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.8100000000000001 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.54 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.4000000000000004 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.023 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 1.51 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.819 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 0.68999999999999995 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 2.9500000000000002 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CD1' HG11 ' A' ' 21' ' ' VAL . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.421 ' C ' HG13 ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.72 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 0.5 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 1.8899999999999999 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.45000000000000001 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 0.31 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.28000000000000003 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.4199999999999999 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 2.52 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.93999999999999995 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 0.46999999999999997 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.29 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.3500000000000001 111.023 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 2.6000000000000001 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 3.6499999999999999 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 2.8300000000000001 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.5 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.46 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.509 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.01 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.3600000000000001 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.2300000000000004 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 3.8799999999999999 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.17999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.1100000000000001 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 26' ' ' VAL . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 0.38 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.1400000000000001 113.739 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 112.707 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.1399999999999999 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.0600000000000001 112.184 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.819 HD13 HG23 ' A' ' 20' ' ' THR . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.3799999999999999 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.629 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.1600000000000001 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.6500000000000004 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.662 HG22 HD12 ' A' ' 9' ' ' LEU . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 3.6099999999999999 110.934 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 1.8700000000000001 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 2.96 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 0.91000000000000003 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.632 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 1.8400000000000001 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' LYS . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 0.46999999999999997 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 76' ' ' VAL . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.85999999999999999 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.782 ' CG ' HG12 ' A' ' 4' ' ' VAL . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.3899999999999999 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.1000000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.86 145.09 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -24.51 40.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 8.3300000000000001 111.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.38 -40.77 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 6.2300000000000004 111.3 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -107.53 -23.68 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 4.3899999999999997 110.899 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.206 -0.902 . . . . 7.79 110.877 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.867 0.365 . . . . 5.6799999999999997 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.78 67.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.69 -0.767 . . . . 4.1100000000000003 112.827 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -132.33 126.2 32.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.027 0.441 . . . . 4.4699999999999998 110.97 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 1.5700000000000001 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 1.79 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.2599999999999998 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' CE1' HD11 ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.29 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.4199999999999999 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.019 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.2400000000000002 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 4.4900000000000002 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.872 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.29 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.8399999999999999 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.8100000000000001 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.872 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.54 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.4000000000000004 110.632 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.019 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 1.51 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 0.68999999999999995 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' CD1' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 1.3899999999999999 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 2.9500000000000002 111.375 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.812 ' CD1' HG11 ' A' ' 21' ' ' VAL . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.82999999999999996 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.72 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG21 HG23 ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.5 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.8899999999999999 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.496 ' N ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.45000000000000001 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.31 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.4199999999999999 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 2.52 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.93999999999999995 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 32' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 0.46999999999999997 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.29 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 21' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.3500000000000001 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 2.6000000000000001 111.279 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 3.6499999999999999 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 2.8300000000000001 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5199999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.5 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.46 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.542 HD11 ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.01 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.2300000000000004 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 3.8799999999999999 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.17999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.1100000000000001 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 26' ' ' VAL . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 0.38 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.687 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 1.3500000000000001 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.1399999999999999 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.0600000000000001 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.3799999999999999 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.1600000000000001 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.6500000000000004 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 3.6099999999999999 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 1.8700000000000001 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 2.96 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.91000000000000003 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 0.46999999999999997 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 0.85999999999999999 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.902 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.3899999999999999 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.3900000000000001 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.1000000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.9 mt -117.13 121.61 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -22.21 23.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.04 -0.527 . . . . 8.3300000000000001 111.645 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -34.26 -44.11 0.18 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.389 0.515 . . . . 6.2300000000000004 112.389 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -117.46 -16.19 10.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 4.3899999999999997 111.435 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.727 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.801 0.334 . . . . 5.6799999999999997 111.347 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.28 14.59 27.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 4.1100000000000003 112.961 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 27.6 mt-30 -140.11 146.81 39.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.942 0.401 . . . . 4.4699999999999998 111.02 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' OG1' ' A' ' 80' ' ' THR . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 1.79 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.2599999999999998 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.29 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.027 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.2400000000000002 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' ILE . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.947 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.29 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.8399999999999999 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.8100000000000001 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.823 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.54 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 16' ' ' ILE . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.4000000000000004 110.572 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.027 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 1.51 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.906 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 0.68999999999999995 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.3899999999999999 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 2.9500000000000002 111.508 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.753 ' CD1' HG11 ' A' ' 21' ' ' VAL . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 0.82999999999999996 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.72 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.947 HG21 HG23 ' A' ' 38' ' ' ILE . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.5 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 1.8899999999999999 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.31 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.906 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 0.28000000000000003 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.4199999999999999 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 2.52 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.93999999999999995 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.947 HG23 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.46999999999999997 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.29 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.3500000000000001 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 2.6000000000000001 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 3.6499999999999999 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 2.8300000000000001 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.439 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5199999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.5 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.46 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.01 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.04 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.3600000000000001 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.2300000000000004 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 3.8799999999999999 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.1100000000000001 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.556 HD11 HG13 ' A' ' 32' ' ' VAL . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 0.38 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.1400000000000001 114.006 -176.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 1.3500000000000001 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.1399999999999999 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.462 ' CD1' HD13 ' A' ' 75' ' ' LEU . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.0600000000000001 112.225 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 20' ' ' THR . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.906 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.3799999999999999 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.6500000000000004 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 3.6099999999999999 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 1.8700000000000001 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 2.96 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 0.91000000000000003 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 1.8400000000000001 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 78' ' ' ILE . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 0.46999999999999997 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.85999999999999999 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.3899999999999999 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.605 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.3900000000000001 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.1000000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 81' ' ' GLU . 3.4 mp -117.02 145.75 43.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -22.16 66.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 8.3300000000000001 111.724 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.26 -49.96 1.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.171 0.434 . . . . 6.2300000000000004 112.171 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.94 -25.25 5.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.565 -0.289 . . . . 4.3899999999999997 111.469 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.21 -0.9 . . . . 7.79 110.906 -179.622 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.873 0.368 . . . . 5.6799999999999997 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.18 -0.95 88.89 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.811 -0.709 . . . . 4.1100000000000003 113.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -82.45 153.06 25.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.047 0.423 . . . . 4.4699999999999998 111.141 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.56 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 1.5700000000000001 111.723 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 1.79 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.2599999999999998 112.606 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.4199999999999999 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.0 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.2400000000000002 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 4.4900000000000002 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.703 ' CG ' HD13 ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.946 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.29 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.8399999999999999 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.8100000000000001 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.946 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.54 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.4000000000000004 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.0 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 1.51 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.939 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 0.68999999999999995 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 1.3899999999999999 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 2.9500000000000002 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.753 ' NE1' HG11 ' A' ' 21' ' ' VAL . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 0.82999999999999996 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.72 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.83 HG23 HD11 ' A' ' 61' ' ' LEU . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.5 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 111.226 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.45000000000000001 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.31 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.728 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 2.52 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.93999999999999995 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.772 HG23 HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.46999999999999997 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.29 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 21' ' ' VAL . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.3500000000000001 111.132 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 2.6000000000000001 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8300000000000001 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5199999999999996 110.608 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.5 111.284 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.46 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.01 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.04 110.545 179.337 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.3600000000000001 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.2300000000000004 111.077 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 3.8799999999999999 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.17999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.1100000000000001 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.683 ' CG1' HG23 ' A' ' 78' ' ' ILE . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 0.38 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.1400000000000001 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 1.3500000000000001 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 26' ' ' VAL . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.1399999999999999 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 24' ' ' TRP . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.0600000000000001 112.433 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' THR . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.939 HD13 HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.3799999999999999 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.1600000000000001 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.6500000000000004 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 3.6099999999999999 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 1.8700000000000001 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 2.96 111.451 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 0.91000000000000003 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 1.8400000000000001 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 0.46999999999999997 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.694 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 0.85999999999999999 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.56 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.3899999999999999 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.3900000000000001 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.62 145.08 49.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -57.87 -23.01 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 8.3300000000000001 111.236 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -42.1 -49.18 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 6.2300000000000004 111.819 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -110.47 -24.64 10.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.423 -0.353 . . . . 4.3899999999999997 110.934 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.243 -0.884 . . . . 7.79 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mmm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.796 0.332 . . . . 5.6799999999999997 111.261 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.79 6.98 73.97 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.975 -0.631 . . . . 4.1100000000000003 113.431 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.07 131.86 55.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.015 0.407 . . . . 4.4699999999999998 111.381 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 79' ' ' GLU . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.5700000000000001 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' A' ' 80' ' ' THR . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 1.79 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.2599999999999998 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.29 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.4199999999999999 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.07 HD11 HD13 ' A' ' 12' ' ' ILE . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.2400000000000002 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.651 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 4.4900000000000002 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.07 HD13 HD11 ' A' ' 9' ' ' LEU . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.29 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.8399999999999999 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.8100000000000001 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.54 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.4000000000000004 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB3' HG22 ' A' ' 68' ' ' ILE . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.026 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 1.51 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 0.68999999999999995 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.677 HG11 ' NE1' ' A' ' 24' ' ' TRP . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 1.3899999999999999 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 2.9500000000000002 111.583 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.859 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.82999999999999996 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.72 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.919 HG11 HG13 ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.5 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.45000000000000001 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.31 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 0.28000000000000003 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.4199999999999999 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 2.52 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 0.93999999999999995 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 32' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 0.46999999999999997 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.29 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 21' ' ' VAL . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.3500000000000001 110.575 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 2.6000000000000001 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 3.6499999999999999 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 2.8300000000000001 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5199999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.5 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.46 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.01 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.04 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.2300000000000004 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 3.8799999999999999 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.17999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.1100000000000001 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 26' ' ' VAL . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 0.38 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.1400000000000001 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 1.3500000000000001 112.693 -178.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 27' ' ' LYS . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.1399999999999999 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.0600000000000001 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.874 HD13 HG23 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.3799999999999999 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.1600000000000001 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.6500000000000004 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 3.6099999999999999 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 1.8700000000000001 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 74' ' ' PRO . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 2.96 111.593 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 0.91000000000000003 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 1.8400000000000001 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 78' ' ' ILE . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.46999999999999997 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.671 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.85999999999999999 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.864 ' HG2' HG12 ' A' ' 4' ' ' VAL . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.3899999999999999 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.3900000000000001 110.494 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.1000000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -120.37 142.64 48.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 -26.0 24.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.696 0.284 . . . . 8.3300000000000001 111.558 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.14 -39.37 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 6.2300000000000004 111.557 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -111.93 -27.98 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 4.3899999999999997 111.355 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.227 -0.892 . . . . 7.79 111.012 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.7 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.785 0.326 . . . . 5.6799999999999997 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.24 18.96 4.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.639 -0.791 . . . . 4.1100000000000003 112.84 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 142.82 38.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 4.4699999999999998 110.769 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.91 HG12 ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 1.5700000000000001 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG21 ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 1.79 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.2599999999999998 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.29 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.4199999999999999 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.134 HD11 HD13 ' A' ' 12' ' ' ILE . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.2400000000000002 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 4.4900000000000002 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.134 HD13 HD11 ' A' ' 9' ' ' LEU . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.29 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.8399999999999999 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.8100000000000001 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.54 111.552 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.4000000000000004 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 68' ' ' ILE . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.93 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 1.51 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.716 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 0.68999999999999995 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.811 HG11 ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 1.3899999999999999 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.588 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 2.9500000000000002 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CD1' HG11 ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.82999999999999996 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' C ' HG13 ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.72 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 38' ' ' ILE . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 0.5 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 61' ' ' LEU . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 1.8899999999999999 111.351 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.31 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.876 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.28000000000000003 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.4199999999999999 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 2.52 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.93999999999999995 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 0.46999999999999997 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.29 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 21' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.3500000000000001 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 2.6000000000000001 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 3.6499999999999999 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 2.8300000000000001 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.5 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.46 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.01 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.04 109.726 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.583 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.3600000000000001 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.2300000000000004 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 3.8799999999999999 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' THR . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.17999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.1100000000000001 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.559 ' CG1' HG23 ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.1400000000000001 113.905 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 1.3500000000000001 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.889 HD11 HG23 ' A' ' 26' ' ' VAL . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.1399999999999999 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.0600000000000001 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.1600000000000001 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.6500000000000004 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG11 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 3.6099999999999999 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 1.8700000000000001 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 2.96 111.343 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 0.91000000000000003 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 1.8400000000000001 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG13 HD11 ' A' ' 78' ' ' ILE . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 0.46999999999999997 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 0.85999999999999999 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.91 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.3899999999999999 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.498 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.3900000000000001 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 83' ' ' LEU . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -123.74 138.55 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.02 14.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 8.3300000000000001 111.211 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.44 -49.61 13.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 6.2300000000000004 111.487 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.04 8.44 3.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.524 -0.307 . . . . 4.3899999999999997 111.783 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 7.79 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.776 0.322 . . . . 5.6799999999999997 111.208 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.76 19.02 77.82 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.766 -0.731 . . . . 4.1100000000000003 112.74 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -98.02 153.18 18.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 111.045 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.792 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.5700000000000001 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 1.79 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.2599999999999998 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.29 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.4199999999999999 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.2400000000000002 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 4.4900000000000002 110.958 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' HB3' HD13 ' A' ' 12' ' ' ILE . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.932 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.29 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.8399999999999999 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.8100000000000001 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.72 HD11 ' CG2' ' A' ' 12' ' ' ILE . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.54 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.4000000000000004 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 68' ' ' ILE . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 1.51 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.807 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 0.68999999999999995 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 41' ' ' VAL . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 1.3899999999999999 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.639 ' O ' HD23 ' A' ' 65' ' ' LEU . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 2.9500000000000002 111.074 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 0.82999999999999996 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.72 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 32' ' ' VAL . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 0.5 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 1.8899999999999999 111.481 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.45000000000000001 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.31 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 0.28000000000000003 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.4199999999999999 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 2.52 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.93999999999999995 110.228 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG12 HG11 ' A' ' 32' ' ' VAL . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 0.46999999999999997 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.29 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' VAL . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.3500000000000001 111.216 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 2.6000000000000001 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 3.6499999999999999 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 2.8300000000000001 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5199999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.5 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 40' ' ' GLU . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.49 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.01 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.04 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.3600000000000001 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.2300000000000004 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 3.8799999999999999 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' THR . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.17999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.1100000000000001 111.487 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 26' ' ' VAL . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 0.38 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.1400000000000001 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 1.3500000000000001 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.631 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.1399999999999999 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.0600000000000001 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.807 HD13 HG23 ' A' ' 20' ' ' THR . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.3799999999999999 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.1600000000000001 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.6500000000000004 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.932 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 3.6099999999999999 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 1.8700000000000001 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 2.96 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 0.91000000000000003 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 1.8400000000000001 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 78' ' ' ILE . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 0.46999999999999997 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.3899999999999999 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.3900000000000001 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.1000000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -121.6 145.57 47.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -77.77 -21.51 51.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.014 -0.539 . . . . 8.3300000000000001 111.497 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -39.93 -49.39 2.44 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.549 0.574 . . . . 6.2300000000000004 112.549 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 -21.26 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.608 0.242 . . . . 4.3899999999999997 111.622 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 86' ' ' LEU . 10.1 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 7.79 111.359 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.745 0.307 . . . . 5.6799999999999997 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 14.7 7.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 4.1100000000000003 112.825 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 mm-40 -129.82 153.41 48.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 4.4699999999999998 110.851 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.831 HG12 ' CG ' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.5700000000000001 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 1.79 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.655 ' O ' HD21 ' A' ' 86' ' ' LEU . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.2599999999999998 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.29 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.4199999999999999 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.006 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.2400000000000002 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.4900000000000002 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.865 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.29 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.8399999999999999 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 71' ' ' VAL . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.8100000000000001 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.865 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.54 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.4000000000000004 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.006 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 1.51 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.905 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.68999999999999995 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG11 ' NE1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 1.3899999999999999 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 2.9500000000000002 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.867 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.82999999999999996 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.059 HG11 HG13 ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.5 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.8899999999999999 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.45000000000000001 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 0.31 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.059 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 0.28000000000000003 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 2.52 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' VAL . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.93999999999999995 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.95 HG12 HG11 ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.29 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 21' ' ' VAL . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.3500000000000001 111.246 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 2.6000000000000001 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 19' ' ' VAL . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 3.6499999999999999 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.8300000000000001 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5199999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 ' OD2' ' A' ' 11' ' ' ASP . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.5 111.79 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.46 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.01 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.04 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.3600000000000001 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.2300000000000004 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 3.8799999999999999 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.17999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.1100000000000001 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 32' ' ' VAL . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 0.38 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.1400000000000001 114.066 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.857 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 1.3500000000000001 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.867 HD22 ' CH2' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.1399999999999999 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 112.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.3799999999999999 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.1600000000000001 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.6500000000000004 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 3.6099999999999999 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 1.8700000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 2.96 110.866 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 0.91000000000000003 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 1.8400000000000001 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 0.46999999999999997 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.831 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.3899999999999999 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.3900000000000001 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.1000000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.59 133.79 55.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -63.17 -22.78 67.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 8.3300000000000001 111.259 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.04 -49.18 8.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.405 -0.361 . . . . 6.2300000000000004 111.658 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.655 HD21 ' O ' ' A' ' 6' ' ' GLN . 1.2 mp -110.84 -21.79 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 4.3899999999999997 111.083 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 84' ' ' LYS . 12.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.909 . . . . 7.79 111.015 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.749 0.309 . . . . 5.6799999999999997 111.297 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.99 -4.56 18.66 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.745 -0.741 . . . . 4.1100000000000003 113.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -105.67 153.34 21.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.0 0.4 . . . . 4.4699999999999998 110.925 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.783 HG12 ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 1.5700000000000001 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 1.79 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.2599999999999998 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.29 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.4199999999999999 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.02 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.2400000000000002 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 9' ' ' LEU . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 4.4900000000000002 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.29 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.8399999999999999 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.8100000000000001 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.54 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.4000000000000004 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.687 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.02 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 1.51 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.766 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 0.68999999999999995 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.832 HG11 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 1.3899999999999999 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 2.9500000000000002 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.842 ' CZ3' HD13 ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.82999999999999996 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.72 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.007 HG11 HG13 ' A' ' 32' ' ' VAL . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.5 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 1.8899999999999999 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.45000000000000001 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.31 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.007 HG13 HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.28000000000000003 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.4199999999999999 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 2.52 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.77 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.93999999999999995 110.27 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 78' ' ' ILE . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 0.46999999999999997 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.29 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.3500000000000001 111.493 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 2.6000000000000001 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 3.6499999999999999 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5199999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.5 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.46 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.01 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.04 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.3600000000000001 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.2300000000000004 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 3.8799999999999999 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 31' ' ' THR . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.1100000000000001 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 ' HB ' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 0.38 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.1400000000000001 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.864 ' C ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 1.3500000000000001 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG2' ' A' ' 58' ' ' ILE . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.1399999999999999 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.654 ' CD1' HD13 ' A' ' 75' ' ' LEU . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 112.901 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 20' ' ' THR . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.766 HD13 HG23 ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.3799999999999999 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.6500000000000004 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 3.6099999999999999 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 1.8700000000000001 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 2.96 111.924 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 0.91000000000000003 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 1.8400000000000001 110.809 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 78' ' ' ILE . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 0.46999999999999997 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.754 HG23 HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.85999999999999999 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.783 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.3899999999999999 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.3900000000000001 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.1000000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp -123.27 135.01 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.16 -22.92 18.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 8.3300000000000001 111.226 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -49.39 61.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 6.2300000000000004 111.263 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -28.15 6.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.513 -0.312 . . . . 4.3899999999999997 111.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.932 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.86 0.362 . . . . 5.6799999999999997 111.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.59 4.64 81.43 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.065 -0.516 . . . . 4.1100000000000003 113.597 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -91.1 152.02 20.78 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 122.563 -0.375 . . . . 4.4699999999999998 111.194 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.706 HG12 ' CG ' ' A' ' 79' ' ' GLU . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 1.5700000000000001 111.008 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 78' ' ' ILE . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 1.79 108.019 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.2599999999999998 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.29 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.4199999999999999 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.089 HD11 HD12 ' A' ' 12' ' ' ILE . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.2400000000000002 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.489 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 4.4900000000000002 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.29 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.8399999999999999 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.8100000000000001 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.54 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.4000000000000004 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 1.51 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.876 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 0.68999999999999995 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.726 ' HA ' HG12 ' A' ' 41' ' ' VAL . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 1.3899999999999999 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 2.9500000000000002 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 0.82999999999999996 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.72 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 1.034 HG23 HD11 ' A' ' 61' ' ' LEU . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 0.5 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 1.8899999999999999 111.005 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 60' ' ' LYS . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.45000000000000001 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.498 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 0.28000000000000003 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 2.52 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 0.93999999999999995 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 0.46999999999999997 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 21' ' ' VAL . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.29 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 21' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.3500000000000001 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 2.6000000000000001 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 3.6499999999999999 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.8300000000000001 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5199999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.5 111.825 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.46 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.01 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.04 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.3600000000000001 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.2300000000000004 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 3.8799999999999999 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.17999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.1100000000000001 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.556 ' CG1' HG23 ' A' ' 78' ' ' ILE . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 0.38 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.1400000000000001 113.528 -176.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD11 HG23 ' A' ' 26' ' ' VAL . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.1399999999999999 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.0600000000000001 112.504 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.876 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.3799999999999999 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.1600000000000001 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.6500000000000004 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 12' ' ' ILE . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 3.6099999999999999 110.942 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 1.8700000000000001 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 2.96 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 0.91000000000000003 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 1.8400000000000001 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 HD11 ' A' ' 78' ' ' ILE . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 0.46999999999999997 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.71 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 0.85999999999999999 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.706 ' CG ' HG12 ' A' ' 4' ' ' VAL . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.3899999999999999 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.429 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.3900000000000001 110.253 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.1000000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.843 HD23 ' OD2' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -118.81 135.47 54.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -49.87 -43.6 49.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.949 0.722 . . . . 8.3300000000000001 112.949 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.843 ' OD2' HD23 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -40.58 -47.38 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.491 0.552 . . . . 6.2300000000000004 112.491 -178.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.54 -23.71 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.798 -0.361 . . . . 4.3899999999999997 111.828 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.556 -0.735 . . . . 7.79 110.761 179.453 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.856 0.36 . . . . 5.6799999999999997 111.113 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.54 18.94 5.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 4.1100000000000003 112.6 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.2 153.14 48.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 4.4699999999999998 110.792 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG12 ' HG3' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 1.5700000000000001 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 1.79 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.2599999999999998 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.29 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.4199999999999999 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.986 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 4.4900000000000002 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.29 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.482 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.8399999999999999 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.8100000000000001 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.953 HD11 ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.54 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.4000000000000004 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 1.51 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.85 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 0.68999999999999995 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.786 HG11 ' NE1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 1.3899999999999999 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.786 ' NE1' HG11 ' A' ' 21' ' ' VAL . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.82999999999999996 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.72 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.5 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 1.8899999999999999 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.45000000000000001 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 0.31 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 0.28000000000000003 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 110.245 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 2.52 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 32' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.29 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.3500000000000001 111.476 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 2.6000000000000001 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 3.6499999999999999 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.8300000000000001 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5199999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.5 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.46 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.01 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.04 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.3600000000000001 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.2300000000000004 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 3.8799999999999999 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.17999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.1100000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.77 HD12 ' HB ' ' A' ' 26' ' ' VAL . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 0.38 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.1400000000000001 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 1.3500000000000001 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 26' ' ' VAL . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.1399999999999999 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.0600000000000001 112.194 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 20' ' ' THR . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.1600000000000001 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.6500000000000004 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.916 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 3.6099999999999999 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 1.8700000000000001 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 2.96 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 0.91000000000000003 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.8400000000000001 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 0.46999999999999997 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.904 HD11 HG13 ' A' ' 76' ' ' VAL . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.876 ' HG3' HG12 ' A' ' 4' ' ' VAL . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.3899999999999999 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.1000000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 83' ' ' LEU . 22.6 mt -114.24 133.68 55.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -54.86 -22.73 15.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.173 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.2 -46.12 5.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.476 -0.329 . . . . 6.2300000000000004 111.573 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.65 -25.53 11.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.915 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.27 -0.872 . . . . 7.79 110.928 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 5.6799999999999997 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.71 -6.94 26.0 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.797 -0.716 . . . . 4.1100000000000003 112.922 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -86.37 140.53 29.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.779 0.323 . . . . 4.4699999999999998 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG12 ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 1.79 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.2599999999999998 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.29 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.015 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.2400000000000002 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 4.4900000000000002 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.901 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.29 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 71' ' ' VAL . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.8399999999999999 112.651 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.8100000000000001 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.54 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.4000000000000004 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.015 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 1.51 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 0.68999999999999995 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.3899999999999999 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 2.9500000000000002 110.9 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.846 ' CD1' HG11 ' A' ' 21' ' ' VAL . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 0.82999999999999996 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.428 ' C ' HG13 ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.72 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 58' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 0.5 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 1.8899999999999999 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.45000000000000001 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 56' ' ' GLY . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.31 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.881 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.28000000000000003 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.4199999999999999 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 2.52 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.93999999999999995 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.881 HG12 HG11 ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 0.46999999999999997 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.29 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.3500000000000001 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 2.6000000000000001 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 3.6499999999999999 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 2.8300000000000001 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5199999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.5 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.46 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.501 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.01 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.04 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.3600000000000001 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.2300000000000004 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 3.8799999999999999 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.17999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.1100000000000001 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 0.38 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.1400000000000001 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 1.3500000000000001 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.1399999999999999 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.518 ' HD2' HD22 ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 112.213 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.513 ' C ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.686 HD13 ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.3799999999999999 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.1600000000000001 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.6500000000000004 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 3.6099999999999999 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 1.8700000000000001 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 2.96 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 0.91000000000000003 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 1.8400000000000001 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG13 HD11 ' A' ' 78' ' ' ILE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 0.46999999999999997 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 0.85999999999999999 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.909 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.3899999999999999 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.3900000000000001 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.1000000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -123.55 134.19 53.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -22.92 9.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 8.3300000000000001 111.061 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.73 -49.41 10.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.36 -0.382 . . . . 6.2300000000000004 111.567 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.85 -28.32 5.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.512 -0.313 . . . . 4.3899999999999997 111.289 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.269 -0.872 . . . . 7.79 110.902 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.831 0.348 . . . . 5.6799999999999997 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 19.13 11.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 4.1100000000000003 112.639 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -139.64 142.03 37.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 4.4699999999999998 110.863 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.2599999999999998 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.29 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.4199999999999999 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.974 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.2400000000000002 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 4.4900000000000002 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 12' ' ' ILE . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.816 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.29 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.8399999999999999 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.8100000000000001 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.816 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.54 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HB2' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 1.51 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.469 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 0.68999999999999995 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.901 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 1.3899999999999999 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 2.9500000000000002 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HA ' HD21 ' A' ' 65' ' ' LEU . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.901 ' CD1' HG11 ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.82999999999999996 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.72 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.722 ' HB ' HD12 ' A' ' 58' ' ' ILE . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.5 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.45000000000000001 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.31 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.28000000000000003 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 2.52 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 0.93999999999999995 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 32' ' ' VAL . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 49' ' ' THR . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.3500000000000001 111.056 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 2.6000000000000001 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 3.6499999999999999 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 2.8300000000000001 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5199999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.5 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.46 109.733 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.01 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.04 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.3600000000000001 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.2300000000000004 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 3.8799999999999999 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.17999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.1100000000000001 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.722 HD12 ' HB ' ' A' ' 26' ' ' VAL . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 0.38 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.1400000000000001 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.1399999999999999 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 23' ' ' GLU . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.0600000000000001 112.089 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 18' ' ' GLU . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.3799999999999999 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.1600000000000001 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.6500000000000004 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 3.6099999999999999 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 1.8700000000000001 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 2.96 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 0.91000000000000003 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 1.8400000000000001 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 0.46999999999999997 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.85999999999999999 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.3899999999999999 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.474 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 111.104 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.1000000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.56 135.27 53.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -61.02 -22.66 64.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 8.3300000000000001 111.154 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.86 -46.32 3.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.34 -0.391 . . . . 6.2300000000000004 111.737 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 tp -104.13 -27.87 11.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 4.3899999999999997 111.045 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.914 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.836 0.351 . . . . 5.6799999999999997 111.242 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.67 -7.2 22.27 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.717 -0.754 . . . . 4.1100000000000003 112.973 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -93.75 153.24 18.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.821 0.31 . . . . 4.4699999999999998 110.815 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.79 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.2599999999999998 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.29 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.4199999999999999 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.013 HD11 HD13 ' A' ' 12' ' ' ILE . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.812 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 4.4900000000000002 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.013 HD13 HD11 ' A' ' 9' ' ' LEU . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.29 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.8399999999999999 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.8100000000000001 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.54 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.595 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.4000000000000004 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.627 ' HB3' HG22 ' A' ' 68' ' ' ILE . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 1.51 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.97 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 0.68999999999999995 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 1.3899999999999999 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 2.9500000000000002 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CH2' HD22 ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.82999999999999996 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.72 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 0.5 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' LEU . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.8899999999999999 111.006 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.45000000000000001 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 0.31 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 0.28000000000000003 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.4199999999999999 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 2.52 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.93999999999999995 110.55 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.838 HG23 HG21 ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 0.46999999999999997 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.29 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.919 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 21' ' ' VAL . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.3500000000000001 111.725 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 2.6000000000000001 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 3.6499999999999999 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 2.8300000000000001 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5199999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.5 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 40' ' ' GLU . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.536 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.471 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.01 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.04 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.3600000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.2300000000000004 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 3.8799999999999999 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.17999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.1100000000000001 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 26' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 0.38 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.1400000000000001 113.973 -177.18 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 1.3500000000000001 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 HD22 ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.0600000000000001 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.97 HD13 HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.3799999999999999 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.1600000000000001 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.6500000000000004 110.219 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 3.6099999999999999 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 1.8700000000000001 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 2.96 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 0.91000000000000003 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 76' ' ' VAL . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 1.8400000000000001 111.275 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 0.46999999999999997 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.58 HG23 HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.85999999999999999 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.3899999999999999 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.3900000000000001 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.1000000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.57 142.49 50.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -22.39 50.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 8.3300000000000001 111.299 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.27 -49.45 0.95 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.221 0.452 . . . . 6.2300000000000004 112.221 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.1 mt -121.04 -28.08 4.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.402 -0.363 . . . . 4.3899999999999997 111.64 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.285 -0.864 . . . . 7.79 110.853 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.858 0.361 . . . . 5.6799999999999997 111.097 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.13 27.12 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.722 -0.751 . . . . 4.1100000000000003 112.705 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -128.08 153.61 46.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.791 0.329 . . . . 4.4699999999999998 110.986 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.894 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.5700000000000001 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 1.79 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 15.6 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.2599999999999998 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.29 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.4199999999999999 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.01 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.2400000000000002 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 4.4900000000000002 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 12' ' ' ILE . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.908 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.29 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.8399999999999999 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.8100000000000001 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.904 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.54 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.4000000000000004 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.732 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.01 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 1.51 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.68999999999999995 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 1.3899999999999999 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 2.9500000000000002 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.812 ' NE1' HG11 ' A' ' 21' ' ' VAL . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.82999999999999996 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' C ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.72 111.555 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 58' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.5 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.45000000000000001 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.31 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.872 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 0.28000000000000003 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.4199999999999999 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 2.52 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.93999999999999995 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.872 HG12 HG11 ' A' ' 32' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 0.46999999999999997 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.29 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 111.424 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 2.6000000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 3.6499999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 2.8300000000000001 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5199999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.5 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 40' ' ' GLU . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.46 110.582 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.419 HG13 ' CE2' ' A' ' 7' ' ' PHE . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.01 111.541 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.04 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.3600000000000001 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.2300000000000004 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 3.8799999999999999 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.17999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.1100000000000001 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 26' ' ' VAL . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 0.38 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.1400000000000001 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.938 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 1.3500000000000001 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.665 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.1399999999999999 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.0600000000000001 112.365 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.3799999999999999 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.1600000000000001 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CA ' ' HG2' ' A' ' 18' ' ' GLU . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.6500000000000004 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 12' ' ' ILE . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 3.6099999999999999 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 1.8700000000000001 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 2.96 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 0.91000000000000003 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 0.46999999999999997 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 HG12 ' A' ' 58' ' ' ILE . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 0.85999999999999999 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.894 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.3899999999999999 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.1000000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -104.9 146.7 28.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -17.83 -48.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.341 1.608 . . . . 8.3300000000000001 115.341 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.44 -57.71 2.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.167 -1.013 . . . . 6.2300000000000004 113.718 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.5 tp -141.13 -31.73 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.867 0.691 . . . . 4.3899999999999997 112.867 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.2 -0.905 . . . . 7.79 110.402 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.349 . . . . 5.6799999999999997 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.01 6.39 10.1 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.804 -0.712 . . . . 4.1100000000000003 112.939 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.18 146.98 30.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.934 0.367 . . . . 4.4699999999999998 110.472 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' CG ' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 1.5700000000000001 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 1.79 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' O ' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.2599999999999998 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.29 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.4199999999999999 112.47 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.923 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.2400000000000002 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 4.4900000000000002 112.1 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.474 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.892 HD12 HD11 ' A' ' 9' ' ' LEU . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.29 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.8399999999999999 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.8100000000000001 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG1' HG23 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.54 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.4000000000000004 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 12' ' ' ILE . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.923 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 1.51 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.932 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 0.68999999999999995 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.751 HG11 ' NE1' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 1.3899999999999999 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 2.9500000000000002 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.751 ' NE1' HG11 ' A' ' 21' ' ' VAL . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.82999999999999996 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.72 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.954 HG11 HG13 ' A' ' 32' ' ' VAL . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.5 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.45000000000000001 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 0.31 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.954 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.28000000000000003 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 2.52 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.93999999999999995 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.887 HG12 HG11 ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.46999999999999997 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.29 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 21' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.3500000000000001 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 111.038 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 3.6499999999999999 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 2.8300000000000001 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5199999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG21 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.5 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.01 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.04 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.3600000000000001 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.2300000000000004 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 3.8799999999999999 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.616 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.17999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.1100000000000001 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.38 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 1.3500000000000001 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 28' ' ' GLU . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.932 HD13 HG23 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.3799999999999999 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.1600000000000001 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.6500000000000004 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 12' ' ' ILE . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 3.6099999999999999 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 1.8700000000000001 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 2.96 111.421 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 0.91000000000000003 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 69' ' ' ALA . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.451 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 0.46999999999999997 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 0.85999999999999999 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.902 ' CG ' HG12 ' A' ' 4' ' ' VAL . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.3899999999999999 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HG21 ' A' ' 5' ' ' VAL . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.3900000000000001 110.657 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.1000000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -117.71 145.38 44.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -65.61 -21.7 66.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 8.3300000000000001 111.598 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -30.02 -49.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.929 0.714 . . . . 6.2300000000000004 112.929 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -108.97 -27.75 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 4.3899999999999997 110.859 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.174 -0.917 . . . . 7.79 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.677 0.275 . . . . 5.6799999999999997 111.348 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.55 58.09 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.667 -0.778 . . . . 4.1100000000000003 113.07 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -86.85 153.3 21.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.847 0.356 . . . . 4.4699999999999998 111.023 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.835 HG12 ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 1.5700000000000001 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 1.79 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.2599999999999998 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HD2' HD21 ' A' ' 75' ' ' LEU . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.29 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HA ' HD13 ' A' ' 75' ' ' LEU . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.4199999999999999 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.917 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.2400000000000002 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 4.4900000000000002 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.638 ' HB2' HD13 ' A' ' 12' ' ' ILE . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.971 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.29 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.8399999999999999 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.8100000000000001 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.795 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.54 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.4000000000000004 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB2' HG21 ' A' ' 68' ' ' ILE . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.917 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 1.51 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 0.68999999999999995 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 41' ' ' VAL . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 1.3899999999999999 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.745 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 2.9500000000000002 111.322 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.725 ' CZ3' HD22 ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 0.82999999999999996 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.72 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.778 ' HB ' HD12 ' A' ' 58' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 0.5 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 1.8899999999999999 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.45000000000000001 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.949 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 0.28000000000000003 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 2.52 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.93999999999999995 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.949 HG12 HG11 ' A' ' 32' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.46999999999999997 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.29 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.675 ' CG ' HG22 ' A' ' 49' ' ' THR . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 21' ' ' VAL . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.3500000000000001 110.954 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 2.6000000000000001 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 3.6499999999999999 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 2.8300000000000001 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5199999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.5 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.675 HG22 ' CG ' ' A' ' 40' ' ' GLU . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.46 110.246 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' ILE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.01 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.04 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.3600000000000001 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 3.8799999999999999 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 31' ' ' THR . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.17999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.1100000000000001 111.633 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.778 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 0.38 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.1400000000000001 113.425 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.793 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 1.3500000000000001 113.361 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.725 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.1399999999999999 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 22' ' ' LYS . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.3799999999999999 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.1600000000000001 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.6500000000000004 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 3.6099999999999999 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 1.8700000000000001 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 2.96 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 0.91000000000000003 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 1.8400000000000001 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 0.46999999999999997 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.784 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 0.85999999999999999 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.835 ' CG ' HG12 ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.3899999999999999 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.59 ' OG1' HG21 ' A' ' 5' ' ' VAL . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 110.782 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.1000000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 83' ' ' LEU . 2.6 tp -105.62 147.99 27.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -17.55 -47.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.264 1.579 . . . . 8.3300000000000001 115.264 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 83' ' ' LEU . 72.6 m-20 -108.7 -57.06 2.19 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.383 -0.927 . . . . 6.2300000000000004 113.257 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 86' ' ' LEU . 13.0 tp -141.25 -31.3 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.014 0.746 . . . . 4.3899999999999997 113.014 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.85 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.842 0.353 . . . . 4.4699999999999998 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 1.79 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.2599999999999998 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.29 109.17 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.4199999999999999 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.969 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.2400000000000002 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.432 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 4.4900000000000002 111.788 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.854 ' OD2' HG21 ' A' ' 41' ' ' VAL . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.871 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.29 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.8399999999999999 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.8100000000000001 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.871 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.54 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.83 ' HG2' HD12 ' A' ' 16' ' ' ILE . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.4000000000000004 110.94 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.969 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 1.51 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.718 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 0.68999999999999995 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.848 HG11 ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.3899999999999999 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 2.9500000000000002 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.848 ' CD1' HG11 ' A' ' 21' ' ' VAL . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 0.82999999999999996 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' C ' HG13 ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.72 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 38' ' ' ILE . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 1.8899999999999999 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 61' ' ' LEU . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.45000000000000001 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.31 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.4199999999999999 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 2.52 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 32' ' ' VAL . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.46999999999999997 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.29 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' OD2' ' A' ' 11' ' ' ASP . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.3500000000000001 110.537 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' SER . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 2.6000000000000001 111.411 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 3.6499999999999999 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 2.8300000000000001 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5199999999999996 110.445 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.768 HG21 ' OD1' ' A' ' 11' ' ' ASP . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.5 111.494 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.46 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 39' ' ' CYS . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.01 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.207 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.3600000000000001 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.2300000000000004 111.006 -178.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 3.8799999999999999 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' THR . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.17999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.1100000000000001 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 0.38 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.1400000000000001 113.671 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 1.3500000000000001 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.1399999999999999 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.0600000000000001 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.3799999999999999 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.1600000000000001 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 3.6099999999999999 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 1.8700000000000001 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 2.96 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 0.91000000000000003 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 1.8400000000000001 111.979 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 60' ' ' LYS . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 0.46999999999999997 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.85999999999999999 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.74 ' HG3' HG12 ' A' ' 4' ' ' VAL . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.443 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.3900000000000001 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.1000000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.026 0.441 . . . . 4.4699999999999998 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.781 HG12 ' CG ' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 1.5700000000000001 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 1.79 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.2599999999999998 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.29 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.4199999999999999 111.313 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.052 HD12 HG23 ' A' ' 71' ' ' VAL . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.2400000000000002 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 4.4900000000000002 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.682 ' C ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.29 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.8399999999999999 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.8100000000000001 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.54 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.4000000000000004 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.848 HG12 HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 1.51 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.792 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 0.68999999999999995 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 1.3899999999999999 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 2.9500000000000002 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.858 ' CD1' HG11 ' A' ' 21' ' ' VAL . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.82999999999999996 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.72 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 0.5 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 1.8899999999999999 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.45000000000000001 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 0.31 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.28000000000000003 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.4199999999999999 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 2.52 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 32' ' ' VAL . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 0.46999999999999997 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.29 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.3500000000000001 111.565 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 2.6000000000000001 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 3.6499999999999999 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 2.8300000000000001 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5199999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' SER . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.5 111.981 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.46 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.01 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.04 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.3600000000000001 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.2300000000000004 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 3.8799999999999999 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 31' ' ' THR . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.17999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.1100000000000001 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.734 HD13 HG21 ' A' ' 26' ' ' VAL . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 0.38 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.1400000000000001 113.75 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 1.3500000000000001 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD22 ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.1399999999999999 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 24' ' ' TRP . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.0600000000000001 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 20' ' ' THR . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.3799999999999999 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 1.043 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.1600000000000001 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.6500000000000004 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.052 HG23 HD12 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 3.6099999999999999 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 1.8700000000000001 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 2.96 111.545 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 0.91000000000000003 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 0.46999999999999997 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.641 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.781 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.3899999999999999 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.1000000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.728 0.299 . . . . 4.4699999999999998 110.73 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.887 HG12 ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 78' ' ' ILE . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 1.79 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.442 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.2599999999999998 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.602 ' CE2' HD21 ' A' ' 75' ' ' LEU . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.29 109.732 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.4199999999999999 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.2400000000000002 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 4.4900000000000002 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 12' ' ' ILE . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.29 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.8399999999999999 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.8100000000000001 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.54 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.543 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.4000000000000004 109.934 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 1.51 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 0.68999999999999995 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 41' ' ' VAL . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 1.3899999999999999 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 65' ' ' LEU . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 2.9500000000000002 111.346 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.777 ' CD1' HG11 ' A' ' 21' ' ' VAL . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 0.82999999999999996 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.72 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG23 ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 0.5 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 1.8899999999999999 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.45000000000000001 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.31 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 0.28000000000000003 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.4199999999999999 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 2.52 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 0.93999999999999995 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.893 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 0.46999999999999997 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.29 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 21' ' ' VAL . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.3500000000000001 110.518 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 2.6000000000000001 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 3.6499999999999999 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 2.8300000000000001 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5199999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' ASP . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.5 111.664 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.46 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.01 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.04 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.3600000000000001 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 3.8799999999999999 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.17999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 31' ' ' THR . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.1100000000000001 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' A' ' 26' ' ' VAL . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.1400000000000001 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.1399999999999999 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.0600000000000001 112.567 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.3799999999999999 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.1600000000000001 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.6500000000000004 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.889 HG22 HD12 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 3.6099999999999999 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 1.8700000000000001 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 2.96 111.292 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 0.91000000000000003 111.892 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 1.8400000000000001 111.89 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 HD11 ' A' ' 78' ' ' ILE . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 0.46999999999999997 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.721 HD11 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.85999999999999999 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.887 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.3899999999999999 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.495 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.3900000000000001 110.581 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.1000000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.816 0.341 . . . . 4.4699999999999998 110.861 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.782 HG12 ' CG ' ' A' ' 79' ' ' GLU . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 1.79 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.2599999999999998 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.632 ' CE2' HD21 ' A' ' 75' ' ' LEU . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.29 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.4199999999999999 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 12' ' ' ILE . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 4.4900000000000002 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.29 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.8399999999999999 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.8100000000000001 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.54 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.4000000000000004 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.023 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 1.51 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.819 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 0.68999999999999995 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 2.9500000000000002 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CD1' HG11 ' A' ' 21' ' ' VAL . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.421 ' C ' HG13 ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.72 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 0.5 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 1.8899999999999999 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.45000000000000001 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 0.31 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.28000000000000003 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.4199999999999999 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 2.52 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.93999999999999995 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 0.46999999999999997 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.29 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.3500000000000001 111.023 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 2.6000000000000001 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 3.6499999999999999 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 2.8300000000000001 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.5 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.46 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.509 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.01 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.3600000000000001 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.2300000000000004 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 3.8799999999999999 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.17999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.1100000000000001 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 26' ' ' VAL . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 0.38 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.1400000000000001 113.739 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 112.707 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.1399999999999999 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.0600000000000001 112.184 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.819 HD13 HG23 ' A' ' 20' ' ' THR . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.3799999999999999 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.629 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.1600000000000001 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.6500000000000004 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.662 HG22 HD12 ' A' ' 9' ' ' LEU . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 3.6099999999999999 110.934 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 1.8700000000000001 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 2.96 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 0.91000000000000003 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.632 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 1.8400000000000001 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' LYS . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 0.46999999999999997 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 76' ' ' VAL . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.85999999999999999 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.782 ' CG ' HG12 ' A' ' 4' ' ' VAL . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.3899999999999999 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.1000000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.027 0.441 . . . . 4.4699999999999998 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 1.5700000000000001 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 1.79 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.2599999999999998 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.542 ' CE1' HD11 ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.29 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.4199999999999999 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.019 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.2400000000000002 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 4.4900000000000002 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.872 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.29 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.8399999999999999 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.8100000000000001 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.872 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.54 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.4000000000000004 110.632 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.019 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 1.51 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 0.68999999999999995 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' CD1' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 1.3899999999999999 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 2.9500000000000002 111.375 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.812 ' CD1' HG11 ' A' ' 21' ' ' VAL . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.82999999999999996 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.72 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.721 HG21 HG23 ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.5 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.8899999999999999 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.496 ' N ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.45000000000000001 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.31 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.4199999999999999 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 2.52 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.93999999999999995 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 32' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 0.46999999999999997 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.29 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 21' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.3500000000000001 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 2.6000000000000001 111.279 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 3.6499999999999999 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 2.8300000000000001 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5199999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.5 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.46 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.542 HD11 ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.01 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.2300000000000004 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 3.8799999999999999 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.17999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.1100000000000001 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 26' ' ' VAL . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 0.38 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.687 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 1.3500000000000001 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.1399999999999999 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.0600000000000001 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.3799999999999999 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.1600000000000001 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.6500000000000004 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 3.6099999999999999 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 1.8700000000000001 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 2.96 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.91000000000000003 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 0.46999999999999997 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 0.85999999999999999 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.902 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.3899999999999999 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.3900000000000001 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.1000000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 27.6 mt-30 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 4.4699999999999998 111.02 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' OG1' ' A' ' 80' ' ' THR . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 1.79 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.2599999999999998 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.29 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.027 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.2400000000000002 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' ILE . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.947 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.29 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.8399999999999999 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.8100000000000001 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.823 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.54 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 16' ' ' ILE . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.4000000000000004 110.572 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.027 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 1.51 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.906 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 0.68999999999999995 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.3899999999999999 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.543 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 2.9500000000000002 111.508 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.753 ' CD1' HG11 ' A' ' 21' ' ' VAL . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 0.82999999999999996 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.72 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.947 HG21 HG23 ' A' ' 38' ' ' ILE . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.5 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 1.8899999999999999 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.31 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.906 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 0.28000000000000003 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.4199999999999999 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 2.52 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.93999999999999995 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.947 HG23 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.46999999999999997 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.29 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.3500000000000001 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 2.6000000000000001 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 3.6499999999999999 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 2.8300000000000001 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.439 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5199999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.5 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.46 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.01 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.04 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.3600000000000001 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.2300000000000004 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 3.8799999999999999 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.1100000000000001 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.556 HD11 HG13 ' A' ' 32' ' ' VAL . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 0.38 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.1400000000000001 114.006 -176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 1.3500000000000001 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.1399999999999999 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.462 ' CD1' HD13 ' A' ' 75' ' ' LEU . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.0600000000000001 112.225 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 20' ' ' THR . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.906 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.3799999999999999 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.6500000000000004 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 3.6099999999999999 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 1.8700000000000001 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 2.96 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 0.91000000000000003 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 1.8400000000000001 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 78' ' ' ILE . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 0.46999999999999997 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.85999999999999999 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.3899999999999999 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.605 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.3900000000000001 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.1000000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 81' ' ' GLU . 3.4 mp . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.831 0.348 . . . . 4.4699999999999998 111.141 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.56 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 1.5700000000000001 111.723 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 1.79 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.2599999999999998 112.606 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.4199999999999999 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.0 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.2400000000000002 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 4.4900000000000002 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.703 ' CG ' HD13 ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.946 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.29 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.8399999999999999 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.8100000000000001 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.946 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.54 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.4000000000000004 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.0 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 1.51 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.939 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 0.68999999999999995 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 1.3899999999999999 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 2.9500000000000002 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.753 ' NE1' HG11 ' A' ' 21' ' ' VAL . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 0.82999999999999996 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.72 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.83 HG23 HD11 ' A' ' 61' ' ' LEU . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.5 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 111.226 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.45000000000000001 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.31 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.728 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 2.52 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.93999999999999995 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.772 HG23 HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.46999999999999997 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.29 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 21' ' ' VAL . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.3500000000000001 111.132 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 2.6000000000000001 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8300000000000001 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5199999999999996 110.608 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.5 111.284 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.46 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.01 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.04 110.545 179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.3600000000000001 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.2300000000000004 111.077 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 3.8799999999999999 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.17999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.1100000000000001 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.683 ' CG1' HG23 ' A' ' 78' ' ' ILE . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 0.38 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.1400000000000001 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 1.3500000000000001 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 26' ' ' VAL . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.1399999999999999 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 24' ' ' TRP . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.0600000000000001 112.433 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' THR . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.939 HD13 HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.3799999999999999 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.1600000000000001 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.6500000000000004 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 3.6099999999999999 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 1.8700000000000001 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 2.96 111.451 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 0.91000000000000003 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 1.8400000000000001 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 0.46999999999999997 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.694 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 0.85999999999999999 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.56 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.3899999999999999 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.3900000000000001 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.831 0.348 . . . . 4.4699999999999998 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 79' ' ' GLU . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.5700000000000001 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' A' ' 80' ' ' THR . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 1.79 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.2599999999999998 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.29 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.4199999999999999 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.07 HD11 HD13 ' A' ' 12' ' ' ILE . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.2400000000000002 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.651 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 4.4900000000000002 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.07 HD13 HD11 ' A' ' 9' ' ' LEU . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.29 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.8399999999999999 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.8100000000000001 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.54 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.4000000000000004 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB3' HG22 ' A' ' 68' ' ' ILE . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.026 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 1.51 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 0.68999999999999995 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.677 HG11 ' NE1' ' A' ' 24' ' ' TRP . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 1.3899999999999999 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 2.9500000000000002 111.583 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.859 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.82999999999999996 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.72 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.919 HG11 HG13 ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.5 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.45000000000000001 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.31 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 0.28000000000000003 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.4199999999999999 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 2.52 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 0.93999999999999995 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 32' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 0.46999999999999997 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.29 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 21' ' ' VAL . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.3500000000000001 110.575 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 2.6000000000000001 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 3.6499999999999999 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 2.8300000000000001 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5199999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.5 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.46 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.01 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.04 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.2300000000000004 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 3.8799999999999999 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.17999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.1100000000000001 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 26' ' ' VAL . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 0.38 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.1400000000000001 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 1.3500000000000001 112.693 -178.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 27' ' ' LYS . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.1399999999999999 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.0600000000000001 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.874 HD13 HG23 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.3799999999999999 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.1600000000000001 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.6500000000000004 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 3.6099999999999999 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 1.8700000000000001 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 74' ' ' PRO . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 2.96 111.593 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 0.91000000000000003 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 1.8400000000000001 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 78' ' ' ILE . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.46999999999999997 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.671 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.85999999999999999 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.864 ' HG2' HG12 ' A' ' 4' ' ' VAL . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.3899999999999999 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.3900000000000001 110.494 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.1000000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 120.768 0.318 . . . . 4.4699999999999998 110.769 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.91 HG12 ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 1.5700000000000001 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.498 HG21 ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 1.79 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.2599999999999998 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.29 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.4199999999999999 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.134 HD11 HD13 ' A' ' 12' ' ' ILE . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.2400000000000002 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 4.4900000000000002 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.134 HD13 HD11 ' A' ' 9' ' ' LEU . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.29 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.8399999999999999 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.8100000000000001 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.54 111.552 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.4000000000000004 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 68' ' ' ILE . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.93 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 1.51 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.716 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 0.68999999999999995 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.811 HG11 ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 1.3899999999999999 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.588 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 2.9500000000000002 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CD1' HG11 ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.82999999999999996 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' C ' HG13 ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.72 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 38' ' ' ILE . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 0.5 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 61' ' ' LEU . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 1.8899999999999999 111.351 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.31 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.876 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.28000000000000003 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.4199999999999999 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 2.52 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.93999999999999995 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 0.46999999999999997 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.29 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 21' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.3500000000000001 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 2.6000000000000001 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 3.6499999999999999 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 2.8300000000000001 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.454 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.5 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.46 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.01 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.04 109.726 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.583 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.3600000000000001 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.2300000000000004 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 3.8799999999999999 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' THR . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.17999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.1100000000000001 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.559 ' CG1' HG23 ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.1400000000000001 113.905 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 1.3500000000000001 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.889 HD11 HG23 ' A' ' 26' ' ' VAL . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.1399999999999999 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.0600000000000001 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.1600000000000001 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.6500000000000004 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG11 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 3.6099999999999999 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 1.8700000000000001 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 2.96 111.343 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 0.91000000000000003 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 1.8400000000000001 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.845 HG13 HD11 ' A' ' 78' ' ' ILE . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 0.46999999999999997 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 0.85999999999999999 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.91 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.3899999999999999 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.498 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.3900000000000001 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 83' ' ' LEU . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.792 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.5700000000000001 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 1.79 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.2599999999999998 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.29 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.4199999999999999 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.2400000000000002 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 4.4900000000000002 110.958 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.555 ' HB3' HD13 ' A' ' 12' ' ' ILE . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.932 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.29 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.8399999999999999 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.8100000000000001 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.72 HD11 ' CG2' ' A' ' 12' ' ' ILE . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.54 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.4000000000000004 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 68' ' ' ILE . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 1.51 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.807 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 0.68999999999999995 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 41' ' ' VAL . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 1.3899999999999999 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.639 ' O ' HD23 ' A' ' 65' ' ' LEU . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 2.9500000000000002 111.074 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 0.82999999999999996 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.72 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 32' ' ' VAL . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 0.5 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 1.8899999999999999 111.481 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.45000000000000001 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.31 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 0.28000000000000003 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.4199999999999999 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 2.52 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.93999999999999995 110.228 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG12 HG11 ' A' ' 32' ' ' VAL . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 0.46999999999999997 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.29 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' VAL . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.3500000000000001 111.216 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 2.6000000000000001 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 3.6499999999999999 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 2.8300000000000001 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5199999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.5 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 40' ' ' GLU . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.49 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.01 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.04 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.3600000000000001 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.2300000000000004 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 3.8799999999999999 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' THR . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.17999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.1100000000000001 111.487 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 26' ' ' VAL . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 0.38 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.1400000000000001 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 1.3500000000000001 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.631 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.1399999999999999 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.0600000000000001 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.807 HD13 HG23 ' A' ' 20' ' ' THR . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.3799999999999999 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.1600000000000001 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.6500000000000004 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.932 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 3.6099999999999999 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 1.8700000000000001 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 2.96 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 0.91000000000000003 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 1.8400000000000001 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 78' ' ' ILE . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 0.46999999999999997 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.792 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.3899999999999999 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.3900000000000001 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.1000000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 mm-40 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.759 0.314 . . . . 4.4699999999999998 110.851 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.831 HG12 ' CG ' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.5700000000000001 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 1.79 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.509 ' HG3' ' CB ' ' A' ' 74' ' ' PRO . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.2599999999999998 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.29 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.4199999999999999 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.006 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.2400000000000002 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.4900000000000002 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.865 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.29 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.8399999999999999 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 71' ' ' VAL . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.8100000000000001 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.865 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.54 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.4000000000000004 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.006 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 1.51 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.905 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.68999999999999995 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.809 HG11 ' NE1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 1.3899999999999999 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 2.9500000000000002 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.867 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.82999999999999996 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.059 HG11 HG13 ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.5 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.8899999999999999 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.45000000000000001 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 0.31 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.059 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 0.28000000000000003 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 2.52 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' VAL . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.93999999999999995 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.95 HG12 HG11 ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.29 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 21' ' ' VAL . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.3500000000000001 111.246 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 2.6000000000000001 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 19' ' ' VAL . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 3.6499999999999999 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.8300000000000001 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5199999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 ' OD2' ' A' ' 11' ' ' ASP . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.5 111.79 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.46 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.01 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.04 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.3600000000000001 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.2300000000000004 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 3.8799999999999999 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.17999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.1100000000000001 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 32' ' ' VAL . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 0.38 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.1400000000000001 114.066 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.857 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 1.3500000000000001 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.867 HD22 ' CH2' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.1399999999999999 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 112.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.3799999999999999 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.1600000000000001 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.6500000000000004 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 3.6099999999999999 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 1.8700000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 2.96 110.866 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 0.91000000000000003 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 1.8400000000000001 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 0.46999999999999997 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.831 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.3899999999999999 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.3900000000000001 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.1000000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.772 0.32 . . . . 4.4699999999999998 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.783 HG12 ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 1.5700000000000001 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 1.79 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.2599999999999998 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.29 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.4199999999999999 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.02 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.2400000000000002 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 9' ' ' LEU . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 4.4900000000000002 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.29 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.8399999999999999 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.8100000000000001 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.54 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.4000000000000004 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.687 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.02 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 1.51 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.766 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 0.68999999999999995 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.832 HG11 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 1.3899999999999999 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 2.9500000000000002 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.842 ' CZ3' HD13 ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.82999999999999996 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.72 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.007 HG11 HG13 ' A' ' 32' ' ' VAL . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.5 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 1.8899999999999999 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.45000000000000001 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.31 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.007 HG13 HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.28000000000000003 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.4199999999999999 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 2.52 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.77 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.93999999999999995 110.27 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 78' ' ' ILE . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 0.46999999999999997 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.29 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.3500000000000001 111.493 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 2.6000000000000001 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 3.6499999999999999 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5199999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.5 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.46 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.01 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.04 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.3600000000000001 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.2300000000000004 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 3.8799999999999999 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 31' ' ' THR . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.1100000000000001 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 ' HB ' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 0.38 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.1400000000000001 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.864 ' C ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 1.3500000000000001 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG2' ' A' ' 58' ' ' ILE . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.1399999999999999 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.654 ' CD1' HD13 ' A' ' 75' ' ' LEU . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 112.901 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 20' ' ' THR . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.766 HD13 HG23 ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.3799999999999999 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.6500000000000004 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 3.6099999999999999 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 1.8700000000000001 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 2.96 111.924 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 0.91000000000000003 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 1.8400000000000001 110.809 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 78' ' ' ILE . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 0.46999999999999997 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.754 HG23 HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.85999999999999999 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.783 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.3899999999999999 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.3900000000000001 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.1000000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 120.853 0.359 . . . . 4.4699999999999998 111.194 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.706 HG12 ' CG ' ' A' ' 79' ' ' GLU . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 1.5700000000000001 111.008 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 78' ' ' ILE . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 1.79 108.019 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.2599999999999998 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.29 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.4199999999999999 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.089 HD11 HD12 ' A' ' 12' ' ' ILE . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.2400000000000002 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.489 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 4.4900000000000002 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.29 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.8399999999999999 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.8100000000000001 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.54 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.4000000000000004 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 1.51 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.876 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 0.68999999999999995 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.726 ' HA ' HG12 ' A' ' 41' ' ' VAL . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 1.3899999999999999 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 2.9500000000000002 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 0.82999999999999996 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.72 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 1.034 HG23 HD11 ' A' ' 61' ' ' LEU . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 0.5 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 1.8899999999999999 111.005 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 60' ' ' LYS . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.45000000000000001 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.498 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 0.28000000000000003 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 2.52 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 0.93999999999999995 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 0.46999999999999997 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 21' ' ' VAL . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.29 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 21' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.3500000000000001 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 2.6000000000000001 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 3.6499999999999999 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.8300000000000001 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5199999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.5 111.825 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.46 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.01 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.04 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.3600000000000001 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.2300000000000004 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 3.8799999999999999 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.17999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.1100000000000001 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.556 ' CG1' HG23 ' A' ' 78' ' ' ILE . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 0.38 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.1400000000000001 113.528 -176.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.034 HD11 HG23 ' A' ' 26' ' ' VAL . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.1399999999999999 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.0600000000000001 112.504 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.876 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.3799999999999999 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.1600000000000001 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.6500000000000004 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 12' ' ' ILE . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 3.6099999999999999 110.942 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 1.8700000000000001 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 2.96 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 0.91000000000000003 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 1.8400000000000001 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 HD11 ' A' ' 78' ' ' ILE . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 0.46999999999999997 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.71 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 0.85999999999999999 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.706 ' CG ' HG12 ' A' ' 4' ' ' VAL . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.3899999999999999 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.429 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.3900000000000001 110.253 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.1000000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.73 0.3 . . . . 4.4699999999999998 110.792 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.876 HG12 ' HG3' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 1.5700000000000001 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 1.79 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.2599999999999998 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.29 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.4199999999999999 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.986 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 4.4900000000000002 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.436 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.29 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.482 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.8399999999999999 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.8100000000000001 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.953 HD11 ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.54 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.4000000000000004 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 1.51 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.85 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 0.68999999999999995 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.786 HG11 ' NE1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 1.3899999999999999 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.786 ' NE1' HG11 ' A' ' 21' ' ' VAL . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.82999999999999996 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.72 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.5 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 1.8899999999999999 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.45000000000000001 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 0.31 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 0.28000000000000003 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 110.245 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 2.52 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 32' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.29 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.3500000000000001 111.476 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 2.6000000000000001 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 3.6499999999999999 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.8300000000000001 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5199999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.5 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.46 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.01 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.04 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.3600000000000001 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.2300000000000004 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 3.8799999999999999 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.17999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.1100000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.77 HD12 ' HB ' ' A' ' 26' ' ' VAL . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 0.38 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.1400000000000001 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 1.3500000000000001 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 26' ' ' VAL . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.1399999999999999 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.0600000000000001 112.194 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 20' ' ' THR . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.1600000000000001 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.6500000000000004 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.916 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 3.6099999999999999 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 1.8700000000000001 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 2.96 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 0.91000000000000003 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.8400000000000001 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 0.46999999999999997 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.904 HD11 HG13 ' A' ' 76' ' ' VAL . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.876 ' HG3' HG12 ' A' ' 4' ' ' VAL . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.3899999999999999 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.1000000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 83' ' ' LEU . 22.6 mt . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.524 -0.041 0 CA-C-O 120.779 0.323 . . . . 4.4699999999999998 110.896 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.909 HG12 ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 1.79 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.2599999999999998 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.29 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.015 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.2400000000000002 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 4.4900000000000002 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.901 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.29 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 71' ' ' VAL . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.8399999999999999 112.651 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.8100000000000001 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.54 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.4000000000000004 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.015 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 1.51 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 0.68999999999999995 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.3899999999999999 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 2.9500000000000002 110.9 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.846 ' CD1' HG11 ' A' ' 21' ' ' VAL . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 0.82999999999999996 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.428 ' C ' HG13 ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.72 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 58' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 0.5 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 1.8899999999999999 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.45000000000000001 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 56' ' ' GLY . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.31 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.881 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.28000000000000003 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.4199999999999999 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 2.52 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.93999999999999995 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.881 HG12 HG11 ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 0.46999999999999997 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.29 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.3500000000000001 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 2.6000000000000001 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 3.6499999999999999 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 2.8300000000000001 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5199999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.5 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.46 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.501 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.01 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.04 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.3600000000000001 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.2300000000000004 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 3.8799999999999999 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.17999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.1100000000000001 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 0.38 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.1400000000000001 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 1.3500000000000001 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.1399999999999999 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.518 ' HD2' HD22 ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 112.213 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.513 ' C ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.686 HD13 ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.3799999999999999 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.1600000000000001 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.6500000000000004 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 3.6099999999999999 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 1.8700000000000001 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 2.96 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 0.91000000000000003 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 1.8400000000000001 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.829 HG13 HD11 ' A' ' 78' ' ' ILE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 0.46999999999999997 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 0.85999999999999999 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.909 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.3899999999999999 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.3900000000000001 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.1000000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.868 0.366 . . . . 4.4699999999999998 110.863 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.2599999999999998 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.29 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.4199999999999999 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.974 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.2400000000000002 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 4.4900000000000002 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 12' ' ' ILE . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.816 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.29 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.8399999999999999 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.8100000000000001 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.816 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.54 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HB2' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 1.51 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.469 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 0.68999999999999995 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.901 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 1.3899999999999999 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 2.9500000000000002 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HA ' HD21 ' A' ' 65' ' ' LEU . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.901 ' CD1' HG11 ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.82999999999999996 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.72 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.722 ' HB ' HD12 ' A' ' 58' ' ' ILE . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.5 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.45000000000000001 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.31 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.28000000000000003 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 2.52 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 0.93999999999999995 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 32' ' ' VAL . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 49' ' ' THR . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.3500000000000001 111.056 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 2.6000000000000001 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 3.6499999999999999 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 2.8300000000000001 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5199999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.5 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.46 109.733 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.01 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.04 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.3600000000000001 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.2300000000000004 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 3.8799999999999999 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.17999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.1100000000000001 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.722 HD12 ' HB ' ' A' ' 26' ' ' VAL . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 0.38 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.1400000000000001 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.1399999999999999 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 23' ' ' GLU . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.0600000000000001 112.089 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 18' ' ' GLU . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.3799999999999999 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.1600000000000001 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.6500000000000004 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 3.6099999999999999 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 1.8700000000000001 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 2.96 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 0.91000000000000003 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 1.8400000000000001 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 0.46999999999999997 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.85999999999999999 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.3899999999999999 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.474 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 111.104 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.1000000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.733 0.301 . . . . 4.4699999999999998 110.815 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.79 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.2599999999999998 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.29 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.4199999999999999 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.013 HD11 HD13 ' A' ' 12' ' ' ILE . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.812 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 4.4900000000000002 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.013 HD13 HD11 ' A' ' 9' ' ' LEU . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.29 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.8399999999999999 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.8100000000000001 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.54 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.595 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.4000000000000004 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.627 ' HB3' HG22 ' A' ' 68' ' ' ILE . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 1.51 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.97 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 0.68999999999999995 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 1.3899999999999999 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 2.9500000000000002 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CH2' HD22 ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.82999999999999996 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.72 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 0.5 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' LEU . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.8899999999999999 111.006 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.45000000000000001 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 0.31 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 0.28000000000000003 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.4199999999999999 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 2.52 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.93999999999999995 110.55 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.838 HG23 HG21 ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 0.46999999999999997 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.29 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.919 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 21' ' ' VAL . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.3500000000000001 111.725 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 2.6000000000000001 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 3.6499999999999999 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 2.8300000000000001 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5199999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.5 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 40' ' ' GLU . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.536 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.471 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.01 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.04 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.3600000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.2300000000000004 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 3.8799999999999999 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.17999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.1100000000000001 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 26' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 0.38 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.1400000000000001 113.973 -177.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 1.3500000000000001 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 HD22 ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.0600000000000001 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.97 HD13 HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.3799999999999999 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.1600000000000001 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.409 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.6500000000000004 110.219 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 3.6099999999999999 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 1.8700000000000001 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 2.96 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 0.91000000000000003 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 76' ' ' VAL . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 1.8400000000000001 111.275 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 0.46999999999999997 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.58 HG23 HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.85999999999999999 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.3899999999999999 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.3900000000000001 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.1000000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 4.4699999999999998 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.894 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.5700000000000001 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 1.79 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 2.8 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.2599999999999998 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.29 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.4199999999999999 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.01 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.2400000000000002 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 4.4900000000000002 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 12' ' ' ILE . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.908 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.29 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.8399999999999999 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.8100000000000001 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.904 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.54 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.4000000000000004 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.732 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.01 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 1.51 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.68999999999999995 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 1.3899999999999999 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 2.9500000000000002 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.812 ' NE1' HG11 ' A' ' 21' ' ' VAL . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.82999999999999996 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' C ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.72 111.555 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 58' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.5 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.45000000000000001 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.31 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.872 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 0.28000000000000003 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.4199999999999999 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 2.52 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.93999999999999995 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.872 HG12 HG11 ' A' ' 32' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 0.46999999999999997 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.29 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 111.424 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 2.6000000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 3.6499999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 2.8300000000000001 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5199999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.5 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 40' ' ' GLU . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.46 110.582 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.419 HG13 ' CE2' ' A' ' 7' ' ' PHE . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.01 111.541 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.04 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.3600000000000001 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.2300000000000004 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 3.8799999999999999 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.17999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.1100000000000001 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 26' ' ' VAL . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 0.38 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.1400000000000001 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.938 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 1.3500000000000001 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.665 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.1399999999999999 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.0600000000000001 112.365 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.3799999999999999 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.1600000000000001 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CA ' ' HG2' ' A' ' 18' ' ' GLU . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.6500000000000004 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 12' ' ' ILE . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 3.6099999999999999 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 1.8700000000000001 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 2.96 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 0.91000000000000003 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 0.46999999999999997 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 HG12 ' A' ' 58' ' ' ILE . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 0.85999999999999999 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.894 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.3899999999999999 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.1000000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.602 0.239 . . . . 4.4699999999999998 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' CG ' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 1.5700000000000001 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 1.79 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.2599999999999998 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.448 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.29 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.4199999999999999 112.47 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.923 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.2400000000000002 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 4.4900000000000002 112.1 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.474 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.892 HD12 HD11 ' A' ' 9' ' ' LEU . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.29 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.8399999999999999 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.8100000000000001 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG1' HG23 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.54 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.4000000000000004 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 12' ' ' ILE . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.923 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 1.51 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.932 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 0.68999999999999995 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.751 HG11 ' NE1' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 1.3899999999999999 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 2.9500000000000002 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.751 ' NE1' HG11 ' A' ' 21' ' ' VAL . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.82999999999999996 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.72 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.954 HG11 HG13 ' A' ' 32' ' ' VAL . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.5 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.45000000000000001 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 0.31 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.954 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.28000000000000003 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 2.52 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.93999999999999995 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.887 HG12 HG11 ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.46999999999999997 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.29 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 21' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.3500000000000001 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 111.038 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 3.6499999999999999 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 2.8300000000000001 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5199999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.474 HG21 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.5 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.01 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.04 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.3600000000000001 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.2300000000000004 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 3.8799999999999999 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.616 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.17999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.1100000000000001 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.38 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 1.3500000000000001 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 28' ' ' GLU . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.932 HD13 HG23 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.3799999999999999 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.1600000000000001 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.6500000000000004 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 12' ' ' ILE . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 3.6099999999999999 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 1.8700000000000001 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 2.96 111.421 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 0.91000000000000003 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 69' ' ' ALA . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.451 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 0.46999999999999997 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 0.85999999999999999 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.902 ' CG ' HG12 ' A' ' 4' ' ' VAL . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.3899999999999999 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HG21 ' A' ' 5' ' ' VAL . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.3900000000000001 110.657 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.1000000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.847 0.356 . . . . 4.4699999999999998 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.835 HG12 ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 1.5700000000000001 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 1.79 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.2599999999999998 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HD2' HD21 ' A' ' 75' ' ' LEU . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.29 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HA ' HD13 ' A' ' 75' ' ' LEU . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.4199999999999999 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.917 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.2400000000000002 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 4.4900000000000002 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.638 ' HB2' HD13 ' A' ' 12' ' ' ILE . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.971 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.29 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.8399999999999999 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.8100000000000001 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.795 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.54 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.4000000000000004 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB2' HG21 ' A' ' 68' ' ' ILE . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.917 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 1.51 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 0.68999999999999995 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 41' ' ' VAL . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 1.3899999999999999 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.745 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 2.9500000000000002 111.322 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.725 ' CZ3' HD22 ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 0.82999999999999996 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.72 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.778 ' HB ' HD12 ' A' ' 58' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 0.5 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 1.8899999999999999 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.45000000000000001 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.949 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 0.28000000000000003 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 2.52 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.93999999999999995 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.949 HG12 HG11 ' A' ' 32' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.46999999999999997 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.29 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.675 ' CG ' HG22 ' A' ' 49' ' ' THR . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 21' ' ' VAL . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.3500000000000001 110.954 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 2.6000000000000001 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 3.6499999999999999 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 2.8300000000000001 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5199999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.5 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.675 HG22 ' CG ' ' A' ' 40' ' ' GLU . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.46 110.246 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' ILE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.01 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.04 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.3600000000000001 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 3.8799999999999999 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 31' ' ' THR . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.17999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.1100000000000001 111.633 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.778 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 0.38 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.1400000000000001 113.425 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.793 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 1.3500000000000001 113.361 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.725 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.1399999999999999 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 22' ' ' LYS . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.3799999999999999 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.1600000000000001 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.6500000000000004 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 3.6099999999999999 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 1.8700000000000001 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 2.96 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 0.91000000000000003 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 1.8400000000000001 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 0.46999999999999997 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.784 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 0.85999999999999999 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.835 ' CG ' HG12 ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.3899999999999999 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.59 ' OG1' HG21 ' A' ' 5' ' ' VAL . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 110.782 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.1000000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 83' ' ' LEU . 2.6 tp . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 ptm . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.893 0.378 . . . . 5.6799999999999997 111.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 19.47 5.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 4.1100000000000003 112.487 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.6 153.64 43.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.842 0.353 . . . . 4.4699999999999998 110.838 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.74 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.0 m -117.13 146.93 20.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.067 -0.515 . . . . 1.5700000000000001 111.473 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 78' ' ' ILE . 32.6 m -97.26 133.96 36.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.894 -0.594 . . . . 1.79 109.566 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 1.2 mt-30 -104.53 142.69 34.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.2 0.524 . . . . 2.2599999999999998 112.264 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -99.25 131.4 45.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.57 -0.741 . . . . 1.29 109.17 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -125.02 129.0 49.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 2.4199999999999999 111.74 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.969 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.7 tm? -50.61 115.28 1.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.972 -0.558 . . . . 2.2400000000000002 109.717 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.432 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -138.87 15.34 2.67 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.788 0.292 . . . . 4.4900000000000002 111.788 -179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.854 ' OD2' HG21 ' A' ' 41' ' ' VAL . 19.5 m-20 -64.58 -20.44 66.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.664 0.268 . . . . 5.4100000000000001 111.239 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.871 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -129.26 -176.59 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.95 0.405 . . . . 3.29 111.552 -179.309 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.35 171.64 48.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.045 -0.598 . . . . 3.8399999999999999 112.699 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -90.55 23.62 2.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.562 0.22 . . . . 7.7199999999999998 111.542 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.99 27.23 0.21 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 3.8100000000000001 112.311 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.871 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -131.89 -168.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.713 0.292 . . . . 2.54 111.094 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.83 ' HG2' HD12 ' A' ' 16' ' ' ILE . 1.7 ptt85 -53.0 148.37 7.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.354 -0.385 . . . . 4.4000000000000004 110.94 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' OE2' ' CD1' ' A' ' 70' ' ' TYR . 1.1 mt-10 -100.92 173.56 6.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.06 -0.518 . . . . 2.1699999999999999 110.516 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.969 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.8 p -133.59 148.12 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.676 0.621 . . . . 1.51 112.676 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.718 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -102.01 165.51 11.13 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.6 -0.727 . . . . 0.68999999999999995 110.745 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.848 HG11 ' CD1' ' A' ' 24' ' ' TRP . 54.4 t -79.6 137.02 22.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.225 -0.898 . . . . 1.3899999999999999 110.918 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.18 -26.17 11.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 2.9500000000000002 111.103 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.26 120.97 14.35 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.928 0.394 . . . . 2.1299999999999999 111.381 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.848 ' CD1' HG11 ' A' ' 21' ' ' VAL . 12.1 m95 -122.7 123.14 40.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.985 -0.552 . . . . 0.82999999999999996 110.176 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' C ' HG13 ' A' ' 26' ' ' VAL . 2.3 m-85 -130.4 39.88 3.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.768 0.318 . . . . 1.72 111.463 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.614 HG21 HG23 ' A' ' 38' ' ' ILE . 10.3 m -156.7 168.63 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.356 -0.384 . . . . 0.5 111.026 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -148.3 158.99 44.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 1.8899999999999999 111.033 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.584 ' N ' HD12 ' A' ' 61' ' ' LEU . 5.5 mt-10 -52.35 134.81 33.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 2.0299999999999998 110.196 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.65 3.77 59.7 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.095 -1.05 . . . . 0.45000000000000001 112.435 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.6 t0 -95.59 154.28 17.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.917 0.389 . . . . 1.3600000000000001 111.401 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.0 m -100.64 147.66 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.31 111.259 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.18 166.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.591 -0.731 . . . . 0.28000000000000003 110.397 179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -132.75 176.57 8.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 1.4199999999999999 110.906 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -65.25 -28.71 69.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 110.977 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -102.22 -17.48 15.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 2.52 111.31 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.7 t0 -95.71 87.32 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.819 0.342 . . . . 1.6899999999999999 111.026 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.06 157.49 10.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.93999999999999995 110.785 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 32' ' ' VAL . 3.0 mt -78.86 -68.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.393 -0.367 . . . . 0.46999999999999997 110.654 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.631 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.5 OUTLIER -140.15 156.79 46.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.147 -0.478 . . . . 1.29 110.945 179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -140.45 124.55 17.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.978 -0.555 . . . . 2.3700000000000001 110.363 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' OD2' ' A' ' 11' ' ' ASP . 18.1 m -110.43 143.63 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.304 -0.407 . . . . 1.3500000000000001 110.537 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' NE2' ' HB3' ' A' ' 47' ' ' SER . 12.2 mt-30 -127.84 121.35 29.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.994 0.426 . . . . 2.6000000000000001 111.411 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -118.81 154.41 32.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.855 -0.611 . . . . 2.29 110.513 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.9 p30 -47.6 -27.0 1.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.422 -0.354 . . . . 4.3899999999999997 111.182 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -72.43 -71.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 3.6499999999999999 110.778 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.24 163.28 33.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.907 -0.588 . . . . 2.8300000000000001 110.837 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.403 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 1.4 m -98.9 115.82 29.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 4.5199999999999996 110.445 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.768 HG21 ' OD1' ' A' ' 11' ' ' ASP . 0.9 OUTLIER -100.96 137.94 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.101 0.477 . . . . 3.5 111.494 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -134.0 129.76 36.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.697 -0.683 . . . . 1.46 109.94 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.631 HD12 ' O ' ' A' ' 39' ' ' CYS . 3.4 mp -98.98 110.08 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.117 0.484 . . . . 1.01 112.032 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.4 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.8 OUTLIER -91.19 -179.27 5.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.207 179.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.1 t -121.26 -33.61 3.65 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.891 0.33 . . . . 1.3600000000000001 111.891 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 0.0 OUTLIER 62.54 11.16 4.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.701 0.286 . . . . 4.2300000000000004 111.006 -178.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -177.62 173.99 1.57 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.906 -0.776 . . . . 3.8799999999999999 108.906 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -96.01 118.6 32.93 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.25 -0.58 . . . . 1.52 109.643 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' O ' HG23 ' A' ' 31' ' ' THR . . . -123.07 165.41 15.7 Favored Glycine 0 C--O 1.223 -0.592 0 C-N-CA 120.81 -0.71 . . . . 0.17999999999999999 113.363 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -106.01 120.84 57.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.314 0.487 . . . . 1.1100000000000001 112.314 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.565 ' CG1' HG23 ' A' ' 78' ' ' ILE . 29.0 mt -99.56 125.67 53.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.458 -0.571 . . . . 0.38 109.458 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 5.7 tttt -98.83 -43.92 6.57 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 113.671 0.989 . . . . 2.1400000000000001 113.671 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.801 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -138.85 146.18 40.91 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.746 0.647 . . . . 1.3500000000000001 112.746 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.584 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -137.85 134.34 35.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.041 -0.981 . . . . 1.1399999999999999 109.397 179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -114.73 -44.72 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.323 0.49 . . . . 3.0800000000000001 112.323 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -92.13 134.17 35.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.135 0.493 . . . . 1.9299999999999999 111.919 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -112.78 -172.15 2.0 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.685 -0.689 . . . . 1.7 111.119 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.4 mp -54.18 -21.81 9.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.301 -0.863 . . . . 1.0600000000000001 111.98 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.82 -27.46 12.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.457 0.54 . . . . 2.3300000000000001 112.457 -178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' C ' ' OG1' ' A' ' 20' ' ' THR . 2.6 m-20 -77.3 144.7 37.91 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.314 0.578 . . . . 1.8500000000000001 111.626 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.718 HD13 ' CB ' ' A' ' 20' ' ' THR . 2.2 mm -99.05 135.46 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-N 115.142 -0.935 . . . . 1.3799999999999999 110.576 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -99.91 146.96 26.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.938 -0.573 . . . . 2.1600000000000001 110.151 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CD1' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.09 147.65 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.836 -179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.484 HG22 HD12 ' A' ' 9' ' ' LEU . 16.4 t -79.0 133.73 29.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.453 . . . . 3.6099999999999999 111.184 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.34 -16.34 9.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 1.8700000000000001 112.773 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.96 131.3 19.86 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.735 0.267 . . . . 2.96 111.152 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -50.4 165.09 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.781 2.32 . . . . 0.91000000000000003 112.164 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.8 tt -123.3 -49.7 1.92 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.979 0.363 . . . . 1.8400000000000001 111.979 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 60' ' ' LYS . 7.3 p -142.79 147.25 20.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.786 0.291 . . . . 0.46999999999999997 111.786 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -107.4 122.89 47.52 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.992 0.425 . . . . 1.1000000000000001 110.32 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.785 HD11 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -134.57 149.35 29.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.645 . . . . 0.85999999999999999 110.768 -179.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.74 ' HG3' HG12 ' A' ' 4' ' ' VAL . 2.7 tt0 -98.81 115.53 28.99 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.7 -0.4 . . . . 1.3899999999999999 110.332 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.443 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -136.15 156.31 48.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.92 -0.582 . . . . 2.3900000000000001 110.406 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.08 150.58 16.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 3.1299999999999999 110.25 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -41.12 110.73 0.17 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.324 -0.398 . . . . 3.1000000000000001 111.982 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.641 HD23 ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -123.87 122.68 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 4.3099999999999996 110.992 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.6 pttm -53.54 -22.49 8.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 8.3300000000000001 111.246 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' HB2' HD23 ' A' ' 83' ' ' LEU . 3.1 t0 -40.36 -49.82 2.81 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.35 -0.386 . . . . 6.2300000000000004 112.005 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.7 tp -116.45 -28.17 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.704 0.288 . . . . 4.3899999999999997 111.102 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.234 -0.888 . . . . 7.79 110.814 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.776 0.322 . . . . 5.6799999999999997 111.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.63 13.74 23.34 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.781 -0.723 . . . . 4.1100000000000003 112.884 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -107.43 153.23 23.11 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.026 0.441 . . . . 4.4699999999999998 111.141 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.781 HG12 ' CG ' ' A' ' 79' ' ' GLU . 30.3 m -108.8 146.02 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.835 -0.621 . . . . 1.5700000000000001 111.26 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.1 m -97.19 125.76 50.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.994 -0.743 . . . . 1.79 108.994 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -99.41 145.79 27.01 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 112.526 0.565 . . . . 2.2599999999999998 112.526 -177.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 29.1 t80 -99.5 141.63 32.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.561 -0.745 . . . . 1.29 109.834 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.12 149.42 50.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.583 -0.735 . . . . 2.4199999999999999 111.313 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.052 HD12 HG23 ' A' ' 71' ' ' VAL . 2.9 tm? -37.36 145.27 0.06 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.788 -0.642 . . . . 2.2400000000000002 110.977 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 9' ' ' LEU . 91.8 p -52.9 -85.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.373 0.879 . . . . 4.4900000000000002 113.373 -176.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.682 ' C ' HG21 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -135.52 -26.83 1.22 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.552 1.686 . . . . 5.4100000000000001 115.552 -177.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.726 HG12 HD11 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -65.12 113.99 2.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 119.267 -0.973 . . . . 3.29 110.24 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.73 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -112.9 171.69 14.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.263 -0.97 . . . . 3.8399999999999999 113.225 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -40.65 98.41 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.873 0.368 . . . . 7.7199999999999998 111.55 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.24 -23.83 0.52 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.017 -0.611 . . . . 3.8100000000000001 112.217 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -129.07 -162.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.85 0.357 . . . . 2.54 110.546 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' N ' HG12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -78.97 143.54 35.65 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.661 -0.496 . . . . 4.4000000000000004 109.661 178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' HA ' ' CD1' ' A' ' 12' ' ' ILE . 4.9 mm-40 -99.01 173.35 6.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.043 -0.354 . . . . 2.1699999999999999 110.043 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.848 HG12 HD21 ' A' ' 9' ' ' LEU . 10.0 p -124.12 147.37 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 119.282 -0.967 . . . . 1.51 113.331 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.792 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 157.38 16.39 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.259 -0.882 . . . . 0.68999999999999995 110.221 179.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.858 HG11 ' CD1' ' A' ' 24' ' ' TRP . 51.5 t -79.03 127.06 39.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.78 -0.368 . . . . 1.3899999999999999 110.41 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.27 -26.5 14.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 2.9500000000000002 111.654 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -140.29 118.81 12.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 2.1299999999999999 111.915 -179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.858 ' CD1' HG11 ' A' ' 21' ' ' VAL . 8.3 m95 -120.93 115.54 23.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.84 -0.618 . . . . 0.82999999999999996 110.038 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.23 6.04 18.75 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.118 0.414 . . . . 1.72 112.118 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.861 HG11 HG13 ' A' ' 32' ' ' VAL . 11.0 m -135.84 162.0 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.647 0.261 . . . . 0.5 110.894 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.0 mmmt -135.8 171.2 14.81 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.106 0.479 . . . . 1.8899999999999999 111.508 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -60.06 132.82 55.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.651 -0.704 . . . . 2.0299999999999998 110.531 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 76.81 2.97 78.85 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.326 -0.94 . . . . 0.45000000000000001 112.746 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -98.89 155.01 17.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.981 0.419 . . . . 1.3600000000000001 111.286 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.1 m -99.14 150.59 21.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 0.31 111.189 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.861 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.01 157.33 5.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.778 -0.646 . . . . 0.28000000000000003 111.2 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -127.64 159.52 34.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.479 -0.782 . . . . 1.4199999999999999 110.148 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -54.38 -25.03 22.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.511 -0.313 . . . . 2.3799999999999999 111.311 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.33 -19.72 16.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.445 -0.343 . . . . 2.52 111.576 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.92 96.46 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.817 0.342 . . . . 1.6899999999999999 111.317 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 p -61.55 159.95 12.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 110.754 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.845 HG12 HG11 ' A' ' 32' ' ' VAL . 3.6 mt -85.62 -72.74 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.523 -0.308 . . . . 0.46999999999999997 110.558 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 24' ' ' TRP . 0.8 OUTLIER -140.25 153.78 46.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.047 0.451 . . . . 1.29 111.55 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -134.11 125.37 27.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.698 -0.683 . . . . 2.3700000000000001 110.174 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 21' ' ' VAL . 25.6 m -119.59 143.13 31.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.89 0.376 . . . . 1.3500000000000001 111.565 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -134.31 118.97 18.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 2.6000000000000001 110.761 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -125.7 154.52 42.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.51 . . . . 2.29 110.984 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -45.92 -33.07 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.297 -0.411 . . . . 4.3899999999999997 110.936 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -67.72 -69.69 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.995 -0.548 . . . . 3.6499999999999999 110.435 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.76 150.82 33.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.501 . . . . 2.8300000000000001 111.085 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 118.52 36.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 4.5199999999999996 110.516 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.588 HG21 ' CB ' ' A' ' 10' ' ' SER . 17.6 t -111.48 136.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.034 0.445 . . . . 3.5 111.981 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -122.86 126.94 48.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.715 -0.675 . . . . 1.46 109.957 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 24.2 mm -99.85 105.95 18.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 1.01 112.267 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.3 p -90.97 147.99 22.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.533 -0.758 . . . . 1.04 109.984 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 68.3 m -69.76 -58.75 3.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.587 -0.279 . . . . 1.3600000000000001 111.259 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.437 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 66.49 9.09 6.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.118 -0.492 . . . . 4.2300000000000004 111.264 -178.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 167.13 2.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.101 -0.703 . . . . 3.8799999999999999 109.101 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.1 t70 -99.93 121.54 41.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.615 -0.434 . . . . 1.52 109.861 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 31' ' ' THR . . . -139.28 164.69 25.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.388 -0.911 . . . . 0.17999999999999999 113.151 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.03 120.27 49.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 111.977 0.362 . . . . 1.1100000000000001 111.977 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.734 HD13 HG21 ' A' ' 26' ' ' VAL . 11.8 mt -98.97 124.72 52.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.537 -0.542 . . . . 0.38 109.537 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 60' ' ' LYS . 10.9 tttt -99.07 -44.14 6.41 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 113.75 1.018 . . . . 2.1400000000000001 113.75 -177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.499 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -140.45 139.19 35.14 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.919 -0.712 . . . . 1.3500000000000001 112.909 -178.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD22 ' CH2' ' A' ' 24' ' ' TRP . 11.4 mt -123.47 97.3 5.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.177 -0.92 . . . . 1.1399999999999999 109.799 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -67.67 -42.19 82.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.947 -0.57 . . . . 3.0800000000000001 112.201 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -103.81 134.64 46.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.981 0.419 . . . . 1.9299999999999999 111.881 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -114.86 -172.96 2.22 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.747 -0.66 . . . . 1.7 111.425 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 24' ' ' TRP . 2.8 mp -51.77 -26.53 9.83 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.172 -0.922 . . . . 1.0600000000000001 112.267 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -98.92 -26.05 14.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.511 0.56 . . . . 2.3300000000000001 112.511 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' C ' HG23 ' A' ' 20' ' ' THR . 0.4 OUTLIER -79.5 152.54 30.15 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.284 0.564 . . . . 1.8500000000000001 112.26 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.792 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -100.52 139.84 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 CA-C-N 115.03 -0.987 . . . . 1.3799999999999999 110.792 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 1.043 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.7 151.72 20.9 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 115.576 -0.738 . . . . 2.1600000000000001 110.3 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.87 148.87 52.69 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.311 -0.858 . . . . 5.6500000000000004 110.537 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.052 HG23 HD12 ' A' ' 9' ' ' LEU . 46.1 t -84.05 141.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.054 0.454 . . . . 3.6099999999999999 111.249 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.18 -11.32 8.64 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.859 -0.686 . . . . 1.8700000000000001 113.091 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -157.53 133.03 5.73 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 117.087 0.444 . . . . 2.96 111.545 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 39.3 Cg_exo -59.32 139.22 88.88 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.306 2.004 . . . . 0.91000000000000003 111.638 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.51 -21.75 15.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.782 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.26 154.48 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 121.014 -0.274 . . . . 0.46999999999999997 111.711 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -119.96 122.59 41.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.546 -0.538 . . . . 1.1000000000000001 109.546 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.641 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.55 145.57 32.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.065 -179.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.781 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -99.06 115.53 29.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.797 -0.361 . . . . 1.3899999999999999 110.228 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -140.4 157.7 45.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.03 -0.532 . . . . 2.3900000000000001 111.065 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -56.37 134.89 53.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 3.1299999999999999 110.603 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.77 111.06 0.15 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.847 -0.615 . . . . 3.1000000000000001 112.34 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.33 126.42 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 4.3099999999999996 110.285 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.6 -32.85 1.58 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.335 -0.393 . . . . 8.3300000000000001 111.577 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -49.64 -45.24 48.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 6.2300000000000004 111.111 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.43 16.04 16.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 4.3899999999999997 111.406 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.215 -0.898 . . . . 7.79 110.937 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mtp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.854 0.359 . . . . 5.6799999999999997 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 16.94 67.2 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 4.1100000000000003 112.632 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -141.73 152.13 43.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.728 0.299 . . . . 4.4699999999999998 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.887 HG12 ' CG ' ' A' ' 79' ' ' GLU . 20.2 m -113.53 145.5 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.208 0.528 . . . . 1.5700000000000001 111.982 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HB ' HD13 ' A' ' 86' ' ' LEU . 36.0 m -98.58 128.27 50.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.319 -0.855 . . . . 1.79 108.831 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.565 ' O ' HD11 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -103.63 144.88 30.85 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.482 0.549 . . . . 2.2599999999999998 112.482 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.602 ' CE2' HD21 ' A' ' 75' ' ' LEU . 22.1 t80 -103.48 140.47 37.45 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.373 -0.83 . . . . 1.29 109.732 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -125.63 145.02 50.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 2.4199999999999999 111.446 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -51.39 114.83 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 2.2400000000000002 110.226 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 t -142.53 120.34 11.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 4.4900000000000002 111.282 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.624 ' CG ' HD13 ' A' ' 12' ' ' ILE . 6.7 p-10 171.99 -29.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.244 -0.435 . . . . 5.4100000000000001 111.554 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -98.66 -95.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.983 -0.287 . . . . 3.29 111.508 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.56 171.19 32.99 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.769 -0.729 . . . . 3.8399999999999999 112.211 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.46 53.67 2.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.857 0.36 . . . . 7.7199999999999998 111.083 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.9 0.66 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.443 -0.884 . . . . 3.8100000000000001 113.125 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.76 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -71.52 -167.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.068 0.461 . . . . 2.54 111.608 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -55.02 153.24 6.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.728 -0.669 . . . . 4.4000000000000004 109.934 178.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' CD ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 mp0 -98.38 173.27 7.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.456 -0.338 . . . . 2.1699999999999999 110.595 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.0 p -129.45 155.04 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 112.883 0.697 . . . . 1.51 112.883 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.94 159.16 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.269 -0.878 . . . . 0.68999999999999995 111.105 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.819 ' HA ' HG12 ' A' ' 41' ' ' VAL . 44.0 t -79.81 129.98 36.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.981 -0.554 . . . . 1.3899999999999999 110.182 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 65' ' ' LEU . 8.6 tttt -94.53 -37.45 11.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.516 -0.311 . . . . 2.9500000000000002 111.346 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.05 130.4 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.632 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.777 ' CD1' HG11 ' A' ' 21' ' ' VAL . 6.1 m95 -125.18 121.93 35.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.682 -0.69 . . . . 0.82999999999999996 109.846 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 6.2 m-85 -132.24 35.46 3.69 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.454 0.539 . . . . 1.72 112.454 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.745 HG21 HG23 ' A' ' 38' ' ' ILE . 17.5 m -157.43 157.13 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.561 0.22 . . . . 0.5 110.828 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -135.85 166.92 22.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.165 0.507 . . . . 1.8899999999999999 111.943 -179.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.2 mt-10 -58.78 135.19 57.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.668 -0.697 . . . . 2.0299999999999998 110.528 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.08 3.4 60.53 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.2 -1.0 . . . . 0.45000000000000001 112.796 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.67 154.14 17.46 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.963 0.411 . . . . 1.3600000000000001 111.487 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.429 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.29 152.59 19.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.945 -0.57 . . . . 0.31 110.626 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -109.21 156.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.005 -0.543 . . . . 0.28000000000000003 111.336 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.2 m -138.83 162.4 34.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.875 -0.602 . . . . 1.4199999999999999 110.868 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -50.94 -24.11 3.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 111.389 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -97.02 -17.13 20.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.449 -0.341 . . . . 2.52 111.583 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -107.45 99.42 8.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.69 -179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -67.85 159.45 30.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.236 -0.438 . . . . 0.93999999999999995 110.054 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.893 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 mt -90.28 -83.07 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 111.725 0.269 . . . . 0.46999999999999997 111.725 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 18.4 t -120.98 146.04 47.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.988 0.423 . . . . 1.29 111.534 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -140.42 125.17 18.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.889 -0.596 . . . . 2.3700000000000001 110.649 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.819 HG12 ' HA ' ' A' ' 21' ' ' VAL . 23.1 m -126.65 156.29 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 1.3500000000000001 110.518 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -130.71 136.3 48.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 2.6000000000000001 111.547 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 t -113.46 149.52 34.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.94 -0.573 . . . . 2.29 110.625 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -50.3 -31.06 13.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 4.3899999999999997 111.345 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 46' ' ' ALA . 18.5 pttt -86.05 -46.3 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.47 -0.332 . . . . 3.6499999999999999 111.443 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 45' ' ' LYS . . . -148.65 159.16 44.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 2.8300000000000001 111.496 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.8 p -111.25 138.01 48.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.914 -0.584 . . . . 4.5199999999999996 110.38 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' ASP . 6.9 m -127.88 140.94 47.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.025 0.44 . . . . 3.5 111.664 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.5 p -132.39 131.9 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.759 -0.655 . . . . 1.46 110.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.88 106.06 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.01 111.4 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.8 p -79.87 -179.1 6.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.548 -0.751 . . . . 1.04 110.452 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.441 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.3 m -97.97 -60.53 1.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.423 -0.353 . . . . 1.3600000000000001 111.473 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.441 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.88 7.08 3.7 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 112.028 -179.113 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.82 169.69 2.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.032 -0.729 . . . . 3.8799999999999999 109.032 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p-10 -100.24 122.84 43.69 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.459 -0.496 . . . . 1.52 110.442 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -135.95 164.03 25.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.346 -0.93 . . . . 0.17999999999999999 112.713 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG22 HG23 ' A' ' 31' ' ' THR . 24.5 t -104.54 121.41 56.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 111.942 0.349 . . . . 1.1100000000000001 111.942 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.657 HD12 ' HB ' ' A' ' 26' ' ' VAL . 16.9 mt -98.87 127.22 51.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -98.71 -37.02 9.65 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 113.773 1.027 . . . . 2.1400000000000001 113.773 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.26 144.84 25.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -135.23 136.26 41.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.98 -1.009 . . . . 1.1399999999999999 109.118 178.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -114.85 -45.61 2.97 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.927 0.714 . . . . 3.0800000000000001 112.927 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.43 137.57 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.096 0.474 . . . . 1.9299999999999999 111.842 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 2.4 m120 -117.33 -175.02 2.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 1.7 111.448 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -53.69 -20.55 5.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.894 -1.048 . . . . 1.0600000000000001 112.567 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.51 -27.05 11.14 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.398 0.518 . . . . 2.3300000000000001 112.398 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.2 m-20 -75.21 151.84 38.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.354 0.597 . . . . 1.8500000000000001 112.016 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 2.9 mm -104.64 135.7 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 CA-C-N 115.15 -0.932 . . . . 1.3799999999999999 110.609 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -102.21 148.18 25.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 2.1600000000000001 109.972 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.421 ' CE2' ' CD ' ' A' ' 18' ' ' GLU . 2.5 m-85 -102.57 148.45 25.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.888 -0.596 . . . . 5.6500000000000004 110.822 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.889 HG22 HD12 ' A' ' 9' ' ' LEU . 11.5 t -86.33 127.19 40.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.072 -0.513 . . . . 3.6099999999999999 111.345 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.79 7.74 9.41 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.572 -0.823 . . . . 1.8700000000000001 113.324 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -156.75 135.05 7.4 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 117.081 0.441 . . . . 2.96 111.292 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.2 Cg_exo -58.48 159.44 19.83 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.565 2.177 . . . . 0.91000000000000003 111.892 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.602 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -128.26 -35.33 2.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.463 -0.335 . . . . 1.8400000000000001 111.89 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.721 HG13 HD11 ' A' ' 78' ' ' ILE . 14.3 p -133.18 151.14 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-O 120.83 0.348 . . . . 0.46999999999999997 111.864 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -116.74 128.16 55.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.128 -0.487 . . . . 1.1000000000000001 110.063 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.721 HD11 HG13 ' A' ' 76' ' ' VAL . 0.9 OUTLIER -138.51 146.59 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 0.85999999999999999 110.776 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.887 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -99.22 113.64 26.01 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.284 -0.566 . . . . 1.3899999999999999 110.34 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.495 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.5 p -142.84 156.37 44.93 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 2.3900000000000001 110.581 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.48 142.95 42.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.176 -0.305 . . . . 3.1299999999999999 110.176 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.94 110.59 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.058 0.392 . . . . 3.1000000000000001 112.058 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.433 ' CD1' ' HD3' ' A' ' 53' ' ' ARG . 12.6 mt -116.66 135.7 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.091 -0.504 . . . . 4.3099999999999996 110.554 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -24.39 67.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 8.3300000000000001 111.239 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.95 -41.66 25.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.304 -0.407 . . . . 6.2300000000000004 111.331 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -95.01 -24.74 16.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.438 -0.346 . . . . 4.3899999999999997 111.14 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.27 -0.871 . . . . 7.79 110.979 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.826 0.346 . . . . 5.6799999999999997 111.181 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.25 19.07 34.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.776 -0.726 . . . . 4.1100000000000003 112.567 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.61 124.92 4.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 4.4699999999999998 110.861 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.782 HG12 ' CG ' ' A' ' 79' ' ' GLU . 15.6 m -140.67 146.44 24.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.177 -0.465 . . . . 1.5700000000000001 111.634 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' OG1' ' A' ' 80' ' ' THR . 18.5 m -97.43 125.87 50.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 108.466 -0.939 . . . . 1.79 108.466 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -99.24 145.97 26.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.416 0.524 . . . . 2.2599999999999998 112.416 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.632 ' CE2' HD21 ' A' ' 75' ' ' LEU . 7.3 t80 -98.36 132.85 43.48 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.648 -0.705 . . . . 1.29 109.345 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ttmt -118.37 144.68 45.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.187 -0.915 . . . . 2.4199999999999999 111.123 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 12' ' ' ILE . 3.1 tm? -62.2 115.74 4.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 110.462 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 1.5 t -114.83 175.18 5.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.378 -0.374 . . . . 4.4900000000000002 111.1 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.9 t0 86.93 -18.22 0.32 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.821 -0.627 . . . . 5.4100000000000001 111.685 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 9' ' ' LEU . 33.3 mt -107.96 157.64 8.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.947 0.403 . . . . 3.29 110.667 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -111.23 158.1 14.56 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.871 -0.68 . . . . 3.8399999999999999 112.159 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -72.25 85.3 1.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.756 0.312 . . . . 7.7199999999999998 111.091 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.51 -24.31 0.58 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.411 -0.899 . . . . 3.8100000000000001 113.032 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.4 ' CG1' HG23 ' A' ' 12' ' ' ILE . 8.6 pt -99.16 -169.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.431 . . . . 2.54 111.558 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -66.66 153.95 41.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.711 -0.677 . . . . 4.4000000000000004 110.995 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.691 ' HA ' HD13 ' A' ' 12' ' ' ILE . 5.7 mp0 -97.45 173.93 6.93 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.527 -0.546 . . . . 2.1699999999999999 109.527 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.023 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -122.04 149.18 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 119.5 -0.88 . . . . 1.51 113.214 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.819 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.11 157.62 16.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.053 -0.976 . . . . 0.68999999999999995 110.982 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.7 t -79.65 132.3 32.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.165 -0.47 . . . . 1.3899999999999999 110.389 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 tptp -105.47 -23.71 12.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 2.9500000000000002 111.154 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -135.32 121.05 19.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 111.304 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CD1' HG11 ' A' ' 21' ' ' VAL . 7.0 m95 -128.95 116.15 18.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.82999999999999996 110.387 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.421 ' C ' HG13 ' A' ' 26' ' ' VAL . 8.7 m-85 -134.42 40.16 3.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 1.72 111.164 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.935 HG21 HG23 ' A' ' 38' ' ' ILE . 12.0 m -157.6 155.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.521 . . . . 0.5 110.522 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HA ' HD13 ' A' ' 61' ' ' LEU . 7.7 mmtt -140.01 165.22 27.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.012 0.434 . . . . 1.8899999999999999 111.546 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.1 mt-10 -54.92 133.5 48.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.836 -0.62 . . . . 2.0299999999999998 110.68 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.74 3.4 63.29 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.236 -0.983 . . . . 0.45000000000000001 112.434 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.55 154.16 17.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.351 . . . . 1.3600000000000001 111.297 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 56' ' ' GLY . 5.3 m -99.69 148.98 23.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.142 0.496 . . . . 0.31 111.391 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -106.75 163.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.28000000000000003 110.506 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -135.81 166.94 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 1.4199999999999999 110.829 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -38.98 66.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 2.3799999999999999 110.97 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -90.61 -20.5 22.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 2.52 111.304 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.67 95.03 8.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.873 0.368 . . . . 1.6899999999999999 111.176 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 70.3 m -66.99 159.99 27.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 0.93999999999999995 110.57 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 2.3 mt -84.55 -73.67 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.565 -0.289 . . . . 0.46999999999999997 110.878 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -140.51 150.96 44.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.878 0.37 . . . . 1.29 110.94 179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' CG ' ' HB3' ' A' ' 23' ' ' GLU . 18.7 mt-10 -136.59 127.51 27.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 2.3700000000000001 110.763 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.1 m -111.38 147.51 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 1.3500000000000001 111.023 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -134.67 125.26 26.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.309 -0.405 . . . . 2.6000000000000001 110.923 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 m -122.91 154.83 37.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 2.29 111.023 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -45.27 -35.9 3.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.214 -0.448 . . . . 4.3899999999999997 111.138 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -67.57 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 3.6499999999999999 110.765 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.74 157.95 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 2.8300000000000001 110.966 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.77 139.33 35.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 4.5199999999999996 110.746 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -123.67 138.83 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.347 -0.388 . . . . 3.5 111.436 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -128.59 128.15 43.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 1.46 110.508 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.509 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 30.8 mm -100.08 105.98 18.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.178 0.513 . . . . 1.01 111.739 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 167.58 12.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.289 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.0 m -96.37 -53.59 3.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.414 -0.357 . . . . 1.3600000000000001 111.293 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 76.34 1.07 3.33 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.336 -0.393 . . . . 4.2300000000000004 110.964 -179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -175.96 173.38 2.28 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.79 -0.819 . . . . 3.8799999999999999 108.79 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.1 m-20 -96.6 121.81 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.278 -0.569 . . . . 1.52 110.771 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.08 165.27 23.58 Favored Glycine 0 C--O 1.223 -0.549 0 CA-C-N 115.45 -0.795 . . . . 0.17999999999999999 112.553 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -105.26 123.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 112.157 0.429 . . . . 1.1100000000000001 112.157 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 26' ' ' VAL . 18.0 mt -98.94 127.29 51.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.944 -0.761 . . . . 0.38 108.944 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 18.7 tttm -98.61 -39.21 8.81 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.739 1.014 . . . . 2.1400000000000001 113.739 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.713 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -147.88 149.56 32.49 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 119.943 -0.703 . . . . 1.3500000000000001 112.707 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.1 mt -135.84 143.0 44.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.002 -0.999 . . . . 1.1399999999999999 109.459 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -119.87 -37.95 3.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.852 0.686 . . . . 3.0800000000000001 112.852 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 15.2 m-85 -96.86 135.22 39.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.015 0.435 . . . . 1.9299999999999999 111.856 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -113.15 -174.21 2.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.892 -0.595 . . . . 1.7 111.218 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mt -55.17 -22.32 16.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.331 -0.849 . . . . 1.0600000000000001 112.184 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.66 -25.83 13.72 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.451 0.537 . . . . 2.3300000000000001 112.451 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.04 153.03 30.56 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.396 0.617 . . . . 1.8500000000000001 112.29 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.819 HD13 HG23 ' A' ' 20' ' ' THR . 2.0 mm -105.3 137.59 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-N 114.822 -1.081 . . . . 1.3799999999999999 110.348 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.629 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -99.58 148.77 23.95 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.972 -0.558 . . . . 2.1600000000000001 109.706 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.485 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.0 OUTLIER -114.1 148.47 37.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.365 -0.834 . . . . 5.6500000000000004 110.693 -179.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.662 HG22 HD12 ' A' ' 9' ' ' LEU . 2.0 t -82.77 139.58 17.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.216 -0.447 . . . . 3.6099999999999999 110.934 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.4 -19.03 8.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.562 -0.828 . . . . 1.8700000000000001 113.142 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.49 130.7 9.2 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.795 0.298 . . . . 2.96 110.95 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 40.2 Cg_exo -55.75 164.74 4.2 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.374 2.049 . . . . 0.91000000000000003 111.786 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.632 HD21 ' CE2' ' A' ' 7' ' ' PHE . 1.4 pp -123.62 -37.4 2.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.226 0.454 . . . . 1.8400000000000001 112.226 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 60' ' ' LYS . 12.2 p -134.19 144.23 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.262 -0.575 . . . . 0.46999999999999997 112.17 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -108.72 133.18 53.15 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 110.365 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.626 HD11 HG13 ' A' ' 76' ' ' VAL . 1.1 mp -139.7 150.47 22.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.85999999999999999 111.359 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.782 ' CG ' HG12 ' A' ' 4' ' ' VAL . 45.5 mt-10 -98.91 113.06 25.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.928 0.394 . . . . 1.3899999999999999 110.266 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 5' ' ' VAL . 9.5 p -143.12 156.99 44.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.426 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.84 149.22 18.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.791 0.329 . . . . 3.1299999999999999 110.515 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.06 113.14 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.104 -0.498 . . . . 3.1000000000000001 112.123 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.86 145.09 45.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.973 -0.558 . . . . 4.3099999999999996 110.823 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -24.51 40.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 8.3300000000000001 111.09 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.38 -40.77 50.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 6.2300000000000004 111.3 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -107.53 -23.68 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 4.3899999999999997 110.899 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.206 -0.902 . . . . 7.79 110.877 179.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.867 0.365 . . . . 5.6799999999999997 111.188 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.78 67.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.69 -0.767 . . . . 4.1100000000000003 112.827 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -132.33 126.2 32.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.027 0.441 . . . . 4.4699999999999998 110.97 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' HG3' ' A' ' 79' ' ' GLU . 35.5 m -140.79 147.42 22.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.903 -0.589 . . . . 1.5700000000000001 111.135 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 78' ' ' ILE . 28.8 m -96.39 124.95 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.273 -0.64 . . . . 1.79 109.273 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -102.88 146.01 28.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.872 -0.604 . . . . 2.2599999999999998 112.155 -177.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' CE1' HD11 ' A' ' 50' ' ' ILE . 22.8 t80 -98.32 131.12 44.89 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.942 -0.762 . . . . 1.29 108.942 178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -121.73 136.64 54.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.536 -0.756 . . . . 2.4199999999999999 111.313 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.019 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -47.57 114.93 0.98 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.188 -0.46 . . . . 2.2400000000000002 110.376 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.7 p -134.48 99.09 4.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.339 -0.391 . . . . 4.4900000000000002 111.368 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.481 ' OD2' HD13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -169.29 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.956 -0.566 . . . . 5.4100000000000001 110.46 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.872 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -115.88 169.86 6.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 3.29 110.964 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.48 171.01 39.43 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.715 -0.755 . . . . 3.8399999999999999 113.008 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.06 92.1 7.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.893 0.378 . . . . 7.7199999999999998 111.04 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.95 -37.68 0.7 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.847 -0.692 . . . . 3.8100000000000001 112.233 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.872 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.08 -170.24 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 2.54 111.04 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -61.77 152.19 32.03 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 4.4000000000000004 110.632 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.0 mp0 -99.28 173.54 6.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.28 -0.418 . . . . 2.1699999999999999 109.884 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.019 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.2 p -117.14 148.21 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.9 -0.72 . . . . 1.51 112.517 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.899 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.62 159.13 15.16 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.555 -0.748 . . . . 0.68999999999999995 111.393 -179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' CD1' ' A' ' 24' ' ' TRP . 63.3 t -79.54 123.75 36.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.771 -0.65 . . . . 1.3899999999999999 110.236 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -93.52 -29.72 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 2.9500000000000002 111.375 -179.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 25' ' ' TYR . 1.8 tm-20 -140.16 118.64 12.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 2.1299999999999999 111.827 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.812 ' CD1' HG11 ' A' ' 21' ' ' VAL . 4.5 m95 -116.13 123.82 48.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.848 -0.615 . . . . 0.82999999999999996 109.715 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.443 ' CD2' ' OE1' ' A' ' 23' ' ' GLU . 1.5 m-85 -130.18 29.93 4.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.147 0.425 . . . . 1.72 112.147 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.721 HG21 HG23 ' A' ' 38' ' ' ILE . 5.9 m -154.38 166.66 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.5 111.637 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HA ' HD13 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -145.3 164.22 32.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.8899999999999999 110.97 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.496 ' N ' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.44 136.93 49.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.0299999999999998 111.032 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.33 3.96 55.02 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.324 -0.941 . . . . 0.45000000000000001 112.718 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -95.24 153.56 17.61 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 120.863 0.363 . . . . 1.3600000000000001 111.53 -178.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -101.89 146.84 27.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.956 -0.566 . . . . 0.31 110.918 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.918 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -106.61 162.19 5.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.82 -0.627 . . . . 0.28000000000000003 110.95 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 52' ' ' SER . 33.4 t -129.39 178.0 6.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.042 -0.526 . . . . 1.4199999999999999 110.689 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' CA ' ' A' ' 54' ' ' TYR . 3.7 mt-30 -67.13 -21.79 65.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.336 -0.393 . . . . 2.3799999999999999 111.421 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -104.28 -18.38 14.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.499 -0.319 . . . . 2.52 111.533 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -96.7 103.56 15.49 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.814 0.34 . . . . 1.6899999999999999 111.363 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.7 m -68.85 159.66 32.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.493 . . . . 0.93999999999999995 110.778 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.918 HG12 HG11 ' A' ' 32' ' ' VAL . 6.8 mt -90.63 -78.04 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.515 -0.311 . . . . 0.46999999999999997 111.206 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.5 t -121.84 145.36 48.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.449 -0.341 . . . . 1.29 110.95 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 23' ' ' GLU . 3.0 mt-10 -140.24 126.85 20.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 2.3700000000000001 110.875 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 21' ' ' VAL . 20.1 m -126.46 148.35 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 1.3500000000000001 110.984 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 22' ' ' LYS . 6.8 mt-30 -129.31 122.48 29.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 2.6000000000000001 111.279 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.47 150.24 27.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.878 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -50.89 -29.31 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 4.3899999999999997 110.882 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -81.0 -54.99 5.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 3.6499999999999999 110.863 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.1 160.16 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 2.8300000000000001 111.087 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 m -102.35 135.71 43.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 4.5199999999999996 110.992 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.471 ' HB ' HG22 ' A' ' 41' ' ' VAL . 2.1 t -114.15 134.67 56.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.435 . . . . 3.5 110.911 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.7 p -135.54 126.15 27.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 1.46 110.82 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.542 HD11 ' CE1' ' A' ' 7' ' ' PHE . 36.3 mm -99.71 105.98 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.151 0.5 . . . . 1.01 111.407 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -84.92 -178.6 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.561 -0.745 . . . . 1.04 110.537 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 33' ' ' SER . 0.8 OUTLIER -112.51 -62.31 1.6 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.58 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.91 2.6 4.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.447 -0.342 . . . . 4.2300000000000004 110.737 -178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 3.0 m-85 -175.16 172.16 2.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.047 -0.723 . . . . 3.8799999999999999 109.047 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 p30 -97.8 123.29 41.68 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.333 -0.547 . . . . 1.52 110.923 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -129.83 165.27 22.35 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.17999999999999999 112.501 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.45 121.56 59.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 112.017 0.377 . . . . 1.1100000000000001 112.017 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.646 HD13 HG21 ' A' ' 26' ' ' VAL . 27.5 mt -99.04 128.62 50.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.651 -0.5 . . . . 0.38 109.651 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HD3' ' CE ' ' A' ' 60' ' ' LYS . 18.6 tttt -98.9 -30.18 12.52 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.687 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -162.17 147.48 12.84 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.254 0.835 . . . . 1.3500000000000001 113.254 -179.112 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.2 mp -137.52 125.79 23.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.951 -1.022 . . . . 1.1399999999999999 109.114 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.87 -45.45 6.3 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.113 0.782 . . . . 3.0800000000000001 113.113 -177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 63' ' ' TYR . 0.7 OUTLIER -92.39 133.33 35.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.139 0.495 . . . . 1.9299999999999999 112.136 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.404 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.7 m120 -104.87 -168.29 1.46 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.729 -0.669 . . . . 1.7 111.174 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.93 -22.49 26.36 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.324 -0.853 . . . . 1.0600000000000001 112.275 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.32 -26.16 13.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.965 0.358 . . . . 2.3300000000000001 111.965 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -71.46 149.47 45.84 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.417 0.627 . . . . 1.8500000000000001 112.16 -179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -109.14 132.78 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.819 -1.082 . . . . 1.3799999999999999 110.203 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -100.2 152.52 20.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.956 -0.565 . . . . 2.1600000000000001 110.484 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 140.9 50.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.618 -0.719 . . . . 5.6500000000000004 109.927 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.44 138.36 21.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.317 -0.401 . . . . 3.6099999999999999 111.518 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 -5.82 10.99 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.642 -0.789 . . . . 1.8700000000000001 113.551 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.43 129.29 4.62 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.229 0.514 . . . . 2.96 111.293 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.53 154.15 31.81 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.497 2.131 . . . . 0.91000000000000003 112.015 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' HG ' ' N ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -121.4 -31.74 4.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.407 -0.36 . . . . 1.8400000000000001 111.488 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.5 p -136.12 145.82 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.792 -0.363 . . . . 0.46999999999999997 111.701 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -112.35 127.92 56.14 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.156 -0.475 . . . . 1.1000000000000001 110.01 179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.671 HG12 HD13 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -139.82 147.83 23.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.752 -0.203 . . . . 0.85999999999999999 110.845 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.902 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -100.05 112.54 24.84 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.442 -0.503 . . . . 1.3899999999999999 110.281 179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.474 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.1 p -143.76 157.92 44.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.722 -0.672 . . . . 2.3900000000000001 110.34 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -56.38 152.91 10.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.698 -0.401 . . . . 3.1299999999999999 109.998 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.02 111.71 0.18 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.502 0.556 . . . . 3.1000000000000001 112.502 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.9 mt -117.13 121.61 41.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.076 -0.511 . . . . 4.3099999999999996 110.497 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -22.21 23.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.04 -0.527 . . . . 8.3300000000000001 111.645 -179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -34.26 -44.11 0.18 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.389 0.515 . . . . 6.2300000000000004 112.389 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.417 HD21 ' O ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -117.46 -16.19 10.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.503 -0.317 . . . . 4.3899999999999997 111.435 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.727 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.801 0.334 . . . . 5.6799999999999997 111.347 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.28 14.59 27.86 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 4.1100000000000003 112.961 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 27.6 mt-30 -140.11 146.81 39.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.942 0.401 . . . . 4.4699999999999998 111.02 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.843 HG12 ' HG3' ' A' ' 79' ' ' GLU . 32.8 m -140.06 147.67 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.876 -0.602 . . . . 1.5700000000000001 111.025 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 ' OG1' ' A' ' 80' ' ' THR . 27.4 m -96.56 137.12 25.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.952 -0.758 . . . . 1.79 108.952 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 0.9 OUTLIER -117.96 147.34 43.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 113.035 0.754 . . . . 2.2599999999999998 113.035 -177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 15.4 t80 -98.02 131.62 44.29 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.237 -0.892 . . . . 1.29 108.866 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -119.1 135.33 54.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 110.695 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.027 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -46.83 115.02 0.94 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.403 -0.362 . . . . 2.2400000000000002 110.739 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.1 t -134.94 73.59 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 4.4900000000000002 110.824 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' HD13 ' A' ' 12' ' ' ILE . 6.9 t0 -135.43 -40.23 0.72 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 5.4100000000000001 111.312 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.947 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -118.46 -178.23 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.8 0.333 . . . . 3.29 111.385 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.08 171.42 34.09 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.917 -0.659 . . . . 3.8399999999999999 112.935 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -84.39 86.59 7.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.719 0.295 . . . . 7.7199999999999998 111.056 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.31 -39.95 0.7 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 3.8100000000000001 112.393 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.823 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.1 pt -79.23 -173.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.999 0.428 . . . . 2.54 111.223 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' HG2' HD12 ' A' ' 16' ' ' ILE . 8.6 ptm180 -56.8 153.06 11.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.927 -0.579 . . . . 4.4000000000000004 110.572 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -98.27 173.6 6.91 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.879 -0.415 . . . . 2.1699999999999999 109.879 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.027 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -117.14 146.34 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 119.871 -0.732 . . . . 1.51 112.847 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.906 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.37 157.07 16.42 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.408 -0.815 . . . . 0.68999999999999995 111.314 -179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 24' ' ' TRP . 47.1 t -79.76 134.46 27.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 1.3899999999999999 110.085 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.543 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.3 tmtt? -102.99 -36.77 8.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.552 -0.295 . . . . 2.9500000000000002 111.508 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' CB ' ' HB2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -128.64 123.19 32.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.996 0.426 . . . . 2.1299999999999999 111.748 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.753 ' CD1' HG11 ' A' ' 21' ' ' VAL . 9.4 m95 -123.98 115.56 21.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.746 -0.661 . . . . 0.82999999999999996 109.928 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.04 24.72 8.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.657 0.265 . . . . 1.72 111.609 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.947 HG21 HG23 ' A' ' 38' ' ' ILE . 7.7 m -151.28 161.86 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.738 0.304 . . . . 0.5 111.134 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 19.7 mmtt -145.37 172.38 13.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.22 0.534 . . . . 1.8899999999999999 111.695 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.7 mt-10 -57.67 136.39 56.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 2.0299999999999998 111.116 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.83 2.96 58.41 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.546 -0.835 . . . . 0.45000000000000001 113.191 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -98.64 154.33 18.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 1.3600000000000001 111.521 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.4 m -99.1 152.79 19.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.601 . . . . 0.31 111.357 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.906 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.68 160.95 9.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.769 -0.65 . . . . 0.28000000000000003 111.137 -179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.74 178.17 7.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.923 -0.58 . . . . 1.4199999999999999 110.598 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -70.35 -23.6 62.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.389 -0.369 . . . . 2.3799999999999999 111.118 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -100.48 -21.1 15.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 2.52 111.174 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.6 101.84 13.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.813 0.339 . . . . 1.6899999999999999 111.205 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 p -68.11 159.63 30.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.93999999999999995 110.752 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.947 HG23 HG21 ' A' ' 26' ' ' VAL . 2.9 mt -85.87 -70.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.858 0.361 . . . . 0.46999999999999997 110.854 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.487 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -139.33 157.42 45.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.101 -0.499 . . . . 1.29 110.636 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' HG2' ' CB ' ' A' ' 49' ' ' THR . 2.4 mt-10 -140.26 125.39 18.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.376 -0.375 . . . . 2.3700000000000001 110.845 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.1 m -117.76 143.14 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.3500000000000001 110.867 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' CB ' ' A' ' 47' ' ' SER . 11.9 mt-30 -126.14 136.37 52.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.285 -0.416 . . . . 2.6000000000000001 111.21 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -123.3 154.32 39.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.021 -0.536 . . . . 2.29 110.696 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -53.54 -22.11 7.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 4.3899999999999997 111.233 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -86.26 -51.17 6.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.509 -0.314 . . . . 3.6499999999999999 111.386 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' N ' ' CG ' ' A' ' 45' ' ' LYS . . . -149.89 162.57 40.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.931 0.396 . . . . 2.8300000000000001 111.549 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.439 ' CB ' ' HG2' ' A' ' 42' ' ' GLN . 6.7 m -106.31 117.22 33.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.036 -0.529 . . . . 4.5199999999999996 110.36 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.8 t -109.79 134.3 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.091 0.472 . . . . 3.5 111.825 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.444 ' CB ' ' HG2' ' A' ' 40' ' ' GLU . 71.9 p -125.27 128.53 48.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 1.46 110.152 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.486 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 18.6 mm -99.64 106.52 19.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.237 0.541 . . . . 1.01 111.945 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.61 -178.95 5.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.517 -0.765 . . . . 1.04 109.96 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.2 t -103.3 -47.03 4.43 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.594 -0.275 . . . . 1.3600000000000001 111.071 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 65.27 9.47 5.67 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.111 -0.495 . . . . 4.2300000000000004 111.348 -178.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.48 171.27 1.97 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.115 -0.698 . . . . 3.8799999999999999 109.115 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -98.65 121.28 40.4 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.488 -0.485 . . . . 1.52 110.317 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.605 ' HA3' HG23 ' A' ' 80' ' ' THR . . . -137.37 164.9 25.33 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 112.939 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.63 122.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.121 0.415 . . . . 1.1100000000000001 112.121 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.556 HD11 HG13 ' A' ' 32' ' ' VAL . 15.2 mt -98.55 125.1 52.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 109.321 -0.622 . . . . 0.38 109.321 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 17.3 tttt -98.28 -39.71 8.7 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 114.006 1.113 . . . . 2.1400000000000001 114.006 -176.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.19 139.67 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.218 0.821 . . . . 1.3500000000000001 113.218 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD23 ' CH2' ' A' ' 24' ' ' TRP . 4.1 mp -137.79 135.19 36.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.915 -1.039 . . . . 1.1399999999999999 109.31 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.3 -38.42 5.0 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.916 0.71 . . . . 3.0800000000000001 112.916 -178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.462 ' CD1' HD13 ' A' ' 75' ' ' LEU . 21.2 m-85 -86.89 134.24 33.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 1.9299999999999999 111.781 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 86.0 m-20 -115.16 -172.84 2.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.697 -0.683 . . . . 1.7 111.264 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -53.96 -24.0 15.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 1.0600000000000001 112.225 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.41 -26.24 13.94 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.529 0.566 . . . . 2.3300000000000001 112.529 -178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 20' ' ' THR . 5.3 m-20 -75.26 151.56 38.35 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 1.8500000000000001 112.204 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.906 HD13 HG23 ' A' ' 20' ' ' THR . 1.1 mm -108.45 142.11 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 CA-C-N 115.069 -0.969 . . . . 1.3799999999999999 110.246 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -108.42 145.8 34.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.797 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -105.13 148.18 27.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.196 -0.911 . . . . 5.6500000000000004 110.072 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.947 HG21 ' O ' ' A' ' 12' ' ' ILE . 11.2 t -79.72 126.84 39.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.839 0.352 . . . . 3.6099999999999999 111.649 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.22 6.84 8.74 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.507 -0.854 . . . . 1.8700000000000001 113.38 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.73 129.48 5.85 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 117.154 0.477 . . . . 2.96 111.131 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.86 165.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.779 2.319 . . . . 0.91000000000000003 112.852 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -120.27 -50.04 2.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 1.8400000000000001 111.334 -179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.772 HG13 HD11 ' A' ' 78' ' ' ILE . 6.8 p -141.89 158.93 20.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.315 -0.402 . . . . 0.46999999999999997 111.558 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -118.81 119.89 35.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.889 0.376 . . . . 1.1000000000000001 110.18 179.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.772 HD11 HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -132.29 149.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.85999999999999999 110.868 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.843 ' HG3' HG12 ' A' ' 4' ' ' VAL . 1.7 mt-10 -99.33 113.44 25.75 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.518 -0.473 . . . . 1.3899999999999999 110.307 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.605 HG23 ' HA3' ' A' ' 56' ' ' GLY . 1.0 OUTLIER -143.18 157.47 44.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.542 -0.754 . . . . 2.3900000000000001 110.532 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -56.99 154.2 10.0 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.888 -0.412 . . . . 3.1299999999999999 109.888 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -38.24 115.2 0.42 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.144 0.424 . . . . 3.1000000000000001 112.144 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 81' ' ' GLU . 3.4 mp -117.02 145.75 43.49 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.047 -0.524 . . . . 4.3099999999999996 111.205 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -22.16 66.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.906 -0.588 . . . . 8.3300000000000001 111.724 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -38.26 -49.96 1.41 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.171 0.434 . . . . 6.2300000000000004 112.171 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.94 -25.25 5.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.565 -0.289 . . . . 4.3899999999999997 111.469 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.21 -0.9 . . . . 7.79 110.906 -179.622 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.873 0.368 . . . . 5.6799999999999997 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.18 -0.95 88.89 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 120.811 -0.709 . . . . 4.1100000000000003 113.282 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -82.45 153.06 25.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.047 0.423 . . . . 4.4699999999999998 111.141 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.56 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.2 m -117.74 146.73 21.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 1.5700000000000001 111.723 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 78' ' ' ILE . 27.5 m -97.04 126.72 49.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.995 -0.742 . . . . 1.79 108.995 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.415 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -101.02 143.77 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.606 0.595 . . . . 2.2599999999999998 112.606 -177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 50' ' ' ILE . 32.5 t80 -111.92 139.15 47.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.437 -0.801 . . . . 1.29 109.657 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 5.8 ptpt -127.46 143.85 51.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.953 -0.567 . . . . 2.4199999999999999 111.025 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.0 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.0 tm? -45.09 115.81 0.98 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.146 -0.479 . . . . 2.2400000000000002 110.818 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 118.78 12.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.027 0.442 . . . . 4.4900000000000002 111.62 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.703 ' CG ' HD13 ' A' ' 12' ' ' ILE . 4.2 p-10 178.1 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.656 -0.702 . . . . 5.4100000000000001 110.369 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.946 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -108.89 174.78 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.377 -0.374 . . . . 3.29 110.555 178.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.2 141.9 32.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.645 -0.788 . . . . 3.8399999999999999 112.149 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.98 77.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 7.7199999999999998 111.399 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.09 -20.02 0.75 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.596 -0.812 . . . . 3.8100000000000001 112.769 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.946 HD11 ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -85.63 -161.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.339 . . . . 2.54 111.543 -179.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.81 152.54 18.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.157 -0.474 . . . . 4.4000000000000004 110.476 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 2.8 mt-10 -99.0 173.61 6.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.141 -0.482 . . . . 2.1699999999999999 110.307 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.0 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.1 p -127.86 151.23 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.866 0.691 . . . . 1.51 112.866 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.939 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.76 153.64 18.59 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.292 -0.867 . . . . 0.68999999999999995 110.661 179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' NE1' ' A' ' 24' ' ' TRP . 12.3 t -79.62 131.35 34.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.138 -0.483 . . . . 1.3899999999999999 110.342 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -90.11 -36.58 14.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.492 -0.322 . . . . 2.9500000000000002 111.487 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -139.39 143.01 37.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 2.1299999999999999 111.595 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.753 ' NE1' HG11 ' A' ' 21' ' ' VAL . 30.6 m95 -133.39 116.35 15.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.702 -0.681 . . . . 0.82999999999999996 110.011 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -116.3 29.53 7.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.938 0.347 . . . . 1.72 111.938 -178.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.83 HG23 HD11 ' A' ' 61' ' ' LEU . 5.4 m -155.31 169.51 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.5 111.621 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -146.44 165.13 30.32 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 1.8899999999999999 111.226 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.9 134.58 55.56 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.103 -0.499 . . . . 2.0299999999999998 110.893 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.53 5.26 59.74 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.008 -1.091 . . . . 0.45000000000000001 112.241 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -96.76 154.35 17.34 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.013 0.435 . . . . 1.3600000000000001 111.364 -178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -99.7 142.92 30.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.31 111.445 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.728 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -99.51 166.01 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.375 -0.83 . . . . 0.28000000000000003 110.393 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.96 179.95 5.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 1.4199999999999999 110.709 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 54' ' ' TYR . 1.6 mt-30 -69.17 -29.93 68.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.864 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -99.82 -19.68 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.144 -0.48 . . . . 2.52 111.004 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.42 102.37 15.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.37 . . . . 1.6899999999999999 110.846 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -73.09 157.26 37.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.93999999999999995 110.671 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.772 HG23 HG21 ' A' ' 26' ' ' VAL . 1.1 mt -81.34 -69.81 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.46999999999999997 110.767 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.497 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.9 OUTLIER -140.17 147.3 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 1.29 111.23 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 mm-40 -130.42 125.73 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.882 -0.599 . . . . 2.3700000000000001 110.499 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.701 HG12 ' HA ' ' A' ' 21' ' ' VAL . 9.3 m -123.03 143.7 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.752 0.31 . . . . 1.3500000000000001 111.132 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 45.6 mt-30 -130.77 122.42 27.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 2.6000000000000001 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -105.83 154.15 20.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 2.29 110.987 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -50.96 -25.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 4.3899999999999997 110.946 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -88.29 -65.22 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 3.6499999999999999 110.916 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.83 152.91 52.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8300000000000001 111.216 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 55.4 p -113.76 123.28 49.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 4.5199999999999996 110.608 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -114.72 150.59 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 3.5 111.284 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 28.8 p -129.18 133.17 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.745 -0.661 . . . . 1.46 110.589 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.535 HD12 ' CE1' ' A' ' 7' ' ' PHE . 27.5 mm -98.2 106.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.081 0.467 . . . . 1.01 111.849 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.41 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -92.74 -178.81 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.692 -0.686 . . . . 1.04 110.545 179.337 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.86 -42.33 2.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.505 -0.316 . . . . 1.3600000000000001 111.489 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' HD3' ' HB ' ' A' ' 51' ' ' THR . 11.1 mmm-85 64.79 11.16 6.65 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.724 0.297 . . . . 4.2300000000000004 111.077 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 0.2 OUTLIER -177.1 173.54 1.8 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.098 -0.704 . . . . 3.8799999999999999 109.098 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -96.3 118.49 32.96 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.185 -0.606 . . . . 1.52 109.404 179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -123.84 165.59 16.63 Favored Glycine 0 C--O 1.222 -0.613 0 C-N-CA 120.628 -0.796 . . . . 0.17999999999999999 113.584 -178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 57.7 t -104.98 119.4 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 111.965 0.357 . . . . 1.1100000000000001 111.965 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.683 ' CG1' HG23 ' A' ' 78' ' ' ILE . 17.9 mt -99.05 130.46 47.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.343 -0.39 . . . . 0.38 110.189 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 ttmm -97.37 -42.96 7.51 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 113.288 0.848 . . . . 2.1400000000000001 113.288 -177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -149.57 154.5 38.81 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.737 -0.785 . . . . 1.3500000000000001 112.8 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.83 HD11 HG23 ' A' ' 26' ' ' VAL . 13.6 mt -136.71 126.2 25.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.761 -1.109 . . . . 1.1399999999999999 109.679 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -102.33 -45.4 5.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 3.0800000000000001 111.857 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 27.0 m-85 -89.06 151.13 22.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.336 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.4 m120 -133.35 -176.21 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.41 0.624 . . . . 1.7 111.57 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 24' ' ' TRP . 4.6 mp -52.0 -24.03 6.0 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.997 -1.002 . . . . 1.0600000000000001 112.433 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -107.33 -26.24 11.1 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.205 0.446 . . . . 2.3300000000000001 112.205 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' THR . 0.5 OUTLIER -77.15 153.99 33.63 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.337 0.589 . . . . 1.8500000000000001 112.572 -178.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.939 HD13 HG23 ' A' ' 20' ' ' THR . 2.1 mm -104.32 143.21 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.012 -0.994 . . . . 1.3799999999999999 111.055 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.27 149.34 31.18 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.504 -0.771 . . . . 2.1600000000000001 110.261 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.03 148.64 31.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.915 -0.584 . . . . 5.6500000000000004 110.903 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 9' ' ' LEU . 5.1 t -83.29 130.5 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 3.6099999999999999 111.312 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.7 11.04 9.66 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.489 -0.863 . . . . 1.8700000000000001 113.508 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -157.89 129.38 3.88 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 117.062 0.431 . . . . 2.96 111.451 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 31.9 Cg_exo -58.55 151.32 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.204 1.936 . . . . 0.91000000000000003 111.738 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 pp -122.62 -32.53 3.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.489 -0.323 . . . . 1.8400000000000001 111.638 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.694 HG13 HD11 ' A' ' 78' ' ' ILE . 7.3 p -140.09 140.48 35.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 112.632 0.604 . . . . 0.46999999999999997 112.632 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' OD2' ' CE ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -105.12 121.95 44.88 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.802 -0.636 . . . . 1.1000000000000001 109.359 178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.694 HD11 HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -134.69 147.63 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 121.037 -0.265 . . . . 0.85999999999999999 111.008 -179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.56 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.71 115.11 27.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.677 -0.49 . . . . 1.3899999999999999 109.677 179.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -140.36 156.16 46.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.02 -0.536 . . . . 2.3900000000000001 111.034 -179.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -57.97 153.65 13.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.69 0.281 . . . . 3.1299999999999999 110.671 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.0 111.34 0.31 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.345 -0.389 . . . . 3.1000000000000001 111.667 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.62 145.08 49.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.156 -0.475 . . . . 4.3099999999999996 110.875 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -57.87 -23.01 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 8.3300000000000001 111.236 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -42.1 -49.18 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.361 -0.381 . . . . 6.2300000000000004 111.819 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tp -110.47 -24.64 10.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.423 -0.353 . . . . 4.3899999999999997 110.934 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.243 -0.884 . . . . 7.79 110.92 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mmm . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.796 0.332 . . . . 5.6799999999999997 111.261 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.79 6.98 73.97 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.975 -0.631 . . . . 4.1100000000000003 113.431 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.07 131.86 55.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.015 0.407 . . . . 4.4699999999999998 111.381 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.864 HG12 ' HG2' ' A' ' 79' ' ' GLU . 29.5 m -141.23 147.73 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.5700000000000001 111.307 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG21 ' OG1' ' A' ' 80' ' ' THR . 17.4 m -97.12 121.96 48.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 108.719 -0.845 . . . . 1.79 108.719 178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.6 OUTLIER -104.04 137.59 41.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.67 0.619 . . . . 2.2599999999999998 112.67 -177.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 33.4 t80 -100.25 135.11 42.18 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.972 -1.013 . . . . 1.29 108.936 178.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.7 OUTLIER -121.22 140.23 52.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.304 -0.407 . . . . 2.4199999999999999 110.649 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.07 HD11 HD13 ' A' ' 12' ' ' ILE . 2.5 tm? -41.97 128.68 3.54 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.278 -0.419 . . . . 2.2400000000000002 110.437 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.651 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.1 m -130.65 177.14 7.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.842 0.353 . . . . 4.4900000000000002 111.236 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER 85.97 -16.76 0.43 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.947 -0.569 . . . . 5.4100000000000001 112.025 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.07 HD13 HD11 ' A' ' 9' ' ' LEU . 3.4 mp -103.37 134.96 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 121.115 0.483 . . . . 3.29 111.277 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -87.66 136.89 14.18 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.797 -0.716 . . . . 3.8399999999999999 112.192 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -56.32 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 7.7199999999999998 111.122 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 153.4 -25.52 0.77 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.605 -0.807 . . . . 3.8100000000000001 112.72 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -95.34 -165.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.971 0.415 . . . . 2.54 111.407 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -68.9 154.39 42.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.65 . . . . 4.4000000000000004 111.254 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.485 ' HB3' HG22 ' A' ' 68' ' ' ILE . 3.5 mt-10 -97.43 174.01 6.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.772 -0.649 . . . . 2.1699999999999999 109.462 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.026 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.5 p -123.74 148.45 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 119.73 -0.788 . . . . 1.51 112.719 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.01 156.26 17.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.23 -0.895 . . . . 0.68999999999999995 110.061 179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.677 HG11 ' NE1' ' A' ' 24' ' ' TRP . 40.6 t -79.87 131.49 34.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.321 -0.551 . . . . 1.3899999999999999 109.579 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -99.99 -28.51 13.04 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.031 -0.268 . . . . 2.9500000000000002 111.583 -178.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -138.69 128.94 25.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.157 0.503 . . . . 2.1299999999999999 112.052 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.859 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.4 m95 -128.21 115.35 18.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.494 -0.775 . . . . 0.82999999999999996 109.462 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.71 6.98 13.37 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.268 0.469 . . . . 1.72 112.268 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.919 HG11 HG13 ' A' ' 32' ' ' VAL . 18.7 m -133.1 167.24 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.756 0.312 . . . . 0.5 111.299 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.945 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -146.88 170.69 16.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.8899999999999999 110.968 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.9 138.21 55.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.987 -0.551 . . . . 2.0299999999999998 110.215 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 71.52 4.15 56.37 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.079 -1.057 . . . . 0.45000000000000001 112.743 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -101.55 152.99 20.13 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.901 0.381 . . . . 1.3600000000000001 111.324 -179.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.7 m -100.09 150.23 22.69 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.99 -0.55 . . . . 0.31 111.981 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.952 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -108.99 167.58 4.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.408 -0.815 . . . . 0.28000000000000003 110.86 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.07 161.91 32.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.958 -0.565 . . . . 1.4199999999999999 110.335 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -57.54 -25.59 60.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.245 -0.434 . . . . 2.3799999999999999 111.335 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -101.41 -20.59 15.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 2.52 111.178 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.14 100.67 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.969 0.414 . . . . 1.6899999999999999 110.812 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.3 m -64.54 150.84 46.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.932 -0.577 . . . . 0.93999999999999995 111.32 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.952 HG12 HG11 ' A' ' 32' ' ' VAL . 8.6 mt -76.84 -71.22 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.293 -0.412 . . . . 0.46999999999999997 110.276 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.6 OUTLIER -136.39 156.89 47.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 1.29 110.421 179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 49' ' ' THR . 1.6 tt0 -139.16 125.57 20.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 2.3700000000000001 111.306 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 21' ' ' VAL . 16.6 m -113.84 141.54 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 1.3500000000000001 110.575 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -133.68 118.84 18.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.339 -0.392 . . . . 2.6000000000000001 110.992 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -106.65 148.52 28.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.133 -0.485 . . . . 2.29 110.53 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -46.73 -28.62 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.33 -0.396 . . . . 4.3899999999999997 110.999 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.27 -50.76 10.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 3.6499999999999999 111.052 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.18 162.22 40.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.078 0.466 . . . . 2.8300000000000001 111.86 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.23 135.24 54.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.663 -0.699 . . . . 4.5199999999999996 110.281 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -132.57 133.12 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.98 0.419 . . . . 3.5 111.664 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.713 HG22 ' HG3' ' A' ' 40' ' ' GLU . 9.1 p -120.28 131.45 54.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.46 110.194 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.497 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 28.6 mm -99.88 108.39 22.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.865 0.691 . . . . 1.01 112.865 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 75.7 p -91.86 -178.35 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.797 -0.638 . . . . 1.04 110.498 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.433 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.3 m -118.92 -38.32 3.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.439 -0.346 . . . . 1.3600000000000001 111.707 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 64.38 11.18 6.28 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.367 -0.379 . . . . 4.2300000000000004 111.225 -178.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.99 171.7 3.0 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.026 -0.731 . . . . 3.8799999999999999 109.026 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.03 125.91 43.2 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.683 -0.407 . . . . 1.52 110.44 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.22 164.07 25.34 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.468 -0.872 . . . . 0.17999999999999999 112.848 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 8.4 t -101.44 122.42 53.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.786 0.327 . . . . 1.1100000000000001 111.835 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.61 HD12 ' HB ' ' A' ' 26' ' ' VAL . 31.6 mt -98.95 125.5 52.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.064 -0.516 . . . . 0.38 109.642 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -98.35 -28.36 13.69 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 114.255 1.206 . . . . 2.1400000000000001 114.255 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -153.65 149.11 27.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.758 -0.777 . . . . 1.3500000000000001 112.693 -178.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.945 HD12 ' HA ' ' A' ' 27' ' ' LYS . 27.2 mt -137.69 115.73 11.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.028 -0.987 . . . . 1.1399999999999999 109.875 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -93.12 -45.73 7.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.516 0.561 . . . . 3.0800000000000001 112.516 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.419 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 22.6 m-85 -89.73 148.55 23.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 1.9299999999999999 111.444 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.8 m-20 -126.69 -174.91 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 1.7 111.105 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.526 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -56.85 -18.39 12.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.792 -1.095 . . . . 1.0600000000000001 112.493 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -107.19 -25.89 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.854 0.687 . . . . 2.3300000000000001 112.854 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.411 ' O ' ' CG2' ' A' ' 20' ' ' THR . 0.1 OUTLIER -78.01 155.42 30.72 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.301 0.572 . . . . 1.8500000000000001 111.992 -178.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.874 HD13 HG23 ' A' ' 20' ' ' THR . 1.0 OUTLIER -109.55 141.53 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 115.119 -0.946 . . . . 1.3799999999999999 110.649 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -114.41 157.11 23.31 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.661 -0.7 . . . . 2.1600000000000001 110.093 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 22.1 p90 -131.34 132.87 44.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.619 -0.718 . . . . 5.6500000000000004 110.617 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 12' ' ' ILE . 14.1 t -53.82 138.24 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.858 0.361 . . . . 3.6099999999999999 111.526 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 120.69 2.88 11.44 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.774 -0.727 . . . . 1.8700000000000001 113.165 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 74' ' ' PRO . 3.8 mmmt -155.46 130.48 5.16 Favored Pre-proline 0 C--O 1.232 0.161 0 CA-C-N 117.147 0.474 . . . . 2.96 111.593 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 83.8 Cg_exo -52.47 146.48 33.06 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.743 2.295 . . . . 0.91000000000000003 112.049 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -104.78 -47.58 4.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 1.8400000000000001 111.417 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG13 HD11 ' A' ' 78' ' ' ILE . 7.7 p -141.04 151.74 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.79 0.329 . . . . 0.46999999999999997 111.879 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.671 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -111.38 123.98 51.31 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.185 -0.461 . . . . 1.1000000000000001 110.07 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -136.43 149.17 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.85999999999999999 111.654 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.864 ' HG2' HG12 ' A' ' 4' ' ' VAL . 42.2 mt-10 -99.17 115.79 29.89 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.457 -0.572 . . . . 1.3899999999999999 109.457 178.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -140.68 157.7 45.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.94 -0.573 . . . . 2.3900000000000001 110.494 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.1 OUTLIER -55.49 150.41 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.877 -0.329 . . . . 3.1299999999999999 110.116 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.0 110.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.031 0.443 . . . . 3.1000000000000001 112.128 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -120.37 142.64 48.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.742 -0.663 . . . . 4.3099999999999996 110.314 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.41 -26.0 24.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.696 0.284 . . . . 8.3300000000000001 111.558 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -47.14 -39.37 13.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 6.2300000000000004 111.557 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -111.93 -27.98 8.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 4.3899999999999997 111.355 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.227 -0.892 . . . . 7.79 111.012 -179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.7 tpp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.785 0.326 . . . . 5.6799999999999997 111.163 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.24 18.96 4.83 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.639 -0.791 . . . . 4.1100000000000003 112.84 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 142.82 38.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.768 0.318 . . . . 4.4699999999999998 110.769 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.91 HG12 ' HG2' ' A' ' 79' ' ' GLU . 16.9 m -140.41 145.56 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.173 -0.467 . . . . 1.5700000000000001 111.367 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG21 ' OG1' ' A' ' 80' ' ' THR . 5.9 m -97.76 120.97 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.795 -0.817 . . . . 1.79 108.795 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 3.0 mt-30 -100.17 142.39 31.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.305 0.574 . . . . 2.2599999999999998 112.452 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 34.0 t80 -102.42 142.18 34.04 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.199 -0.909 . . . . 1.29 109.93 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -125.46 143.73 50.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 2.4199999999999999 110.528 179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.134 HD11 HD13 ' A' ' 12' ' ' ILE . 2.9 tm? -46.53 114.34 0.8 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.848 0.356 . . . . 2.2400000000000002 110.399 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CB ' ' A' ' 11' ' ' ASP . 6.3 p -109.1 175.19 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 4.4900000000000002 111.225 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' A' ' 10' ' ' SER . 9.4 t0 85.56 -16.79 0.44 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.886 -0.597 . . . . 5.4100000000000001 111.502 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.134 HD13 HD11 ' A' ' 9' ' ' LEU . 3.1 mp -109.58 158.41 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 121.007 0.432 . . . . 3.29 110.846 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' N ' HG22 ' A' ' 12' ' ' ILE . . . -114.75 143.63 18.13 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.781 -0.645 . . . . 3.8399999999999999 112.098 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.71 0.291 . . . . 7.7199999999999998 111.201 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' GLY . . . 156.85 -25.85 0.5 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.523 -0.846 . . . . 3.8100000000000001 113.025 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.7 pt -97.35 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 2.54 111.552 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 152.51 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 4.4000000000000004 111.418 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.523 ' HB3' HG22 ' A' ' 68' ' ' ILE . 8.0 mp0 -99.5 173.98 6.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.85 -0.614 . . . . 2.1699999999999999 110.415 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.93 ' CG1' HD21 ' A' ' 9' ' ' LEU . 9.8 p -132.57 150.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 112.457 0.54 . . . . 1.51 112.457 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.716 ' CB ' HD13 ' A' ' 68' ' ' ILE . 0.9 OUTLIER -101.16 164.9 11.57 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.728 -0.669 . . . . 0.68999999999999995 110.615 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.811 HG11 ' CD1' ' A' ' 24' ' ' TRP . 33.5 t -79.93 136.72 22.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.345 -0.843 . . . . 1.3899999999999999 110.49 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.588 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.9 tptt -103.9 -31.13 9.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.365 -0.38 . . . . 2.9500000000000002 111.197 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.77 124.46 19.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.989 0.423 . . . . 2.1299999999999999 111.547 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.811 ' CD1' HG11 ' A' ' 21' ' ' VAL . 19.2 m95 -120.33 117.57 28.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.82999999999999996 110.02 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' C ' HG13 ' A' ' 26' ' ' VAL . 4.3 m-85 -123.42 34.09 5.19 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.822 0.305 . . . . 1.72 111.822 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 38' ' ' ILE . 11.2 m -156.74 156.37 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.481 -0.327 . . . . 0.5 110.864 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' A' ' 61' ' ' LEU . 2.4 tptt -134.51 169.35 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.082 0.468 . . . . 1.8899999999999999 111.351 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -61.47 134.75 57.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.665 -0.698 . . . . 2.0299999999999998 110.468 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.91 3.37 63.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.257 -0.973 . . . . 0.45000000000000001 112.579 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.1 154.8 17.05 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.439 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.6 m -99.59 149.22 23.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.31 111.387 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.876 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.19 163.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.28000000000000003 110.701 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.27 165.37 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.4199999999999999 110.88 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -54.8 -25.25 26.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 2.3799999999999999 111.029 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -101.73 -19.43 15.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 2.52 111.207 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -95.7 99.6 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 1.6899999999999999 111.27 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -70.24 159.53 33.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.262 -0.426 . . . . 0.93999999999999995 110.509 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 26' ' ' VAL . 6.0 mt -89.64 -73.91 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.672 -0.24 . . . . 0.46999999999999997 111.232 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 1.6 p -133.85 144.72 49.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.99 0.424 . . . . 1.29 111.297 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -133.21 125.32 29.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.117 -0.492 . . . . 2.3700000000000001 110.532 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 21' ' ' VAL . 24.4 m -116.67 150.31 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 1.3500000000000001 110.99 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.3 133.07 42.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.155 -0.475 . . . . 2.6000000000000001 111.009 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -121.04 154.52 35.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 2.29 110.859 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.73 -23.86 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.11 -0.496 . . . . 4.3899999999999997 111.191 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.96 -72.8 0.49 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.338 . . . . 3.6499999999999999 111.085 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.0 160.35 30.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 2.8300000000000001 111.087 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.64 143.58 29.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 4.5199999999999996 110.245 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.454 ' HB ' ' CG2' ' A' ' 41' ' ' VAL . 2.8 t -126.75 135.32 64.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.097 0.475 . . . . 3.5 111.82 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -136.89 122.91 20.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.666 -0.697 . . . . 1.46 109.939 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.489 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 34.1 mm -99.76 108.88 23.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.629 0.603 . . . . 1.01 112.629 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -87.37 -179.51 6.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.667 -0.697 . . . . 1.04 109.726 178.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.583 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -117.02 -25.05 7.33 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 121.063 -0.255 . . . . 1.3600000000000001 111.654 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 46.96 15.54 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 112.44 0.533 . . . . 4.2300000000000004 112.44 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -176.62 171.84 2.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.379 -0.6 . . . . 3.8799999999999999 109.379 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -98.76 120.62 39.51 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.965 -0.383 . . . . 1.52 109.965 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 31' ' ' THR . . . -136.05 164.7 25.01 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 120.301 -0.952 . . . . 0.17999999999999999 113.622 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 75.4 t -101.71 120.02 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.211 0.448 . . . . 1.1100000000000001 112.211 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.559 ' CG1' HG23 ' A' ' 78' ' ' ILE . 19.9 mt -99.03 122.68 51.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 108.319 -0.993 . . . . 0.38 108.319 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 27.3 tttp -99.59 -28.49 13.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.905 1.076 . . . . 2.1400000000000001 113.905 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -151.26 140.11 20.89 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.592 -0.843 . . . . 1.3500000000000001 112.929 -179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.889 HD11 HG23 ' A' ' 26' ' ' VAL . 13.4 mt -127.78 136.43 51.48 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.312 -0.858 . . . . 1.1399999999999999 109.804 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -116.43 -45.71 2.81 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.019 0.377 . . . . 3.0800000000000001 112.019 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 35.0 m-85 -86.48 142.66 28.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 1.9299999999999999 111.188 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 5.5 m120 -125.4 -174.32 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 1.7 111.752 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -55.54 -20.71 14.0 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.579 -1.191 . . . . 1.0600000000000001 112.369 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.18 -26.14 11.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.857 0.688 . . . . 2.3300000000000001 112.857 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.6 147.05 33.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.39 0.614 . . . . 1.8500000000000001 111.947 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.716 HD13 ' CB ' ' A' ' 20' ' ' THR . 3.1 mm -100.8 139.3 22.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 110.309 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -110.67 152.46 26.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.055 -0.521 . . . . 2.1600000000000001 110.69 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.36 144.06 45.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 5.6500000000000004 110.478 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG11 ' CA ' ' A' ' 13' ' ' GLY . 13.8 p -74.09 136.96 24.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 3.6099999999999999 111.264 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.8 1.99 13.0 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.615 -0.803 . . . . 1.8700000000000001 113.299 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -156.94 132.15 5.5 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.13 0.465 . . . . 2.96 111.343 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 6' ' ' GLN . 32.1 Cg_exo -60.54 156.13 43.7 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.425 2.083 . . . . 0.91000000000000003 111.76 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' CD1' ' A' ' 63' ' ' TYR . 3.5 pp -124.51 -29.82 3.44 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 1.8400000000000001 111.912 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.845 HG13 HD11 ' A' ' 78' ' ' ILE . 10.9 p -133.16 158.73 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 120.871 -0.332 . . . . 0.46999999999999997 111.869 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.663 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -125.76 120.52 30.82 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 109.862 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.845 HD11 HG13 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -134.1 148.36 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.453 -0.34 . . . . 0.85999999999999999 111.405 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.91 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.6 mt-10 -99.73 115.95 30.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.703 0.287 . . . . 1.3899999999999999 110.374 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.498 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -138.86 156.7 47.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.221 -0.445 . . . . 2.3900000000000001 110.389 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' O ' HD12 ' A' ' 83' ' ' LEU . 44.5 mm-40 -56.65 144.42 32.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.699 0.285 . . . . 3.1299999999999999 110.438 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.92 110.07 0.14 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.89 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -123.74 138.55 54.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.965 -0.561 . . . . 4.3099999999999996 110.717 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.54 -23.02 14.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 8.3300000000000001 111.211 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.44 -49.61 13.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.433 -0.349 . . . . 6.2300000000000004 111.487 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.04 8.44 3.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.524 -0.307 . . . . 4.3899999999999997 111.783 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.233 -0.889 . . . . 7.79 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.776 0.322 . . . . 5.6799999999999997 111.208 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.76 19.02 77.82 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.766 -0.731 . . . . 4.1100000000000003 112.74 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -98.02 153.18 18.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.856 0.36 . . . . 4.4699999999999998 111.045 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.792 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.8 m -113.73 146.77 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 1.5700000000000001 111.201 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -96.84 122.18 48.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.088 -0.708 . . . . 1.79 109.088 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.56 145.98 26.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.127 -0.488 . . . . 2.2599999999999998 112.282 -177.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 30.6 t80 -98.48 142.66 29.8 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.799 -0.637 . . . . 1.29 109.319 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -125.85 144.02 50.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.891 -0.595 . . . . 2.4199999999999999 111.808 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.988 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.9 tm? -56.39 116.89 3.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.787 -0.642 . . . . 2.2400000000000002 110.272 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 6.3 p -133.59 112.77 11.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 4.4900000000000002 110.958 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.555 ' HB3' HD13 ' A' ' 12' ' ' ILE . 21.0 t70 176.92 -33.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 5.4100000000000001 111.171 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.932 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -130.33 170.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.008 0.432 . . . . 3.29 111.502 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.72 171.61 54.66 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.885 -0.598 . . . . 3.8399999999999999 111.873 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.21 73.98 8.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.616 0.246 . . . . 7.7199999999999998 111.433 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.33 -27.74 0.78 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.459 -0.877 . . . . 3.8100000000000001 113.095 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.72 HD11 ' CG2' ' A' ' 12' ' ' ILE . 2.2 pp -64.86 -34.69 72.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 111.83 0.307 . . . . 2.54 111.83 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER 151.29 146.44 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.922 -1.14 . . . . 4.4000000000000004 107.922 -178.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.509 ' HB3' HG22 ' A' ' 68' ' ' ILE . 2.7 mt-10 -99.28 172.21 7.49 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.905 -0.318 . . . . 2.1699999999999999 110.993 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.988 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.5 p -121.09 147.39 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.222 0.823 . . . . 1.51 113.222 -178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.807 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.23 154.35 17.85 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.245 -0.888 . . . . 0.68999999999999995 110.947 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.574 ' HA ' HG12 ' A' ' 41' ' ' VAL . 13.8 t -80.35 135.64 24.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.104 -0.498 . . . . 1.3899999999999999 110.711 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.639 ' O ' HD23 ' A' ' 65' ' ' LEU . 18.9 tptt -100.24 -32.49 10.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.416 . . . . 2.9500000000000002 111.074 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -135.69 135.81 40.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.053 0.454 . . . . 2.1299999999999999 111.573 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CH2' ' CD2' ' A' ' 61' ' ' LEU . 7.3 m95 -131.51 119.54 21.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.7 -0.682 . . . . 0.82999999999999996 109.765 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 -2.6 12.64 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.892 0.701 . . . . 1.72 112.892 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG11 HG13 ' A' ' 32' ' ' VAL . 5.6 m -128.58 163.93 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.734 -0.386 . . . . 0.5 111.405 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HA ' HD13 ' A' ' 61' ' ' LEU . 4.9 mmtm -141.53 164.4 30.32 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.956 0.408 . . . . 1.8899999999999999 111.481 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.3 mp0 -51.29 135.45 26.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.918 -0.583 . . . . 2.0299999999999998 111.093 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.88 3.76 60.59 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.271 -0.966 . . . . 0.45000000000000001 112.615 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -96.09 153.2 17.91 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.92 0.39 . . . . 1.3600000000000001 111.598 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 56' ' ' GLY . 8.5 m -100.02 148.7 24.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.31 110.675 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -105.16 160.49 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.053 -0.521 . . . . 0.28000000000000003 111.116 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' SER . 58.4 m -138.78 170.68 15.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.634 -0.712 . . . . 1.4199999999999999 110.323 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -61.1 -21.81 64.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.608 -0.269 . . . . 2.3799999999999999 111.358 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -101.94 -20.0 15.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.288 . . . . 2.52 111.439 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.92 101.7 13.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 1.6899999999999999 111.445 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.479 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.4 m -68.47 159.9 30.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 0.93999999999999995 110.228 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG12 HG11 ' A' ' 32' ' ' VAL . 33.9 mt -94.87 -83.66 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 120.933 -0.307 . . . . 0.46999999999999997 110.969 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 11.7 p -111.89 150.42 30.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 1.29 111.314 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -138.3 125.38 21.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 2.3700000000000001 110.284 179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' VAL . 15.3 m -129.52 156.38 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 1.3500000000000001 111.216 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -138.8 129.76 26.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 2.6000000000000001 111.267 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.35 152.3 35.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.402 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -47.59 -50.59 23.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 4.3899999999999997 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HE2' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -59.0 -59.28 5.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 3.6499999999999999 111.313 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.23 162.86 39.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 2.8300000000000001 111.299 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.9 m -103.19 144.51 31.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 4.5199999999999996 110.607 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -130.26 121.31 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.901 0.382 . . . . 3.5 111.543 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.544 HG22 ' CG ' ' A' ' 40' ' ' GLU . 67.9 p -113.58 131.11 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.49 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 45.0 mm -100.85 106.24 19.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.225 0.536 . . . . 1.01 112.051 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.8 p -83.63 -179.07 7.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.775 . . . . 1.04 110.119 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 33' ' ' SER . 1.6 t -98.47 -63.85 1.09 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.781 0.324 . . . . 1.3600000000000001 111.283 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 74.54 3.26 4.25 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.26 -0.427 . . . . 4.2300000000000004 110.602 -179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.7 m-85 -175.94 166.34 3.01 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.093 -0.706 . . . . 3.8799999999999999 109.093 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.8 t70 -99.6 126.52 45.6 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.605 -0.438 . . . . 1.52 110.125 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 31' ' ' THR . . . -140.17 164.8 26.14 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.33 -0.938 . . . . 0.17999999999999999 113.277 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.6 t -99.94 118.97 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.701 0.286 . . . . 1.1100000000000001 111.487 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 26' ' ' VAL . 9.6 mt -98.23 126.39 51.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 N-CA-C 109.178 -0.675 . . . . 0.38 109.178 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -97.98 -40.02 8.67 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.412 0.893 . . . . 2.1400000000000001 113.412 -176.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -151.76 148.38 27.81 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.777 -0.769 . . . . 1.3500000000000001 112.751 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.631 HD13 ' HA ' ' A' ' 27' ' ' LYS . 1.4 mp -137.03 112.33 9.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.032 -0.986 . . . . 1.1399999999999999 109.732 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -85.43 -39.67 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.096 0.406 . . . . 3.0800000000000001 112.096 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 75' ' ' LEU . 20.8 m-85 -89.44 139.34 30.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.066 0.46 . . . . 1.9299999999999999 111.534 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 13.5 m120 -123.37 -173.21 2.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.772 -0.649 . . . . 1.7 110.962 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.639 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.9 OUTLIER -55.44 -18.35 6.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.236 -0.893 . . . . 1.0600000000000001 112.373 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.28 -25.87 11.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.375 0.509 . . . . 2.3300000000000001 112.375 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -79.93 157.24 26.94 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.411 0.624 . . . . 1.8500000000000001 112.25 -178.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.807 HD13 HG23 ' A' ' 20' ' ' THR . 1.4 mm -107.73 142.76 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.918 -1.037 . . . . 1.3799999999999999 111.124 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.9 146.1 30.42 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.625 -0.716 . . . . 2.1600000000000001 109.726 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.438 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.97 148.98 41.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.028 -0.533 . . . . 5.6500000000000004 110.82 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.932 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.2 t -79.95 139.96 17.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.861 -0.608 . . . . 3.6099999999999999 111.403 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.52 -19.32 8.56 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.909 -0.662 . . . . 1.8700000000000001 113.044 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -146.35 131.92 9.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.731 0.265 . . . . 2.96 111.095 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.86 160.73 7.22 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.36 2.04 . . . . 0.91000000000000003 111.527 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.494 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 1.2 pp -120.56 -29.57 4.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.831 0.308 . . . . 1.8400000000000001 111.831 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 HD11 ' A' ' 78' ' ' ILE . 12.0 p -137.9 148.04 25.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.815 -0.354 . . . . 0.46999999999999997 111.951 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -115.3 129.66 56.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.203 -0.453 . . . . 1.1000000000000001 110.408 179.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.657 HD11 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -140.29 149.32 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.85999999999999999 111.039 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.792 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.21 113.21 25.06 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.366 -0.534 . . . . 1.3899999999999999 109.858 179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' HA3' ' A' ' 56' ' ' GLY . 0.1 OUTLIER -142.74 157.4 44.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.623 -0.717 . . . . 2.3900000000000001 110.795 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -56.7 153.56 10.37 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.086 -0.338 . . . . 3.1299999999999999 110.086 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.88 114.58 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.983 0.364 . . . . 3.1000000000000001 111.983 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -121.6 145.57 47.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.155 -0.475 . . . . 4.3099999999999996 111.064 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -77.77 -21.51 51.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.014 -0.539 . . . . 8.3300000000000001 111.497 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -39.93 -49.39 2.44 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.549 0.574 . . . . 6.2300000000000004 112.549 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 -21.26 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.608 0.242 . . . . 4.3899999999999997 111.622 -179.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 86' ' ' LEU . 10.1 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 7.79 111.359 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.745 0.307 . . . . 5.6799999999999997 111.223 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.6 14.7 7.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 4.1100000000000003 112.825 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 1.9 mm-40 -129.82 153.41 48.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 4.4699999999999998 110.851 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.831 HG12 ' CG ' ' A' ' 79' ' ' GLU . 17.1 m -137.04 146.76 27.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.122 -0.49 . . . . 1.5700000000000001 111.544 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HD12 ' A' ' 78' ' ' ILE . 29.3 m -96.74 132.85 40.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.799 -0.637 . . . . 1.79 109.497 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.655 ' O ' HD21 ' A' ' 86' ' ' LEU . 4.4 pm0 -98.14 146.44 25.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 112.438 0.533 . . . . 2.2599999999999998 112.438 -177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 50' ' ' ILE . 22.3 t80 -104.76 146.12 29.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.615 -0.72 . . . . 1.29 110.173 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -128.02 145.31 51.02 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.846 -0.616 . . . . 2.4199999999999999 111.264 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.006 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -43.26 118.14 1.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.858 0.361 . . . . 2.2400000000000002 110.74 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.1 p -124.38 108.15 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 4.4900000000000002 110.954 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.688 ' HB3' HD13 ' A' ' 12' ' ' ILE . 10.8 t70 -177.31 -40.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.079 -0.509 . . . . 5.4100000000000001 110.956 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.865 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -126.95 179.04 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 3.29 111.478 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.61 149.81 19.75 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.886 -0.673 . . . . 3.8399999999999999 112.53 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' N ' HG13 ' A' ' 71' ' ' VAL . 13.4 tp10 -62.48 92.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 7.7199999999999998 111.052 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.47 -58.33 0.41 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.763 -0.732 . . . . 3.8100000000000001 112.246 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.865 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.3 pt -62.3 -172.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.372 . . . . 2.54 111.077 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.98 152.24 5.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 4.4000000000000004 110.52 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HG2' ' CD2' ' A' ' 70' ' ' TYR . 2.2 mp0 -99.03 173.97 6.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.182 -0.463 . . . . 2.1699999999999999 110.269 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.006 ' CG1' HD21 ' A' ' 9' ' ' LEU . 10.7 p -123.51 148.95 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 112.925 0.713 . . . . 1.51 112.925 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.905 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.29 157.29 16.27 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.318 -0.856 . . . . 0.68999999999999995 110.788 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.809 HG11 ' NE1' ' A' ' 24' ' ' TRP . 43.0 t -79.8 127.88 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.183 -0.462 . . . . 1.3899999999999999 110.398 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.66 -26.82 15.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.812 0.339 . . . . 2.9500000000000002 110.783 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.15 139.91 35.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.052 0.453 . . . . 2.1299999999999999 111.36 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.867 ' CH2' HD22 ' A' ' 61' ' ' LEU . 15.5 m95 -137.85 115.71 11.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.681 -0.69 . . . . 0.82999999999999996 109.734 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.87 12.85 12.18 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.104 0.409 . . . . 1.72 112.104 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.059 HG11 HG13 ' A' ' 32' ' ' VAL . 34.1 m -141.2 163.03 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.816 0.341 . . . . 0.5 110.958 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -142.5 165.44 27.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 1.8899999999999999 110.97 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -51.6 136.02 27.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.071 -0.513 . . . . 2.0299999999999998 110.615 179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.15 3.62 61.37 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.291 -0.956 . . . . 0.45000000000000001 112.637 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.15 154.39 17.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.865 0.364 . . . . 1.3600000000000001 111.373 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.449 HG23 ' O ' ' A' ' 56' ' ' GLY . 2.6 m -100.43 145.61 28.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.509 . . . . 0.31 111.467 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.059 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -104.58 169.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.502 -0.772 . . . . 0.28000000000000003 110.459 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.34 161.94 34.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.351 -0.386 . . . . 1.4199999999999999 110.989 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -50.64 -39.61 51.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 2.3799999999999999 111.007 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -93.8 -18.63 21.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.137 -0.483 . . . . 2.52 111.208 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' VAL . 1.5 m-20 -92.59 88.12 6.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 1.6899999999999999 110.806 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.32 159.44 7.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.93999999999999995 110.95 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.95 HG12 HG11 ' A' ' 32' ' ' VAL . 4.8 mt -82.95 -70.49 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 116.297 -0.41 . . . . 0.46999999999999997 110.754 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.481 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 3.0 p -140.11 143.24 36.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.065 0.459 . . . . 1.29 111.267 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -118.86 125.16 48.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.3700000000000001 110.407 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 21' ' ' VAL . 34.0 m -117.54 143.32 28.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.424 -0.353 . . . . 1.3500000000000001 111.246 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -140.13 127.15 20.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 2.6000000000000001 110.836 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 19' ' ' VAL . 27.1 p -130.65 154.69 47.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 2.29 110.848 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -40.65 -31.8 0.18 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.877 0.37 . . . . 4.3899999999999997 111.384 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -63.68 -74.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 3.6499999999999999 110.11 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.583 ' HB3' ' HD3' ' A' ' 45' ' ' LYS . . . -148.9 161.17 42.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 2.8300000000000001 110.848 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -99.37 124.11 44.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.177 -0.465 . . . . 4.5199999999999996 110.432 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.608 HG23 ' OD2' ' A' ' 11' ' ' ASP . 4.2 t -125.75 133.85 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.032 0.444 . . . . 3.5 111.79 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.3 p -115.17 131.96 56.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.709 -0.678 . . . . 1.46 110.131 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.569 HD12 ' CE1' ' A' ' 7' ' ' PHE . 17.1 mm -99.15 106.89 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.055 0.455 . . . . 1.01 111.863 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -179.55 4.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.718 -0.674 . . . . 1.04 109.82 178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 t -117.43 -28.94 5.96 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.037 -0.265 . . . . 1.3600000000000001 111.288 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 61.63 11.54 3.97 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 4.2300000000000004 111.149 -179.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -177.52 173.32 1.69 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.125 -0.694 . . . . 3.8799999999999999 109.125 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.2 m-20 -96.12 118.23 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.039 -0.726 . . . . 1.52 109.039 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -128.79 164.68 21.86 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.232 -0.985 . . . . 0.17999999999999999 114.194 -177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.5 t -100.52 119.11 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.315 0.487 . . . . 1.1100000000000001 112.315 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 32' ' ' VAL . 14.0 mt -100.17 122.67 52.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 0.38 109.662 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 2.2 tttp -99.4 -41.17 7.53 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 114.066 1.136 . . . . 2.1400000000000001 114.066 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.857 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -136.18 135.7 39.37 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.068 0.766 . . . . 1.3500000000000001 113.068 -178.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.867 HD22 ' CH2' ' A' ' 24' ' ' TRP . 19.1 mt -136.01 127.09 27.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.326 -0.852 . . . . 1.1399999999999999 109.374 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.47 -36.69 6.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.702 0.63 . . . . 3.0800000000000001 112.702 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 21.8 m-85 -90.69 138.12 31.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 1.9299999999999999 112.153 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 2.5 m120 -118.23 -173.14 2.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.625 -0.716 . . . . 1.7 111.411 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.76 -20.17 5.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.128 -0.942 . . . . 1.0600000000000001 112.41 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.2 m-20 -107.41 -26.22 11.07 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.784 0.661 . . . . 2.3300000000000001 112.784 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -76.58 153.39 35.39 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.29 0.566 . . . . 1.8500000000000001 112.122 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.905 HD13 HG23 ' A' ' 20' ' ' THR . 1.6 mm -105.53 143.2 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 115.101 -0.954 . . . . 1.3799999999999999 110.832 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -114.34 155.88 25.44 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.644 . . . . 2.1600000000000001 110.532 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -113.53 142.48 45.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 5.6500000000000004 110.616 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.813 HG11 ' O ' ' A' ' 12' ' ' ILE . 7.6 p -83.12 136.51 22.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.45 . . . . 3.6099999999999999 111.01 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.08 -19.06 8.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 1.8700000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 tptt -136.52 129.11 17.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.452 0.168 . . . . 2.96 110.866 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' CB ' ' HG3' ' A' ' 6' ' ' GLN . 27.8 Cg_exo -61.7 153.46 67.2 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.366 2.044 . . . . 0.91000000000000003 112.085 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.81 -25.92 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.125 -0.488 . . . . 1.8400000000000001 111.56 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 60' ' ' LYS . 5.5 p -140.45 145.74 25.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.435 0.532 . . . . 0.46999999999999997 112.435 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -99.89 128.7 45.96 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.809 -0.812 . . . . 1.1000000000000001 108.809 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -136.61 143.4 35.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.342 -0.39 . . . . 0.85999999999999999 111.281 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.831 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -98.08 114.95 27.28 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.531 -0.468 . . . . 1.3899999999999999 109.957 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.409 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.74 157.54 45.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.084 -0.507 . . . . 2.3900000000000001 110.735 -179.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -56.4 152.83 10.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 3.1299999999999999 110.603 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.51 110.64 0.16 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.158 -0.474 . . . . 3.1000000000000001 111.9 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.59 133.79 55.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.992 -0.549 . . . . 4.3099999999999996 110.932 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -63.17 -22.78 67.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.976 -0.556 . . . . 8.3300000000000001 111.259 -179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.04 -49.18 8.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.405 -0.361 . . . . 6.2300000000000004 111.658 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.655 HD21 ' O ' ' A' ' 6' ' ' GLN . 1.2 mp -110.84 -21.79 11.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.435 -0.348 . . . . 4.3899999999999997 111.083 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 84' ' ' LYS . 12.5 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.909 . . . . 7.79 111.015 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.749 0.309 . . . . 5.6799999999999997 111.297 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.99 -4.56 18.66 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.745 -0.741 . . . . 4.1100000000000003 113.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -105.67 153.34 21.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.0 0.4 . . . . 4.4699999999999998 110.925 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.783 HG12 ' CG ' ' A' ' 79' ' ' GLU . 14.3 m -108.2 142.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.53 . . . . 1.5700000000000001 111.496 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 31.2 m -98.78 137.75 25.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.451 -0.795 . . . . 1.79 109.32 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.562 ' HG3' ' HB3' ' A' ' 74' ' ' PRO . 0.8 OUTLIER -109.85 146.79 34.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.469 0.652 . . . . 2.2599999999999998 112.695 -178.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 27.5 t80 -110.47 128.91 55.83 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.82 -1.082 . . . . 1.29 108.677 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -115.28 139.43 49.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.694 0.283 . . . . 2.4199999999999999 110.909 -179.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.02 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.1 tm? -44.37 123.87 3.76 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.375 -0.375 . . . . 2.2400000000000002 110.522 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 9' ' ' LEU . 4.6 m -127.63 -179.49 4.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.355 -0.384 . . . . 4.4900000000000002 111.133 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.5 t0 87.11 -22.17 0.16 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.95 -0.568 . . . . 5.4100000000000001 111.868 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.8 mp -92.62 163.1 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-O 120.953 0.406 . . . . 3.29 110.517 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.456 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -85.89 171.53 44.93 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.089 -0.577 . . . . 3.8399999999999999 112.867 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -50.42 -61.83 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.697 0.284 . . . . 7.7199999999999998 111.336 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -127.15 65.93 0.57 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.446 -0.883 . . . . 3.8100000000000001 113.235 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.3 pt -133.28 -167.95 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.67 0.271 . . . . 2.54 110.616 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -56.55 143.73 34.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.475 -0.33 . . . . 4.4000000000000004 110.161 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.687 ' HB3' HG22 ' A' ' 68' ' ' ILE . 23.2 mp0 -99.33 173.77 6.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.32 -0.4 . . . . 2.1699999999999999 110.514 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.02 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.6 p -121.06 146.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.667 0.618 . . . . 1.51 112.667 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.766 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.84 156.14 16.72 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.453 -0.794 . . . . 0.68999999999999995 110.963 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.832 HG11 ' CD1' ' A' ' 24' ' ' TRP . 93.5 t -79.66 127.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.844 -0.617 . . . . 1.3899999999999999 110.299 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -97.97 -25.12 15.09 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.572 -0.286 . . . . 2.9500000000000002 110.969 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 40' ' ' GLU . 0.4 OUTLIER -140.56 130.09 24.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.792 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.842 ' CZ3' HD13 ' A' ' 61' ' ' LEU . 6.5 m95 -130.09 115.53 17.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.67 -0.695 . . . . 0.82999999999999996 109.22 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -117.13 20.17 13.87 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.752 0.649 . . . . 1.72 112.752 -178.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.007 HG11 HG13 ' A' ' 32' ' ' VAL . 3.0 m -163.52 165.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.868 0.366 . . . . 0.5 111.513 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 3.9 mttt -149.42 171.41 16.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.501 0.667 . . . . 1.8899999999999999 111.77 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -40.8 135.3 1.69 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 111.839 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 68.63 4.6 40.21 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.6 -0.809 . . . . 0.45000000000000001 113.937 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.71 153.25 19.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.277 0.538 . . . . 1.3600000000000001 111.748 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 56' ' ' GLY . 27.2 m -100.27 141.46 33.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.31 110.989 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.007 HG13 HG11 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -99.64 168.89 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.851 -0.613 . . . . 0.28000000000000003 110.203 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.22 178.81 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 1.4199999999999999 111.056 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -59.58 -43.82 93.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 2.3799999999999999 110.83 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -90.61 -19.52 23.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 2.52 111.174 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.77 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -88.11 87.11 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.84 0.352 . . . . 1.6899999999999999 111.187 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.1 m -63.06 159.43 17.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.93999999999999995 110.27 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD13 HG12 ' A' ' 78' ' ' ILE . 87.2 mt -90.85 -80.9 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.973 -0.291 . . . . 0.46999999999999997 110.968 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 11.6 t -112.06 141.9 45.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 1.29 111.105 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 3.9 tt0 -133.8 125.9 29.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 2.3700000000000001 110.104 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 21' ' ' VAL . 33.6 m -129.42 145.52 35.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.892 0.377 . . . . 1.3500000000000001 111.493 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -132.14 122.58 25.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.014 -0.539 . . . . 2.6000000000000001 110.728 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.01 154.18 37.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 2.29 111.116 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.85 -46.31 15.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.106 -0.497 . . . . 4.3899999999999997 111.158 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -57.71 -67.85 0.3 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 3.6499999999999999 110.802 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.64 157.99 43.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 111.203 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -107.41 131.34 54.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.187 -0.461 . . . . 4.5199999999999996 110.705 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.32 130.45 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 3.5 111.679 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.3 p -111.86 131.96 55.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 1.46 110.273 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 15.5 mm -99.24 107.23 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.296 0.48 . . . . 1.01 112.296 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.448 ' HB ' ' HD3' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -95.63 -178.71 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.746 -0.661 . . . . 1.04 109.866 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.3 t -119.37 -30.79 4.81 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.261 0.467 . . . . 1.3600000000000001 112.261 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER 60.35 12.19 3.29 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.647 0.26 . . . . 4.2300000000000004 110.986 -178.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -177.05 173.47 1.83 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.879 -0.785 . . . . 3.8799999999999999 108.879 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 3.3 m-20 -96.17 118.42 32.71 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.213 -0.595 . . . . 1.52 109.743 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.664 ' O ' HG23 ' A' ' 31' ' ' THR . . . -121.69 165.23 14.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.17999999999999999 113.605 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 46.4 t -101.76 122.76 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.883 0.327 . . . . 1.1100000000000001 111.883 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.947 HD12 ' HB ' ' A' ' 26' ' ' VAL . 2.7 mt -100.51 129.77 50.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-N 116.079 -0.509 . . . . 0.38 110.81 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -97.02 -38.67 9.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.838 -0.619 . . . . 2.1400000000000001 112.485 -178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.864 ' C ' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -163.33 143.83 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.062 0.764 . . . . 1.3500000000000001 113.062 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.868 HD21 ' CG2' ' A' ' 58' ' ' ILE . 2.9 mt -130.11 103.15 6.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.085 -0.961 . . . . 1.1399999999999999 108.922 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -76.93 -45.12 28.93 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.933 0.716 . . . . 3.0800000000000001 112.933 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.654 ' CD1' HD13 ' A' ' 75' ' ' LEU . 22.7 m-85 -85.47 139.59 31.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 1.9299999999999999 111.581 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 1.8 m-20 -116.44 -173.03 2.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.543 0.687 . . . . 1.7 111.912 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.8 OUTLIER -54.49 -27.36 37.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.683 -1.144 . . . . 1.0600000000000001 112.901 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.54 -25.5 14.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.352 0.501 . . . . 2.3300000000000001 112.352 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.499 ' O ' HG23 ' A' ' 20' ' ' THR . 0.2 OUTLIER -76.78 153.22 35.16 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.494 0.664 . . . . 1.8500000000000001 112.241 -178.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.766 HD13 HG23 ' A' ' 20' ' ' THR . 1.3 mm -107.45 142.79 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 CA-C-N 114.7 -1.136 . . . . 1.3799999999999999 110.283 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CG ' ' A' ' 9' ' ' LEU . . . -111.3 155.98 22.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.242 -0.435 . . . . 2.1600000000000001 110.59 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.487 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -117.37 148.3 41.87 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.496 -0.774 . . . . 5.6500000000000004 110.221 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.592 HG23 ' HB ' ' A' ' 12' ' ' ILE . 26.0 t -82.6 136.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 3.6099999999999999 111.261 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.33 3.32 12.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.585 -0.817 . . . . 1.8700000000000001 113.128 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD3' ' HD2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER -154.48 133.78 7.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 117.191 0.496 . . . . 2.96 111.924 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HB3' ' HG3' ' A' ' 6' ' ' GLN . 35.2 Cg_exo -46.37 152.01 1.57 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.498 2.799 . . . . 0.91000000000000003 113.628 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -119.89 -48.78 2.34 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.886 -0.597 . . . . 1.8400000000000001 110.809 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG22 HG13 ' A' ' 78' ' ' ILE . 2.1 p -142.46 147.46 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 121.119 0.485 . . . . 0.46999999999999997 111.812 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -104.78 120.67 41.93 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.11 -0.7 . . . . 1.1000000000000001 109.11 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.754 HG23 HG12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -133.21 148.9 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.586 -0.279 . . . . 0.85999999999999999 111.727 -178.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.783 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -98.55 114.85 27.44 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.893 -0.41 . . . . 1.3899999999999999 109.893 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.441 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -140.7 156.69 46.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.801 -0.636 . . . . 2.3900000000000001 110.49 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.22 149.04 20.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.742 0.306 . . . . 3.1299999999999999 110.512 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.6 112.91 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 3.1000000000000001 111.595 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tp -123.27 135.01 54.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.93 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -55.16 -22.92 18.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.023 -0.535 . . . . 8.3300000000000001 111.226 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.28 -49.39 61.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 6.2300000000000004 111.263 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.58 -28.15 6.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.513 -0.312 . . . . 4.3899999999999997 111.244 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.267 -0.873 . . . . 7.79 110.932 179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mmm . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.86 0.362 . . . . 5.6799999999999997 111.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.59 4.64 81.43 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.065 -0.516 . . . . 4.1100000000000003 113.597 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -91.1 152.02 20.78 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 122.563 -0.375 . . . . 4.4699999999999998 111.194 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.706 HG12 ' CG ' ' A' ' 79' ' ' GLU . 33.9 m -136.85 146.85 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.496 -0.32 . . . . 1.5700000000000001 111.008 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 78' ' ' ILE . 15.3 m -97.92 124.48 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.019 -1.104 . . . . 1.79 108.019 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 1.8 mt-30 -100.94 144.45 29.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.504 0.557 . . . . 2.2599999999999998 112.504 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 6.6 t80 -104.19 139.93 38.53 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.644 -0.707 . . . . 1.29 110.256 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.94 145.21 51.03 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 115.293 -0.867 . . . . 2.4199999999999999 111.086 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.089 HD11 HD12 ' A' ' 12' ' ' ILE . 2.9 tm? -47.76 123.73 6.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.292 -0.413 . . . . 2.2400000000000002 111.087 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.489 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -119.93 170.47 9.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 4.4900000000000002 110.999 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 10' ' ' SER . 5.4 t70 87.86 -16.24 0.35 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.754 -0.657 . . . . 5.4100000000000001 111.922 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.089 HD12 HD11 ' A' ' 9' ' ' LEU . 25.2 mt -110.56 146.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.781 0.324 . . . . 3.29 111.54 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.61 131.46 10.5 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.887 -0.597 . . . . 3.8399999999999999 112.361 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -47.76 93.44 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.914 0.339 . . . . 7.7199999999999998 111.914 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.2 -20.18 0.95 Allowed Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.209 -0.996 . . . . 3.8100000000000001 112.867 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.443 ' CG1' HG23 ' A' ' 12' ' ' ILE . 19.4 pt -105.51 -158.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.709 0.29 . . . . 2.54 110.969 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 17' ' ' ARG . 1.1 mtm105 -79.44 152.45 30.29 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.01 0.434 . . . . 4.4000000000000004 110.352 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' HD13 ' A' ' 12' ' ' ILE . 22.6 mm-40 -98.87 173.84 6.66 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.968 -0.382 . . . . 2.1699999999999999 109.968 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.4 p -126.83 151.36 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 114.25 1.204 . . . . 1.51 114.25 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.876 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.97 161.41 13.64 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.612 -1.176 . . . . 0.68999999999999995 110.893 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.726 ' HA ' HG12 ' A' ' 41' ' ' VAL . 40.4 t -85.41 126.89 40.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.204 -0.907 . . . . 1.3899999999999999 109.55 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -95.42 -27.1 15.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.694 0.283 . . . . 2.9500000000000002 111.741 -178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' CE2' ' A' ' 25' ' ' TYR . 1.6 tt0 -140.69 127.25 20.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.574 -0.284 . . . . 2.1299999999999999 111.265 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.817 ' CH2' HD22 ' A' ' 61' ' ' LEU . 12.9 m95 -123.32 115.51 21.8 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 109.89 -0.411 . . . . 0.82999999999999996 109.89 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 20.8 m-85 -120.34 29.17 7.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.569 0.581 . . . . 1.72 112.569 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 1.034 HG23 HD11 ' A' ' 61' ' ' LEU . 16.3 m -149.89 167.55 2.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.675 -0.41 . . . . 0.5 111.704 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -147.95 162.18 39.84 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.491 -0.483 . . . . 1.8899999999999999 111.005 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 60' ' ' LYS . 9.7 mt-10 -55.07 139.84 40.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.707 -0.679 . . . . 2.0299999999999998 109.947 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.94 4.52 41.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.46 -0.876 . . . . 0.45000000000000001 113.139 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -99.09 153.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.913 0.387 . . . . 1.3600000000000001 111.13 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.9 m -102.82 146.57 28.06 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.498 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -105.86 166.28 3.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.881 -0.6 . . . . 0.28000000000000003 111.297 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 t -137.52 167.83 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.215 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.02 -17.97 30.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.367 0.506 . . . . 2.3799999999999999 112.367 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.9 -20.69 14.17 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.709 0.29 . . . . 2.52 111.47 179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.08 105.44 16.62 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.335 -0.393 . . . . 1.6899999999999999 111.122 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.87 159.63 31.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.95 -0.568 . . . . 0.93999999999999995 111.331 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.819 HG23 HG21 ' A' ' 26' ' ' VAL . 5.4 mt -87.16 -79.35 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.608 0.242 . . . . 0.46999999999999997 111.37 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 21' ' ' VAL . 51.3 t -122.98 138.18 54.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 1.29 111.407 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -130.55 124.18 31.26 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.985 -0.552 . . . . 2.3700000000000001 109.915 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 21' ' ' VAL . 31.4 m -119.67 143.84 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.824 -0.626 . . . . 1.3500000000000001 110.626 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -126.48 132.1 51.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.857 -0.611 . . . . 2.6000000000000001 111.235 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.98 152.22 35.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.961 -0.563 . . . . 2.29 110.335 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -56.46 -22.44 32.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.811 -0.632 . . . . 4.3899999999999997 111.539 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -100.1 -43.73 6.23 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.268 0.47 . . . . 3.6499999999999999 112.268 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.25 141.15 30.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.083 0.468 . . . . 2.8300000000000001 111.234 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.49 138.61 37.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.643 -0.708 . . . . 4.5199999999999996 110.13 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.52 145.86 35.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.562 0.696 . . . . 3.5 111.825 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -139.5 130.4 26.23 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.059 -0.973 . . . . 1.46 110.167 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.491 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 23.3 mm -97.48 109.04 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.182 0.515 . . . . 1.01 111.357 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.93 172.63 8.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.513 -0.767 . . . . 1.04 110.237 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -114.05 -46.39 3.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.799 -0.637 . . . . 1.3600000000000001 111.131 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER 68.37 11.36 8.33 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.995 0.426 . . . . 4.2300000000000004 110.725 -178.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CE2' ' OE2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -175.55 172.85 2.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.571 -0.9 . . . . 3.8799999999999999 108.571 -178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -98.24 124.76 43.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.235 -0.586 . . . . 1.52 110.292 179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 31' ' ' THR . . . -132.14 166.35 23.28 Favored Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.753 -0.737 . . . . 0.17999999999999999 112.388 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 40.1 t -104.01 121.46 55.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 112.041 0.386 . . . . 1.1100000000000001 112.041 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.556 ' CG1' HG23 ' A' ' 78' ' ' ILE . 24.2 mt -99.79 128.47 51.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.234 -0.654 . . . . 0.38 109.234 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -98.58 -33.03 11.14 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 113.528 0.936 . . . . 2.1400000000000001 113.528 -176.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -158.59 155.36 28.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.778 0.799 . . . . 1.3500000000000001 112.849 -179.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.034 HD11 HG23 ' A' ' 26' ' ' VAL . 48.0 mt -136.62 140.67 42.98 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.572 -1.195 . . . . 1.1399999999999999 109.48 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -113.3 -45.61 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.807 0.669 . . . . 3.0800000000000001 112.807 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.46 ' O ' ' CZ2' ' A' ' 24' ' ' TRP . 25.6 m-85 -94.46 135.61 35.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.167 0.508 . . . . 1.9299999999999999 111.354 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 9.8 m120 -110.54 -172.68 2.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.638 0.732 . . . . 1.7 111.555 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -55.61 -20.81 14.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.787 -1.097 . . . . 1.0600000000000001 112.504 -179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.29 -27.83 11.77 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.578 0.584 . . . . 2.3300000000000001 112.578 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.7 m-20 -76.15 152.8 36.6 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.739 0.644 . . . . 1.8500000000000001 112.739 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.876 HD13 HG23 ' A' ' 20' ' ' THR . 1.7 mm -105.75 137.47 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.436 -0.802 . . . . 1.3799999999999999 109.854 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -104.19 151.05 23.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.811 -0.632 . . . . 2.1600000000000001 110.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 1.1 m-85 -112.39 149.42 32.54 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.393 -1.276 . . . . 5.6500000000000004 109.419 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG11 ' O ' ' A' ' 12' ' ' ILE . 8.5 p -83.2 138.32 19.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.001 0.429 . . . . 3.6099999999999999 110.942 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 117.25 -9.0 15.51 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 115.938 -0.574 . . . . 1.8700000000000001 113.009 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 20.5 mmtm -144.59 130.18 9.59 Favored Pre-proline 0 N--CA 1.469 0.487 0 O-C-N 122.586 -0.361 . . . . 2.96 111.26 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.1 Cg_exo -71.56 146.8 50.3 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.343 2.028 . . . . 0.91000000000000003 111.278 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -109.51 -14.76 14.34 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.02 -0.672 . . . . 1.8400000000000001 111.448 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.71 HG13 HD11 ' A' ' 78' ' ' ILE . 9.7 p -138.81 156.67 28.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 112.815 0.672 . . . . 0.46999999999999997 112.815 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.596 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.4 OUTLIER -124.34 120.4 32.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 109.01 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.71 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -138.08 149.38 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 112.183 0.438 . . . . 0.85999999999999999 112.183 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.706 ' CG ' HG12 ' A' ' 4' ' ' VAL . 85.3 mt-10 -100.29 113.28 25.87 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.889 -0.412 . . . . 1.3899999999999999 109.889 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.429 ' OG1' HG21 ' A' ' 5' ' ' VAL . 1.6 p -141.91 159.19 42.72 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.087 -0.506 . . . . 2.3900000000000001 110.253 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.416 ' OE2' ' CE2' ' A' ' 54' ' ' TYR . 5.3 mp0 -56.65 142.27 40.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.676 -0.49 . . . . 3.1299999999999999 109.676 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.95 117.41 0.85 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.469 0.544 . . . . 3.1000000000000001 112.469 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.843 HD23 ' OD2' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -118.81 135.47 54.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.512 -0.313 . . . . 4.3099999999999996 111.062 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -49.87 -43.6 49.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.949 0.722 . . . . 8.3300000000000001 112.949 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.843 ' OD2' HD23 ' A' ' 83' ' ' LEU . 0.7 OUTLIER -40.58 -47.38 2.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.491 0.552 . . . . 6.2300000000000004 112.491 -178.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.54 -23.71 6.51 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.798 -0.361 . . . . 4.3899999999999997 111.828 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.556 -0.735 . . . . 7.79 110.761 179.453 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.856 0.36 . . . . 5.6799999999999997 111.113 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.54 18.94 5.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.754 -0.736 . . . . 4.1100000000000003 112.6 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.2 153.14 48.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.73 0.3 . . . . 4.4699999999999998 110.792 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.876 HG12 ' HG3' ' A' ' 79' ' ' GLU . 27.3 m -114.33 145.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.195 0.521 . . . . 1.5700000000000001 111.767 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' VAL . 35.8 m -97.81 122.12 49.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.513 -0.767 . . . . 1.79 109.196 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.449 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -101.07 140.85 34.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.202 0.525 . . . . 2.2599999999999998 112.395 -178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 25.9 t80 -102.9 122.12 43.9 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.461 -0.791 . . . . 1.29 109.114 178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -109.25 144.63 37.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.4199999999999999 110.989 -179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.986 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.7 tm? -54.08 113.81 1.37 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.89 73.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.016 0.436 . . . . 4.4900000000000002 111.029 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' CB ' HD13 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -129.46 -40.66 1.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.78 -0.646 . . . . 5.4100000000000001 110.66 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -121.67 -176.04 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.992 -0.549 . . . . 3.29 110.924 -179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.482 ' O ' HD13 ' A' ' 16' ' ' ILE . . . -117.25 136.91 12.97 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.913 -0.66 . . . . 3.8399999999999999 112.206 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.2 105.8 0.06 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.663 0.268 . . . . 7.7199999999999998 111.441 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.8 -17.82 0.65 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.424 -0.894 . . . . 3.8100000000000001 113.285 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.953 HD11 ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -125.05 -161.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.989 0.423 . . . . 2.54 111.364 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 16' ' ' ILE . 10.7 mtp180 -65.29 153.26 41.6 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.841 -0.618 . . . . 4.4000000000000004 110.318 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 69' ' ' ALA . 5.2 mt-10 -97.67 173.8 6.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.196 -0.457 . . . . 2.1699999999999999 110.02 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 7.1 p -115.8 147.0 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 113.279 0.844 . . . . 1.51 113.279 -177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.85 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -97.52 157.52 15.97 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.14 -0.936 . . . . 0.68999999999999995 110.97 -179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.786 HG11 ' NE1' ' A' ' 24' ' ' TRP . 25.7 t -79.44 127.53 39.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.974 -0.557 . . . . 1.3899999999999999 110.424 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -88.85 -36.25 16.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 111.403 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -140.1 134.07 30.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.047 0.451 . . . . 2.1299999999999999 111.638 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.786 ' NE1' HG11 ' A' ' 21' ' ' VAL . 14.2 m95 -127.75 116.9 20.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.735 -0.666 . . . . 0.82999999999999996 109.893 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 26' ' ' VAL . 21.3 m-85 -123.5 38.9 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.88 -0.328 . . . . 1.72 111.618 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.801 HG21 HG23 ' A' ' 38' ' ' ILE . 15.3 m -157.39 167.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.784 0.326 . . . . 0.5 111.299 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.404 ' C ' HD12 ' A' ' 61' ' ' LEU . 23.8 mmtt -147.31 158.88 44.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 1.8899999999999999 110.923 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.0 mp0 -53.95 133.77 43.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.287 -0.415 . . . . 2.0299999999999998 110.675 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.13 3.87 61.95 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.209 -0.996 . . . . 0.45000000000000001 112.34 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -95.23 154.61 17.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.031 0.443 . . . . 1.3600000000000001 111.509 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 56' ' ' GLY . 1.6 m -99.23 151.58 20.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.817 -0.629 . . . . 0.31 110.899 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -110.9 166.0 5.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.768 -0.651 . . . . 0.28000000000000003 111.019 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.41 ' HB2' ' HB2' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -132.03 163.78 27.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.774 -0.648 . . . . 1.4199999999999999 110.245 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -55.78 -29.97 60.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.762 0.315 . . . . 2.3799999999999999 111.372 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -98.52 -18.49 18.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.433 -0.348 . . . . 2.52 111.507 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -93.42 91.42 7.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.896 0.379 . . . . 1.6899999999999999 111.069 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.7 p -59.22 159.52 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.135 -0.484 . . . . 0.93999999999999995 110.9 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 32' ' ' VAL . 10.9 mt -91.2 -75.24 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 111.276 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 24.8 t -123.14 142.6 50.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 1.29 111.339 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -137.02 124.83 22.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.089 -0.505 . . . . 2.3700000000000001 110.177 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -123.84 143.37 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.929 0.395 . . . . 1.3500000000000001 111.476 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' OE1' ' NZ ' ' A' ' 22' ' ' LYS . 8.3 mt-30 -127.44 118.8 24.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.93 -0.577 . . . . 2.6000000000000001 110.613 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.27 151.37 40.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 2.29 110.936 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -50.37 -32.71 18.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 4.3899999999999997 110.794 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -62.59 1.41 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 3.6499999999999999 110.732 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.97 153.44 37.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.8300000000000001 111.281 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.3 m -114.17 130.76 56.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 4.5199999999999996 110.255 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.8 t -128.89 125.78 63.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.044 0.45 . . . . 3.5 112.048 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 68.6 p -106.32 130.86 54.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.75 -0.659 . . . . 1.46 109.715 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.8 mm -99.32 106.86 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.102 0.477 . . . . 1.01 112.002 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.79 -179.1 5.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.62 -0.718 . . . . 1.04 110.099 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.68 -51.22 2.59 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.905 -0.318 . . . . 1.3600000000000001 111.579 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 tpt180 68.87 8.58 6.89 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.107 0.479 . . . . 4.2300000000000004 110.361 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.94 172.49 2.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.981 -0.748 . . . . 3.8799999999999999 108.981 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.7 m-20 -97.13 123.38 40.88 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 1.52 110.471 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -129.19 164.76 22.11 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.619 -0.8 . . . . 0.17999999999999999 113.161 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.0 t -105.65 119.6 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 111.992 0.367 . . . . 1.1100000000000001 111.992 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.77 HD12 ' HB ' ' A' ' 26' ' ' VAL . 34.8 mt -98.8 126.81 51.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 109.403 -0.592 . . . . 0.38 109.403 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -98.65 -40.54 8.14 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.759 1.022 . . . . 2.1400000000000001 113.759 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -145.48 147.81 32.57 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.837 -0.745 . . . . 1.3500000000000001 112.981 -178.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 26' ' ' VAL . 4.8 mt -137.7 135.52 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.72 -1.127 . . . . 1.1399999999999999 109.16 178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.63 -45.4 3.01 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.174 0.435 . . . . 3.0800000000000001 112.174 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 31.6 m-85 -87.98 138.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.042 0.448 . . . . 1.9299999999999999 111.451 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 34.2 m120 -118.55 -173.42 2.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.794 -0.639 . . . . 1.7 111.528 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -53.41 -26.1 18.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.049 -0.978 . . . . 1.0600000000000001 112.194 -179.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -25.82 13.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.403 0.519 . . . . 2.3300000000000001 112.403 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 20' ' ' THR . 2.3 t0 -76.22 156.1 33.88 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 111.876 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.85 HD13 HG23 ' A' ' 20' ' ' THR . 1.5 mm -110.03 140.17 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-N 114.951 -1.022 . . . . 1.3799999999999999 111.246 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -104.49 147.11 27.95 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.775 -0.648 . . . . 2.1600000000000001 110.31 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -105.62 148.47 27.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.748 -0.66 . . . . 5.6500000000000004 110.461 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.916 HG21 ' O ' ' A' ' 12' ' ' ILE . 2.9 t -83.9 133.01 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.231 -0.44 . . . . 3.6099999999999999 111.331 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.1 11.11 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.503 -0.856 . . . . 1.8700000000000001 113.649 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -153.6 146.15 17.41 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 117.249 0.524 . . . . 2.96 111.607 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 53.3 Cg_exo -54.76 165.15 2.71 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.87 2.38 . . . . 0.91000000000000003 112.472 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.7 tt -125.15 -48.38 1.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 1.8400000000000001 111.305 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 60' ' ' LYS . 11.6 p -141.91 144.19 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 112.007 0.373 . . . . 0.46999999999999997 112.007 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -104.82 126.86 52.32 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.101 0.477 . . . . 1.1000000000000001 110.437 178.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.904 HD11 HG13 ' A' ' 76' ' ' VAL . 1.2 mp -137.11 150.66 26.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 110.834 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.876 ' HG3' HG12 ' A' ' 4' ' ' VAL . 5.3 mt-10 -98.14 113.18 25.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.152 -0.685 . . . . 1.3899999999999999 109.152 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.05 157.12 45.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 2.3900000000000001 110.984 -178.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -57.13 153.51 11.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.732 0.301 . . . . 3.1299999999999999 110.391 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.26 110.64 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.356 -0.384 . . . . 3.1000000000000001 111.52 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 83' ' ' LEU . 22.6 mt -114.24 133.68 55.46 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 4.3099999999999996 110.656 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -54.86 -22.73 15.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 8.3300000000000001 111.173 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.2 -46.12 5.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.476 -0.329 . . . . 6.2300000000000004 111.573 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.65 -25.53 11.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.915 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.27 -0.872 . . . . 7.79 110.928 -179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.7 mtt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.804 0.335 . . . . 5.6799999999999997 111.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 112.71 -6.94 26.0 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.797 -0.716 . . . . 4.1100000000000003 112.922 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -86.37 140.53 29.94 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.779 0.323 . . . . 4.4699999999999998 110.896 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.909 HG12 ' CG ' ' A' ' 79' ' ' GLU . 16.0 m -140.55 148.05 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.53 . . . . 1.5700000000000001 111.445 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 78' ' ' ILE . 30.8 m -96.59 132.93 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.338 -0.616 . . . . 1.79 109.338 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -99.33 137.98 37.07 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.722 0.638 . . . . 2.2599999999999998 112.722 -177.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 8.2 t80 -100.93 131.58 46.74 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 1.29 109.027 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 144.65 48.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 2.4199999999999999 111.541 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.015 HD21 ' CG1' ' A' ' 19' ' ' VAL . 2.8 tm? -51.2 114.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.775 -0.648 . . . . 2.2400000000000002 110.006 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 11' ' ' ASP . 4.5 m -140.72 116.29 10.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.96 0.41 . . . . 4.4900000000000002 111.245 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' SER . 28.9 t70 175.12 -35.12 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.66 -0.7 . . . . 5.4100000000000001 110.175 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.901 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -105.52 173.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 3.29 111.019 179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 71' ' ' VAL . . . -74.82 164.56 54.59 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.73 -0.748 . . . . 3.8399999999999999 112.651 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -84.93 78.14 9.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.854 0.359 . . . . 7.7199999999999998 110.895 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.63 -36.84 0.73 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.851 -0.69 . . . . 3.8100000000000001 112.154 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.901 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -65.09 -168.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.741 0.305 . . . . 2.54 110.762 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.6 152.27 26.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.279 -0.419 . . . . 4.4000000000000004 110.592 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.8 mp0 -98.58 174.09 6.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.348 -0.612 . . . . 2.1699999999999999 109.348 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.015 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.9 p -125.36 147.79 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 113.641 0.978 . . . . 1.51 113.641 -177.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.83 156.92 16.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 114.978 -1.01 . . . . 0.68999999999999995 110.976 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.846 HG11 ' CD1' ' A' ' 24' ' ' TRP . 46.4 t -79.52 130.98 35.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.227 -0.442 . . . . 1.3899999999999999 110.551 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.466 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.22 -28.44 13.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.413 -0.358 . . . . 2.9500000000000002 110.9 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 3.5 mm-40 -140.22 130.04 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 2.1299999999999999 111.181 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.846 ' CD1' HG11 ' A' ' 21' ' ' VAL . 16.4 m95 -125.05 119.63 29.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.963 -0.562 . . . . 0.82999999999999996 110.423 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.428 ' C ' HG13 ' A' ' 26' ' ' VAL . 19.0 m-85 -119.75 30.73 6.9 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.025 0.379 . . . . 1.72 112.025 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.834 ' HB ' HD12 ' A' ' 58' ' ' ILE . 11.1 m -156.44 157.7 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.674 0.273 . . . . 0.5 111.161 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.2 mmpt? -132.64 157.82 43.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 1.8899999999999999 111.321 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' LEU . 8.1 mp0 -55.12 135.07 49.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.151 -0.477 . . . . 2.0299999999999998 110.577 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.1 3.15 64.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.432 -0.89 . . . . 0.45000000000000001 112.452 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -96.28 154.99 16.95 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.96 0.41 . . . . 1.3600000000000001 111.506 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 56' ' ' GLY . 17.2 m -98.8 147.4 24.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.852 -0.613 . . . . 0.31 110.795 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.881 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -101.66 160.51 3.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.832 -0.622 . . . . 0.28000000000000003 110.804 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.11 161.68 35.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.969 -0.56 . . . . 1.4199999999999999 110.532 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -50.51 -28.4 8.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.381 -0.372 . . . . 2.3799999999999999 111.284 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -98.09 -17.47 19.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.428 -0.351 . . . . 2.52 111.563 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -96.31 94.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.793 0.33 . . . . 1.6899999999999999 111.497 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.25 159.64 20.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.93999999999999995 109.884 179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.881 HG12 HG11 ' A' ' 32' ' ' VAL . 7.5 mt -91.72 -83.04 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 120.66 -0.416 . . . . 0.46999999999999997 111.76 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 44.5 t -116.83 143.63 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 1.29 111.838 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 34.3 mt-10 -135.54 124.77 24.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 2.3700000000000001 110.007 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 m -119.46 148.45 22.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.84 0.352 . . . . 1.3500000000000001 111.346 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -133.31 118.92 19.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 2.6000000000000001 110.911 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.45 154.59 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 2.29 111.033 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -55.91 -20.55 16.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.035 -0.53 . . . . 4.3899999999999997 111.218 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -40.79 7.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.553 -0.294 . . . . 3.6499999999999999 111.605 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.32 162.87 39.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.926 0.393 . . . . 2.8300000000000001 111.57 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.25 117.72 25.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.941 -0.572 . . . . 4.5199999999999996 110.443 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.74 147.66 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.027 0.442 . . . . 3.5 111.736 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.6 p -139.31 127.12 22.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.762 -0.654 . . . . 1.46 110.356 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.501 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 36.2 mm -100.7 106.65 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.095 0.474 . . . . 1.01 111.699 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 p -79.58 -179.07 6.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.691 -0.686 . . . . 1.04 110.562 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -107.37 -60.42 1.69 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.483 -0.326 . . . . 1.3600000000000001 111.456 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER 73.24 5.0 5.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.283 -0.417 . . . . 4.2300000000000004 111.07 -179.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -175.51 171.92 2.72 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.668 -0.493 . . . . 3.8799999999999999 109.668 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -98.19 126.21 43.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.986 0.422 . . . . 1.52 110.503 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 31' ' ' THR . . . -135.24 165.0 24.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.654 -0.784 . . . . 0.17999999999999999 113.188 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.56 118.49 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 1.1100000000000001 111.626 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.834 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.1 mt -99.29 121.88 50.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.115 -0.698 . . . . 0.38 109.115 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CE ' ' A' ' 60' ' ' LYS . 5.8 ttpt -99.53 -43.45 6.51 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.219 0.822 . . . . 2.1400000000000001 113.219 -177.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -137.83 139.03 39.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.926 -0.71 . . . . 1.3500000000000001 112.524 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -136.78 98.41 3.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.229 -0.896 . . . . 1.1399999999999999 109.545 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.83 -45.62 27.84 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 3.0800000000000001 112.642 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.518 ' HD2' HD22 ' A' ' 75' ' ' LEU . 10.4 m-30 -83.38 136.97 34.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.187 0.517 . . . . 1.9299999999999999 111.991 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' N ' ' OD2' ' A' ' 67' ' ' ASP . 36.1 m120 -121.99 -172.59 2.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.328 -0.851 . . . . 1.7 110.51 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER -54.79 -18.91 5.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.421 -0.809 . . . . 1.0600000000000001 112.213 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -107.04 -26.17 11.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.63 0.604 . . . . 2.3300000000000001 112.63 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.513 ' C ' HG23 ' A' ' 20' ' ' THR . 4.9 m-20 -79.15 150.38 31.74 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.381 0.61 . . . . 1.8500000000000001 112.277 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.686 HD13 ' OG1' ' A' ' 20' ' ' THR . 0.8 OUTLIER -102.82 142.99 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.98 -1.009 . . . . 1.3799999999999999 110.966 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -105.75 144.59 32.28 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.223 -0.898 . . . . 2.1600000000000001 110.436 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' OE2' ' A' ' 18' ' ' GLU . 2.8 m-85 -97.14 137.27 36.44 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.445 -0.798 . . . . 5.6500000000000004 111.472 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 12' ' ' ILE . 4.9 t -55.78 139.23 15.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.858 -0.61 . . . . 3.6099999999999999 112.24 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.53 11.13 59.24 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.87 -0.604 . . . . 1.8700000000000001 113.903 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -114.94 128.1 26.23 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 117.345 0.572 . . . . 2.96 111.511 -179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 12.6 Cg_exo -68.62 138.47 41.76 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.395 2.063 . . . . 0.91000000000000003 111.393 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.518 HD22 ' HD2' ' A' ' 63' ' ' TYR . 2.3 pp -123.94 -27.06 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.249 0.463 . . . . 1.8400000000000001 112.249 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.829 HG13 HD11 ' A' ' 78' ' ' ILE . 10.5 p -139.18 143.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 112.342 0.497 . . . . 0.46999999999999997 112.342 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 1.0 OUTLIER -108.21 126.41 52.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.729 -0.669 . . . . 1.1000000000000001 109.608 178.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.829 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -137.74 148.61 25.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 0.85999999999999999 111.834 -178.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.909 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -99.88 114.42 27.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.987 -0.551 . . . . 1.3899999999999999 109.6 178.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -141.73 156.46 45.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.448 -0.342 . . . . 2.3900000000000001 111.232 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.878 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -57.4 148.52 23.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.391 -0.368 . . . . 3.1299999999999999 110.414 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -42.36 110.7 0.19 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.315 -0.402 . . . . 3.1000000000000001 111.786 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -123.55 134.19 53.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 4.3099999999999996 110.79 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -22.92 9.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.448 . . . . 8.3300000000000001 111.061 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.73 -49.41 10.55 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.36 -0.382 . . . . 6.2300000000000004 111.567 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.7 tp -117.85 -28.32 5.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.512 -0.313 . . . . 4.3899999999999997 111.289 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.269 -0.872 . . . . 7.79 110.902 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.831 0.348 . . . . 5.6799999999999997 111.219 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.93 19.13 11.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 4.1100000000000003 112.639 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -139.64 142.03 37.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 4.4699999999999998 110.863 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.958 HG12 ' HG2' ' A' ' 79' ' ' GLU . 14.7 m -140.56 146.17 24.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 1.5700000000000001 111.501 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 HG21 ' OG1' ' A' ' 80' ' ' THR . 7.3 m -97.82 127.61 50.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.839 -0.8 . . . . 1.79 108.839 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -98.89 135.13 40.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.255 0.55 . . . . 2.2599999999999998 112.194 -178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 10.0 t80 -100.73 132.78 45.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.309 -0.86 . . . . 1.29 110.111 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HA ' HD13 ' A' ' 75' ' ' LEU . 0.0 OUTLIER -125.72 144.87 50.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.371 -0.831 . . . . 2.4199999999999999 110.455 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.974 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -48.2 114.89 1.03 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.914 0.388 . . . . 2.2400000000000002 110.62 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 57.9 m -132.5 95.54 3.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.031 -0.532 . . . . 4.4900000000000002 110.401 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.614 ' HB2' HD13 ' A' ' 12' ' ' ILE . 7.8 m-20 -159.11 -42.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.977 -0.556 . . . . 5.4100000000000001 110.935 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.816 ' CG2' HD11 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -112.62 175.66 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 3.29 111.508 -179.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.3 164.34 54.26 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.862 -0.685 . . . . 3.8399999999999999 112.546 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 71' ' ' VAL . 7.5 mp0 -82.91 77.23 9.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.728 0.299 . . . . 7.7199999999999998 111.169 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.73 -27.13 0.74 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.585 -0.816 . . . . 3.8100000000000001 112.639 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.816 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -83.26 -169.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.815 0.341 . . . . 2.54 111.197 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.4 ttt85 -54.96 151.62 8.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.771 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' HB2' HG21 ' A' ' 68' ' ' ILE . 1.9 mt-10 -100.17 174.39 6.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 2.1699999999999999 110.406 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.974 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.6 p -125.34 153.07 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 113.361 0.875 . . . . 1.51 113.361 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.469 ' OG1' HD13 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -98.99 161.23 13.74 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.511 -0.768 . . . . 0.68999999999999995 111.075 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.901 HG11 ' CD1' ' A' ' 24' ' ' TRP . 50.0 t -84.35 115.09 25.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.837 -0.62 . . . . 1.3899999999999999 110.214 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -80.86 -32.13 35.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.45 -0.341 . . . . 2.9500000000000002 111.291 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HA ' HD21 ' A' ' 65' ' ' LEU . 8.4 mt-10 -141.32 129.47 22.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.04 0.447 . . . . 2.1299999999999999 111.766 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.901 ' CD1' HG11 ' A' ' 21' ' ' VAL . 3.8 m95 -125.05 116.37 21.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.898 -0.592 . . . . 0.82999999999999996 109.801 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.426 ' O ' ' CG1' ' A' ' 26' ' ' VAL . 32.2 m-85 -122.66 39.66 3.88 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.842 -0.343 . . . . 1.72 111.847 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.722 ' HB ' HD12 ' A' ' 58' ' ' ILE . 15.5 m -157.51 158.98 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.845 0.355 . . . . 0.5 111.078 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.6 mtpt -139.06 157.44 45.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 1.8899999999999999 110.793 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.2 mp0 -53.14 133.63 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 2.0299999999999998 110.489 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 73.43 3.79 63.04 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.25 -0.976 . . . . 0.45000000000000001 112.336 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 11.9 t0 -95.81 155.18 16.86 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.012 0.434 . . . . 1.3600000000000001 111.518 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 56' ' ' GLY . 4.3 m -98.78 153.75 18.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.882 -0.599 . . . . 0.31 110.968 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.868 HG11 HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -113.07 168.27 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.735 -0.666 . . . . 0.28000000000000003 111.02 -179.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 m -135.66 156.24 49.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 110.419 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.46 -24.56 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.37 -0.377 . . . . 2.3799999999999999 111.061 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -96.76 -24.1 16.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.294 -0.412 . . . . 2.52 111.076 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -96.18 102.76 14.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.324 -0.398 . . . . 1.6899999999999999 110.881 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.4 154.73 41.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.501 . . . . 0.93999999999999995 110.941 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.868 HG12 HG11 ' A' ' 32' ' ' VAL . 8.2 mt -79.94 -75.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 111.061 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 16.8 t -117.75 149.9 40.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.189 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 49' ' ' THR . 1.9 mt-10 -138.92 125.28 20.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.981 -0.554 . . . . 2.3700000000000001 110.22 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 21' ' ' VAL . 27.8 m -127.25 145.06 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.81 0.338 . . . . 1.3500000000000001 111.056 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 7.4 mt-30 -128.83 126.1 39.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 2.6000000000000001 111.383 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.48 150.38 37.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.885 -0.598 . . . . 2.29 110.713 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -56.03 -31.31 63.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.328 -0.396 . . . . 4.3899999999999997 111.063 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HE3' ' CG2' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -85.19 -43.27 13.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 3.6499999999999999 111.368 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.2 154.65 39.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.91 0.385 . . . . 2.8300000000000001 111.412 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.02 128.2 49.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.939 -0.573 . . . . 4.5199999999999996 110.358 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.67 143.26 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.139 0.495 . . . . 3.5 112.074 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 40' ' ' GLU . 37.3 p -124.5 131.91 53.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.553 -0.749 . . . . 1.46 109.733 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.503 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 29.3 mm -98.77 107.21 20.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.124 0.488 . . . . 1.01 111.84 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 52' ' ' SER . 1.3 t -98.17 -179.0 4.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 1.04 109.966 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.465 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.4 OUTLIER -118.11 -39.78 3.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.581 -0.281 . . . . 1.3600000000000001 111.526 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 66.79 11.91 8.54 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.016 0.436 . . . . 4.2300000000000004 110.441 -178.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 16.2 m-85 -171.08 172.46 5.4 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.724 -0.843 . . . . 3.8799999999999999 108.724 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -97.11 123.95 41.01 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.348 -0.541 . . . . 1.52 110.529 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.13 164.42 24.19 Favored Glycine 0 C--O 1.223 -0.577 0 C-N-CA 120.66 -0.781 . . . . 0.17999999999999999 113.156 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.0 t -104.85 120.35 55.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.424 0.527 . . . . 1.1100000000000001 112.424 -179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.722 HD12 ' HB ' ' A' ' 26' ' ' VAL . 35.8 mt -99.51 128.29 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.985 -0.552 . . . . 0.38 109.759 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -99.41 -38.38 8.84 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 113.885 1.069 . . . . 2.1400000000000001 113.885 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.949 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.73 142.7 32.01 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.089 0.774 . . . . 1.3500000000000001 113.089 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 28' ' ' GLU . 1.7 mt -138.09 121.24 16.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.93 -1.032 . . . . 1.1399999999999999 109.101 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -102.61 -44.69 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.663 0.616 . . . . 3.0800000000000001 112.663 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -85.17 133.88 34.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.95 0.405 . . . . 1.9299999999999999 111.777 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -106.97 -171.16 1.83 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.444 0.64 . . . . 1.7 111.554 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 23' ' ' GLU . 1.1 mt -63.04 -17.77 62.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.861 -1.063 . . . . 1.0600000000000001 112.089 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -105.41 -25.88 12.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.769 0.318 . . . . 2.3300000000000001 111.623 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 20' ' ' THR . 1.5 m-20 -75.69 154.11 36.7 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.457 0.646 . . . . 1.8500000000000001 112.523 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 18' ' ' GLU . 6.5 mm -103.49 142.38 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-N 114.728 -1.124 . . . . 1.3799999999999999 110.614 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.682 ' HB1' ' HB2' ' A' ' 9' ' ' LEU . . . -111.01 150.87 28.67 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.636 -0.711 . . . . 2.1600000000000001 109.816 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -119.86 136.85 54.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.054 -0.521 . . . . 5.6500000000000004 110.556 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 14' ' ' GLU . 7.2 p -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 3.6099999999999999 111.317 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.69 -11.16 9.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.671 -0.776 . . . . 1.8700000000000001 112.991 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 16.2 mmmt -150.93 132.67 7.87 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.913 0.357 . . . . 2.96 111.149 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 6.9 Cg_exo -70.46 153.76 65.5 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.412 2.075 . . . . 0.91000000000000003 111.96 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -119.4 -17.83 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.872 -0.331 . . . . 1.8400000000000001 111.719 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -141.5 145.49 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.18 0.807 . . . . 0.46999999999999997 113.18 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -112.04 126.3 55.02 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.57 -0.741 . . . . 1.1000000000000001 109.179 178.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.793 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -134.92 149.45 29.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.85999999999999999 111.722 -178.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.958 ' HG2' HG12 ' A' ' 4' ' ' VAL . 3.4 mt-10 -99.08 114.13 26.68 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 109.791 -0.448 . . . . 1.3899999999999999 109.791 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.474 ' OG1' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -141.66 155.61 45.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 2.3900000000000001 111.104 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.02 154.04 13.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 3.1299999999999999 110.486 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.57 110.18 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.914 0.388 . . . . 3.1000000000000001 111.484 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.56 135.27 53.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 110.967 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -61.02 -22.66 64.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 8.3300000000000001 111.154 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -41.86 -46.32 3.93 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.34 -0.391 . . . . 6.2300000000000004 111.737 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 tp -104.13 -27.87 11.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 4.3899999999999997 111.045 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.914 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.836 0.351 . . . . 5.6799999999999997 111.242 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 114.67 -7.2 22.27 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.717 -0.754 . . . . 4.1100000000000003 112.973 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -93.75 153.24 18.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.821 0.31 . . . . 4.4699999999999998 110.815 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 79' ' ' GLU . 22.5 m -116.77 146.53 21.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.112 0.482 . . . . 1.5700000000000001 111.754 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 78' ' ' ILE . 33.8 m -97.72 127.43 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.79 109.21 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.469 ' HG3' ' HA ' ' A' ' 77' ' ' ASP . 0.8 OUTLIER -99.78 137.86 37.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 2.2599999999999998 112.398 -178.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 9.5 t80 -100.12 137.94 37.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.368 -0.833 . . . . 1.29 110.012 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -127.88 144.77 51.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 2.4199999999999999 111.298 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.013 HD11 HD13 ' A' ' 12' ' ' ILE . 1.8 tm? -47.19 133.91 11.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.25 -0.432 . . . . 2.2400000000000002 110.002 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.812 ' N ' HD13 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -129.88 168.49 16.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.67 0.272 . . . . 4.4900000000000002 111.317 -179.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t0 87.69 -24.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.907 -0.588 . . . . 5.4100000000000001 111.916 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.013 HD13 HD11 ' A' ' 9' ' ' LEU . 2.7 mp -93.78 164.39 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 120.959 0.409 . . . . 3.29 110.649 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -113.85 171.69 13.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.199 -0.524 . . . . 3.8399999999999999 112.64 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -45.35 -34.15 2.86 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.796 0.295 . . . . 7.7199999999999998 111.796 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.88 63.52 0.27 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.268 -0.968 . . . . 3.8100000000000001 113.172 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 17' ' ' ARG . 1.7 pp -119.02 -35.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.947 0.403 . . . . 2.54 111.234 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.595 ' HB3' HD12 ' A' ' 16' ' ' ILE . 19.8 ttm180 157.09 134.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.553 -0.906 . . . . 4.4000000000000004 108.553 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.627 ' HB3' HG22 ' A' ' 68' ' ' ILE . 4.6 mt-10 -98.4 167.24 10.95 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.92 -0.312 . . . . 2.1699999999999999 110.558 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.986 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.0 p -122.51 148.77 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.751 0.648 . . . . 1.51 112.751 -178.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.97 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.18 154.39 18.18 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.362 -0.835 . . . . 0.68999999999999995 110.48 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.559 HG11 ' CD1' ' A' ' 24' ' ' TRP . 37.8 t -79.41 127.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.699 -0.4 . . . . 1.3899999999999999 110.6 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -94.0 -28.89 15.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.326 -0.397 . . . . 2.9500000000000002 111.295 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -140.16 134.54 31.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.949 0.404 . . . . 2.1299999999999999 111.61 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.574 ' CH2' HD22 ' A' ' 61' ' ' LEU . 6.2 m95 -130.63 115.24 16.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.887 -0.597 . . . . 0.82999999999999996 109.908 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.29 23.34 11.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.652 0.263 . . . . 1.72 111.684 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.838 HG21 HG23 ' A' ' 38' ' ' ILE . 16.0 m -147.02 157.46 10.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.497 -0.319 . . . . 0.5 111.081 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' LEU . 2.5 mttt -139.95 158.27 44.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 1.8899999999999999 111.006 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.8 mt-10 -52.47 135.01 34.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 2.0299999999999998 110.609 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 77.25 3.09 81.33 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.306 -0.949 . . . . 0.45000000000000001 112.437 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -100.63 154.1 18.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.018 0.437 . . . . 1.3600000000000001 111.682 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 56' ' ' GLY . 11.0 m -99.53 149.71 22.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.794 -0.639 . . . . 0.31 110.499 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.776 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -103.53 159.54 4.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.285 -0.416 . . . . 0.28000000000000003 111.413 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -137.68 161.71 35.76 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.59 -0.732 . . . . 1.4199999999999999 110.316 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HA ' ' HB2' ' A' ' 52' ' ' SER . 1.2 tt0 -53.91 -23.11 11.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.537 -0.301 . . . . 2.3799999999999999 111.354 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.46 -18.31 16.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.375 -0.375 . . . . 2.52 111.563 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.56 ' O ' HG12 ' A' ' 32' ' ' VAL . 7.1 m-20 -101.76 90.42 4.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.331 . . . . 1.6899999999999999 111.309 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.4 p -60.38 159.78 9.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 0.93999999999999995 110.55 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.838 HG23 HG21 ' A' ' 26' ' ' VAL . 13.6 mt -91.23 -82.42 0.17 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 121.096 -0.242 . . . . 0.46999999999999997 111.191 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.523 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 16.4 p -117.24 146.41 43.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.977 0.418 . . . . 1.29 111.528 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.919 ' CG ' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -136.04 130.56 33.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.831 -0.622 . . . . 2.3700000000000001 110.037 179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 21' ' ' VAL . 30.0 m -128.82 153.89 39.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.941 0.401 . . . . 1.3500000000000001 111.725 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.39 121.84 16.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.883 -0.598 . . . . 2.6000000000000001 110.871 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.5 p -124.33 154.46 40.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 2.29 110.88 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.38 -45.45 17.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.857 0.361 . . . . 4.3899999999999997 111.188 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -59.77 -68.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 3.6499999999999999 110.689 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.69 154.39 39.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 2.8300000000000001 110.986 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 p -99.6 128.89 45.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.333 -0.394 . . . . 4.5199999999999996 110.708 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.81 136.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 3.5 111.417 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.919 HG22 ' CG ' ' A' ' 40' ' ' GLU . 42.4 p -127.53 130.28 48.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.536 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.471 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 43.6 mm -104.55 106.08 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.073 0.463 . . . . 1.01 111.639 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 33.5 p -84.88 -179.76 7.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.792 -0.64 . . . . 1.04 110.214 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 15.2 m -94.92 -64.31 1.08 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.513 -0.312 . . . . 1.3600000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 77.19 -2.26 2.65 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.351 -0.386 . . . . 4.2300000000000004 111.272 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -176.17 172.55 2.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.132 -0.692 . . . . 3.8799999999999999 109.132 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.75 124.78 42.25 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.281 -0.567 . . . . 1.52 110.499 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 31' ' ' THR . . . -137.12 164.36 25.29 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.43 -0.89 . . . . 0.17999999999999999 113.295 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 91.3 t -101.3 118.06 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 112.13 0.418 . . . . 1.1100000000000001 112.13 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.598 HD12 ' HB ' ' A' ' 26' ' ' VAL . 37.3 mt -98.92 119.69 47.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 109.647 -0.501 . . . . 0.38 109.647 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -105.29 -23.57 12.85 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.973 1.101 . . . . 2.1400000000000001 113.973 -177.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -142.24 131.1 22.92 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.949 0.722 . . . . 1.3500000000000001 112.949 -178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 HD22 ' CH2' ' A' ' 24' ' ' TRP . 9.8 mt -137.34 106.45 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.699 -0.682 . . . . 1.1399999999999999 109.654 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -93.86 -39.2 10.84 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.6 0.593 . . . . 3.0800000000000001 112.6 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -90.01 134.4 34.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.974 0.416 . . . . 1.9299999999999999 111.808 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.455 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 19.7 m120 -114.02 -171.03 1.83 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.453 0.644 . . . . 1.7 111.225 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.6 OUTLIER -59.64 -17.73 36.09 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.846 -1.07 . . . . 1.0600000000000001 112.483 -179.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 20' ' ' THR . 3.4 m-20 -107.52 -25.67 11.27 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.166 0.432 . . . . 2.3300000000000001 112.166 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.49 152.68 37.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.386 0.612 . . . . 1.8500000000000001 112.445 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.97 HD13 HG23 ' A' ' 20' ' ' THR . 0.9 OUTLIER -110.8 143.37 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.828 -1.078 . . . . 1.3799999999999999 110.488 179.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.588 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -117.08 157.25 26.2 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.878 -0.601 . . . . 2.1600000000000001 110.899 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.409 ' HB3' ' HG2' ' A' ' 18' ' ' GLU . 18.9 p90 -127.98 142.55 51.21 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.539 -0.755 . . . . 5.6500000000000004 110.219 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 12' ' ' ILE . 60.3 t -64.95 138.29 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.675 0.274 . . . . 3.6099999999999999 111.105 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.62 -0.3 11.13 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.423 -0.894 . . . . 1.8700000000000001 113.774 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -156.77 129.48 4.28 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.306 0.553 . . . . 2.96 111.496 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 8' ' ' LYS . 18.9 Cg_exo -64.98 142.38 74.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.356 2.038 . . . . 0.91000000000000003 111.642 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' HG12 ' A' ' 76' ' ' VAL . 3.5 pp -106.64 -33.28 7.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.484 -0.325 . . . . 1.8400000000000001 111.275 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 60' ' ' LYS . 6.5 p -140.46 143.81 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.19 0.519 . . . . 0.46999999999999997 112.396 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -108.3 126.4 52.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.555 -0.748 . . . . 1.1000000000000001 109.544 178.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.58 HG23 HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -133.88 147.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.186 -0.461 . . . . 0.85999999999999999 111.124 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.692 ' HG3' HG12 ' A' ' 4' ' ' VAL . 0.6 OUTLIER -98.52 113.25 25.19 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.299 -0.56 . . . . 1.3899999999999999 109.912 179.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.8 p -143.07 157.29 44.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.317 -0.856 . . . . 2.3900000000000001 110.605 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.98 154.28 9.86 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.004 -0.278 . . . . 3.1299999999999999 110.312 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -37.91 110.91 0.14 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.292 0.478 . . . . 3.1000000000000001 112.292 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.57 142.49 50.98 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.113 -0.494 . . . . 4.3099999999999996 111.164 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -22.39 50.36 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 8.3300000000000001 111.299 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.27 -49.45 0.95 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.221 0.452 . . . . 6.2300000000000004 112.221 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 86' ' ' LEU . 3.1 mt -121.04 -28.08 4.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.402 -0.363 . . . . 4.3899999999999997 111.64 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.285 -0.864 . . . . 7.79 110.853 -179.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.858 0.361 . . . . 5.6799999999999997 111.097 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.14 14.13 27.12 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.722 -0.751 . . . . 4.1100000000000003 112.705 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -128.08 153.61 46.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.791 0.329 . . . . 4.4699999999999998 110.986 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.894 HG12 ' CG ' ' A' ' 79' ' ' GLU . 18.1 m -134.91 146.81 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 1.5700000000000001 111.332 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' N ' ' O ' ' A' ' 78' ' ' ILE . 19.3 m -96.8 129.14 47.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.752 -0.658 . . . . 1.79 109.642 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HG2' ' OD1' ' A' ' 77' ' ' ASP . 2.8 mt-30 -100.3 143.54 30.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.425 0.528 . . . . 2.2599999999999998 112.425 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.454 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -99.55 134.28 42.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.724 -0.843 . . . . 1.29 108.724 177.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -126.87 144.63 50.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.369 -0.832 . . . . 2.4199999999999999 111.159 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.01 HD21 ' CG1' ' A' ' 19' ' ' VAL . 3.1 tm? -53.71 117.46 3.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 2.2400000000000002 110.807 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 60.1 p -131.12 109.39 10.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 4.4900000000000002 111.094 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 12' ' ' ILE . 57.0 t0 -178.86 -38.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 5.4100000000000001 110.876 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.908 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.89 178.24 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 3.29 111.208 -179.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.36 171.11 49.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.851 -0.69 . . . . 3.8399999999999999 112.706 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 80.84 6.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.827 0.346 . . . . 7.7199999999999998 110.808 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.53 -20.84 0.72 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.819 -0.705 . . . . 3.8100000000000001 112.485 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.904 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -91.3 -168.17 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 2.54 111.291 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 -59.65 152.37 22.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 4.4000000000000004 110.612 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.732 ' HB3' HG22 ' A' ' 68' ' ' ILE . 1.3 mp0 -99.34 173.19 6.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 2.1699999999999999 110.803 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.01 ' CG1' HD21 ' A' ' 9' ' ' LEU . 11.6 p -122.9 151.69 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.149 0.499 . . . . 1.51 112.152 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -98.09 156.15 16.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.865 -0.607 . . . . 0.68999999999999995 111.371 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 24' ' ' TRP . 42.5 t -79.34 132.0 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.945 -0.571 . . . . 1.3899999999999999 110.336 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -31.74 13.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 2.9500000000000002 111.362 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -138.49 141.71 39.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.075 0.464 . . . . 2.1299999999999999 111.505 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.812 ' NE1' HG11 ' A' ' 21' ' ' VAL . 24.2 m95 -139.21 116.83 11.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.672 -0.695 . . . . 0.82999999999999996 109.98 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' C ' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -121.25 33.71 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.625 -0.261 . . . . 1.72 111.555 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.806 ' HB ' HD12 ' A' ' 58' ' ' ILE . 4.6 m -154.85 170.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.915 0.388 . . . . 0.5 111.637 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 12.6 mmtp -148.59 160.01 43.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.8899999999999999 110.808 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' HD12 ' A' ' 61' ' ' LEU . 1.6 mp0 -55.82 132.01 48.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.515 -0.311 . . . . 2.0299999999999998 110.221 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 74.82 3.5 68.07 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.012 -1.089 . . . . 0.45000000000000001 111.981 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 4.1 t0 -96.13 155.41 16.77 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-O 120.895 0.379 . . . . 1.3600000000000001 111.295 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 56' ' ' GLY . 3.7 m -99.24 152.47 19.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.037 -0.529 . . . . 0.31 111.313 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.872 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -107.07 153.75 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.633 -0.712 . . . . 0.28000000000000003 111.058 -179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.78 162.64 26.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 1.4199999999999999 110.69 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -30.81 36.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.285 -0.416 . . . . 2.3799999999999999 111.207 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.74 -19.61 19.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 2.52 111.618 -179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -97.5 96.55 8.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 1.6899999999999999 111.561 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.0 p -67.23 160.03 27.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.167 -0.469 . . . . 0.93999999999999995 110.637 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.872 HG12 HG11 ' A' ' 32' ' ' VAL . 3.3 mt -85.46 -72.33 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.587 -0.279 . . . . 0.46999999999999997 111.298 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.492 ' HB3' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -136.37 146.31 46.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.12 0.486 . . . . 1.29 111.378 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 1.6 mt-10 -140.43 125.38 18.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 2.3700000000000001 110.039 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' A' ' 21' ' ' VAL . 18.7 m -117.93 154.54 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.947 0.403 . . . . 1.3500000000000001 111.424 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -140.02 122.42 16.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.57 . . . . 2.6000000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.8 t -124.02 154.12 40.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 2.29 110.854 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -49.11 -28.52 4.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 4.3899999999999997 110.915 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -76.36 -68.99 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 3.6499999999999999 110.75 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.91 148.24 31.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 2.8300000000000001 111.048 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -105.54 136.57 44.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 4.5199999999999996 111.016 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.27 140.04 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 3.5 111.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.442 HG22 ' HB3' ' A' ' 40' ' ' GLU . 41.8 p -128.97 129.12 45.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.928 -0.578 . . . . 1.46 110.582 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.419 HG13 ' CE2' ' A' ' 7' ' ' PHE . 18.9 mm -106.93 106.28 20.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 121.091 0.472 . . . . 1.01 111.541 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.29 -179.49 7.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.728 -0.669 . . . . 1.04 109.704 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 17.2 m -96.02 -53.48 3.65 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.923 -0.311 . . . . 1.3600000000000001 111.347 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 8.1 tpp180 67.45 5.43 4.3 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 120.967 0.413 . . . . 4.2300000000000004 110.993 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 7.5 m-85 -177.22 172.52 1.89 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.619 -0.882 . . . . 3.8799999999999999 108.619 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 4.9 p-10 -97.37 118.46 33.89 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.17 -0.612 . . . . 1.52 109.779 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 79' ' ' GLU . . . -127.19 164.91 20.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.615 -0.803 . . . . 0.17999999999999999 113.353 -178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.24 119.93 57.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.209 0.448 . . . . 1.1100000000000001 112.209 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.806 HD12 ' HB ' ' A' ' 26' ' ' VAL . 24.9 mt -100.44 124.97 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.053 -0.521 . . . . 0.38 109.981 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -99.46 -34.4 10.28 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.549 0.944 . . . . 2.1400000000000001 113.549 -177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.938 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -150.83 143.47 24.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.105 0.78 . . . . 1.3500000000000001 113.105 -179.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.665 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 3.9 mt -128.48 144.87 51.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.986 -1.007 . . . . 1.1399999999999999 108.87 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -115.09 -41.02 3.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.521 0.563 . . . . 3.0800000000000001 112.521 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.61 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 25.4 m-85 -105.44 142.15 35.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.089 0.471 . . . . 1.9299999999999999 112.015 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' NE1' ' A' ' 24' ' ' TRP . 7.8 m-20 -117.36 -174.75 2.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.556 -0.747 . . . . 1.7 111.162 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -51.84 -21.42 2.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.204 -0.907 . . . . 1.0600000000000001 112.365 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -106.56 -25.47 11.81 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.713 0.635 . . . . 2.3300000000000001 112.713 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' THR . 0.7 OUTLIER -78.54 154.47 30.38 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.433 0.635 . . . . 1.8500000000000001 112.256 -178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 20' ' ' THR . 1.9 mm -106.38 142.75 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 114.855 -1.066 . . . . 1.3799999999999999 110.523 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.61 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -112.02 149.93 31.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.06 -0.518 . . . . 2.1600000000000001 110.852 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' CA ' ' HG2' ' A' ' 18' ' ' GLU . 39.3 t80 -109.03 148.46 30.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.734 -0.666 . . . . 5.6500000000000004 110.658 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 12' ' ' ILE . 13.5 t -82.12 134.51 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.487 . . . . 3.6099999999999999 111.371 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.46 -14.18 9.36 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.795 -0.717 . . . . 1.8700000000000001 113.066 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 21.0 ptmt -145.26 130.8 9.38 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.825 0.313 . . . . 2.96 111.329 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -70.31 160.63 48.89 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.338 2.025 . . . . 0.91000000000000003 111.358 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -125.39 -17.12 5.69 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.401 0.519 . . . . 1.8400000000000001 112.401 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.938 HG23 ' O ' ' A' ' 60' ' ' LYS . 14.6 p -140.1 140.86 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 119.916 -0.714 . . . . 0.46999999999999997 112.709 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -109.65 129.15 55.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.934 -0.576 . . . . 1.1000000000000001 109.736 178.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.61 HG23 HG12 ' A' ' 58' ' ' ILE . 1.7 mp -135.69 149.82 28.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.265 -0.425 . . . . 0.85999999999999999 110.78 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.894 ' CG ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -97.6 112.84 24.54 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.897 -0.721 . . . . 1.3899999999999999 109.185 178.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' OG1' ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -142.49 157.62 44.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.703 -179.031 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -56.74 121.6 10.17 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.9 0.381 . . . . 3.1299999999999999 109.999 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.04 117.94 1.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 3.1000000000000001 112.005 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -104.9 146.7 28.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 4.3099999999999996 110.673 179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -17.83 -48.72 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.341 1.608 . . . . 8.3300000000000001 115.341 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -110.44 -57.71 2.18 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 119.167 -1.013 . . . . 6.2300000000000004 113.718 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.5 tp -141.13 -31.73 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.867 0.691 . . . . 4.3899999999999997 112.867 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.58 ' O ' HD23 ' A' ' 83' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.2 -0.905 . . . . 7.79 110.402 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.832 0.349 . . . . 5.6799999999999997 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.01 6.39 10.1 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.804 -0.712 . . . . 4.1100000000000003 112.939 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -81.18 146.98 30.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.934 0.367 . . . . 4.4699999999999998 110.472 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.902 HG12 ' CG ' ' A' ' 79' ' ' GLU . 34.6 m -134.25 146.08 31.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.124 0.488 . . . . 1.5700000000000001 111.767 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 78' ' ' ILE . 33.2 m -97.3 133.13 40.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.299 -1.0 . . . . 1.79 108.299 178.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' O ' HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -108.54 146.48 33.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 113.263 0.838 . . . . 2.2599999999999998 113.263 -177.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.448 ' CZ ' HG13 ' A' ' 50' ' ' ILE . 4.5 t80 -98.0 115.8 28.91 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.139 -1.06 . . . . 1.29 108.139 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -113.3 125.48 54.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.934 -0.575 . . . . 2.4199999999999999 112.47 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.923 HD21 ' CG1' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -55.71 114.39 1.86 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.383 -0.969 . . . . 2.2400000000000002 108.383 177.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.488 ' HA ' HG22 ' A' ' 71' ' ' VAL . 41.9 t -141.5 15.35 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.1 0.407 . . . . 4.4900000000000002 112.1 -178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.474 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.2 t70 -88.2 -17.42 30.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 5.4100000000000001 111.056 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.892 HD12 HD11 ' A' ' 9' ' ' LEU . 2.3 mt -92.34 162.44 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.19 0.519 . . . . 3.29 111.515 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.474 ' N ' ' CG2' ' A' ' 12' ' ' ILE . . . -73.34 171.76 50.98 Favored Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.45 -0.795 . . . . 3.8399999999999999 112.969 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -67.65 -30.32 69.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.831 0.308 . . . . 7.7199999999999998 111.831 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.45 57.75 0.52 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.191 -1.004 . . . . 3.8100000000000001 113.359 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 ' CG1' HG23 ' A' ' 12' ' ' ILE . 1.6 pt -133.96 -154.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.609 0.205 . . . . 2.54 110.771 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.71 144.54 41.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.694 0.283 . . . . 4.4000000000000004 110.541 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' HD13 ' A' ' 12' ' ' ILE . 46.2 mm-40 -99.01 174.49 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 2.1699999999999999 110.295 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.923 ' CG1' HD21 ' A' ' 9' ' ' LEU . 12.7 p -123.17 147.78 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.901 1.074 . . . . 1.51 113.901 -177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.932 HG23 HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.29 161.89 13.36 Favored 'General case' 0 CA--C 1.522 -0.11 0 CA-C-N 114.935 -1.03 . . . . 0.68999999999999995 111.238 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.751 HG11 ' NE1' ' A' ' 24' ' ' TRP . 71.9 t -80.68 114.35 21.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.955 -0.566 . . . . 1.3899999999999999 110.147 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 40' ' ' GLU . 3.4 tttt -79.93 -30.22 39.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.465 -0.334 . . . . 2.9500000000000002 111.815 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' HD21 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -140.42 143.68 35.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 2.1299999999999999 111.746 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.751 ' NE1' HG11 ' A' ' 21' ' ' VAL . 1.8 m95 -138.51 114.91 10.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.796 -0.638 . . . . 0.82999999999999996 109.825 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.95 -7.34 13.73 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.24 0.459 . . . . 1.72 112.24 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.954 HG11 HG13 ' A' ' 32' ' ' VAL . 35.3 m -129.95 158.61 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 0.5 111.526 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HA ' ' CD1' ' A' ' 61' ' ' LEU . 3.1 tttt -129.15 167.46 17.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.234 -0.439 . . . . 1.8899999999999999 111.409 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 61' ' ' LEU . 7.7 mt-10 -52.6 137.21 31.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.86 -0.609 . . . . 2.0299999999999998 110.928 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.25 3.8 58.19 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.371 -0.919 . . . . 0.45000000000000001 112.79 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 3.2 t0 -97.92 153.88 18.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.927 0.394 . . . . 1.3600000000000001 111.584 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' GLY . 20.7 m -100.02 143.79 29.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.917 -0.583 . . . . 0.31 111.063 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.954 HG13 HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -100.57 161.35 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.28000000000000003 110.764 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 52' ' ' SER . 36.6 m -131.72 169.07 16.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.148 -0.478 . . . . 1.4199999999999999 110.962 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -58.36 -25.03 61.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.301 -0.409 . . . . 2.3799999999999999 111.108 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -102.86 -17.38 15.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 2.52 111.413 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -99.5 91.52 4.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.828 0.347 . . . . 1.6899999999999999 111.548 -179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.3 p -60.33 160.32 8.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.93999999999999995 110.221 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.887 HG12 HG11 ' A' ' 32' ' ' VAL . 4.2 mt -85.32 -73.56 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.965 -0.294 . . . . 0.46999999999999997 110.679 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.54 ' CB ' ' CH2' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -140.38 158.97 43.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.098 0.475 . . . . 1.29 110.791 179.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' LYS . 4.1 mt-10 -137.57 124.72 21.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 2.3700000000000001 109.797 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG12 ' HA ' ' A' ' 21' ' ' VAL . 19.5 m -117.21 144.53 24.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 1.3500000000000001 111.347 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 22' ' ' LYS . 3.7 mp0 -133.17 134.0 43.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.045 -0.525 . . . . 2.6000000000000001 111.038 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.27 150.46 52.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.076 -0.511 . . . . 2.29 110.748 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -52.19 -28.43 18.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.367 -0.379 . . . . 4.3899999999999997 110.741 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -77.36 -61.74 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 3.6499999999999999 110.877 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.73 158.67 44.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 2.8300000000000001 111.227 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -102.43 138.42 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 4.5199999999999996 110.796 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.474 HG21 ' CB ' ' A' ' 11' ' ' ASP . 1.8 t -133.9 111.99 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 3.5 111.083 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -112.8 131.42 55.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 1.46 110.607 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' CZ ' ' A' ' 7' ' ' PHE . 35.0 mm -102.76 105.58 18.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.263 0.554 . . . . 1.01 111.994 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -178.59 6.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.487 -0.778 . . . . 1.04 110.568 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 2.4 m -102.96 -72.14 0.7 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.528 -0.305 . . . . 1.3600000000000001 111.582 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' CG ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 82.79 -11.44 0.97 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.763 0.425 . . . . 4.2300000000000004 111.469 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.42 171.81 14.22 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.119 -0.697 . . . . 3.8799999999999999 109.119 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 1.0 OUTLIER -97.16 121.98 39.66 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.505 -0.478 . . . . 1.52 110.793 -179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.616 ' O ' HG23 ' A' ' 31' ' ' THR . . . -133.25 164.77 24.2 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.626 -0.715 . . . . 0.17999999999999999 112.674 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 78' ' ' ILE . 48.4 t -103.36 121.52 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.104 0.409 . . . . 1.1100000000000001 112.104 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HG21 ' A' ' 26' ' ' VAL . 23.0 mt -99.09 127.19 52.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.065 -0.516 . . . . 0.38 109.675 178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -44.87 5.94 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 113.832 1.049 . . . . 2.1400000000000001 113.832 -177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -143.11 140.72 30.99 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.73 0.641 . . . . 1.3500000000000001 112.73 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 28' ' ' GLU . 2.2 mt -125.57 104.57 8.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.37 -0.832 . . . . 1.1399999999999999 109.422 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -70.46 -45.23 66.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.445 0.905 . . . . 3.0800000000000001 113.445 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 67' ' ' ASP . 23.9 m-85 -107.41 133.23 52.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.645 0.609 . . . . 1.9299999999999999 112.645 -178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -98.05 -166.94 1.44 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.735 -0.666 . . . . 1.7 111.063 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 21' ' ' VAL . 4.8 mt -57.4 -22.3 42.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 112.249 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' A' ' 20' ' ' THR . 15.7 t0 -101.64 -25.56 13.83 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.979 0.363 . . . . 2.3300000000000001 111.979 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CD1' ' A' ' 63' ' ' TYR . 10.2 m-20 -71.25 149.79 45.88 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.353 0.597 . . . . 1.8500000000000001 112.352 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.932 HD13 HG23 ' A' ' 20' ' ' THR . 1.2 mm -110.75 136.36 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 114.869 -1.059 . . . . 1.3799999999999999 110.343 179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.68 ' HB3' HD23 ' A' ' 9' ' ' LEU . . . -101.24 145.39 28.9 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.74 -0.664 . . . . 2.1600000000000001 109.894 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' HA ' ' OE1' ' A' ' 18' ' ' GLU . 52.6 p90 -126.73 142.8 51.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.221 -0.899 . . . . 5.6500000000000004 110.514 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 12' ' ' ILE . 16.8 t -60.88 140.0 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 3.6099999999999999 111.612 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.36 -12.06 9.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.782 -0.723 . . . . 1.8700000000000001 113.224 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -155.41 137.07 9.56 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 117.112 0.456 . . . . 2.96 111.421 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 51.0 Cg_exo -54.95 164.61 3.27 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.681 2.254 . . . . 0.91000000000000003 112.444 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.541 HD12 ' HB2' ' A' ' 69' ' ' ALA . 9.2 tt -112.95 -47.5 3.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.451 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 HD11 ' A' ' 78' ' ' ILE . 4.4 p -140.45 154.58 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.638 -0.256 . . . . 0.46999999999999997 111.45 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -114.76 124.59 52.15 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.67 -0.492 . . . . 1.1000000000000001 109.67 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.661 HD11 HG13 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -136.52 149.2 26.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 0.85999999999999999 111.506 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.902 ' CG ' HG12 ' A' ' 4' ' ' VAL . 1.1 mt-10 -99.06 112.59 24.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.446 -0.502 . . . . 1.3899999999999999 110.092 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 ' OG1' HG21 ' A' ' 5' ' ' VAL . 5.3 p -143.73 156.55 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.703 -0.68 . . . . 2.3900000000000001 110.657 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.833 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 mt-10 -57.45 154.07 11.59 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.096 -0.335 . . . . 3.1299999999999999 110.096 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -39.02 112.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.869 0.366 . . . . 3.1000000000000001 111.862 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.833 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -117.71 145.38 44.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 4.3099999999999996 111.286 -179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -65.61 -21.7 66.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.808 -0.633 . . . . 8.3300000000000001 111.598 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -30.02 -49.28 0.1 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.929 0.714 . . . . 6.2300000000000004 112.929 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -108.97 -27.75 9.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 4.3899999999999997 110.859 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.174 -0.917 . . . . 7.79 110.877 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.677 0.275 . . . . 5.6799999999999997 111.348 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.49 -7.55 58.09 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.667 -0.778 . . . . 4.1100000000000003 113.07 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -86.85 153.3 21.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.847 0.356 . . . . 4.4699999999999998 111.023 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.835 HG12 ' CG ' ' A' ' 79' ' ' GLU . 4.3 m -136.08 147.15 28.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.176 -0.465 . . . . 1.5700000000000001 111.73 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 78' ' ' ILE . 28.3 m -96.67 138.35 22.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.651 -0.704 . . . . 1.79 109.106 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.83 145.19 28.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.812 0.671 . . . . 2.2599999999999998 112.812 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HD2' HD21 ' A' ' 75' ' ' LEU . 11.5 t80 -109.36 134.46 51.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.113 -0.949 . . . . 1.29 109.029 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HA ' HD13 ' A' ' 75' ' ' LEU . 18.1 ptpt -126.45 145.11 50.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 2.4199999999999999 111.8 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.917 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.9 tm? -51.22 114.35 1.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.215 -0.661 . . . . 2.2400000000000002 109.215 178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 m -135.79 67.24 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.905 0.383 . . . . 4.4900000000000002 111.533 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.638 ' HB2' HD13 ' A' ' 12' ' ' ILE . 12.0 m-20 -123.99 -34.41 2.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.941 -0.572 . . . . 5.4100000000000001 110.996 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.971 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -116.26 -175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.252 -0.431 . . . . 3.29 111.378 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.78 171.36 50.35 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 121.133 -0.556 . . . . 3.8399999999999999 112.752 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.412 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 25.7 tt0 -86.11 14.45 6.3 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 111.889 0.329 . . . . 7.7199999999999998 111.889 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.11 32.34 0.41 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.349 -0.929 . . . . 3.8100000000000001 112.686 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.795 HD11 ' CG2' ' A' ' 12' ' ' ILE . 1.0 OUTLIER -133.43 -169.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.36 . . . . 2.54 111.255 -179.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 145.91 6.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 4.4000000000000004 110.707 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.477 ' HB2' HG21 ' A' ' 68' ' ' ILE . 8.8 mt-10 -99.8 173.52 6.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.121 -0.49 . . . . 2.1699999999999999 110.65 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.917 ' CG1' HD21 ' A' ' 9' ' ' LEU . 8.0 p -127.81 146.75 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.768 0.655 . . . . 1.51 112.768 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.46 156.54 16.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.687 -0.688 . . . . 0.68999999999999995 110.728 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.682 ' HA ' HG12 ' A' ' 41' ' ' VAL . 21.2 t -79.56 137.27 22.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.129 -0.487 . . . . 1.3899999999999999 110.328 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.745 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -102.92 -32.49 9.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.461 -0.336 . . . . 2.9500000000000002 111.322 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -140.54 125.91 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.044 0.45 . . . . 2.1299999999999999 111.72 -179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.725 ' CZ3' HD22 ' A' ' 61' ' ' LEU . 28.9 m95 -118.64 115.57 24.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.86 -0.609 . . . . 0.82999999999999996 109.738 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -120.33 35.46 4.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.359 0.503 . . . . 1.72 112.359 -178.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.778 ' HB ' HD12 ' A' ' 58' ' ' ILE . 6.4 m -156.57 157.73 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.642 0.258 . . . . 0.5 111.052 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 168.1 20.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.164 0.507 . . . . 1.8899999999999999 111.601 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 59' ' ' LYS . 3.3 mt-10 -56.7 135.95 55.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.563 -0.744 . . . . 2.0299999999999998 110.57 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 58' ' ' ILE . . . 72.68 3.71 59.69 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.081 -1.057 . . . . 0.45000000000000001 112.661 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -97.21 154.05 17.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.779 0.323 . . . . 1.3600000000000001 111.145 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 56' ' ' GLY . 7.9 m -99.74 152.13 20.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.355 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.949 HG11 HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -110.91 160.11 10.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.728 -0.669 . . . . 0.28000000000000003 111.06 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.37 159.8 41.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 1.4199999999999999 110.825 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.83 -33.14 15.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 2.3799999999999999 110.757 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.79 -24.79 21.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.531 . . . . 2.52 110.933 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.94 92.39 6.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.6899999999999999 111.108 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 63.3 p -63.07 159.32 17.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.93999999999999995 110.71 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.949 HG12 HG11 ' A' ' 32' ' ' VAL . 2.4 mt -86.02 -64.9 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.46999999999999997 110.8 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.522 ' HB3' ' CZ3' ' A' ' 24' ' ' TRP . 18.7 p -139.26 160.34 40.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 1.29 110.557 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.675 ' CG ' HG22 ' A' ' 49' ' ' THR . 8.2 tt0 -140.58 124.6 17.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.142 -0.481 . . . . 2.3700000000000001 110.064 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG12 ' HA ' ' A' ' 21' ' ' VAL . 32.7 m -120.17 147.1 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.796 0.331 . . . . 1.3500000000000001 110.954 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.12 123.57 23.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.262 -0.426 . . . . 2.6000000000000001 111.24 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.5 t -107.34 154.06 21.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.835 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -58.86 -17.69 26.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 4.3899999999999997 111.531 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.47 -45.6 6.06 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.7 0.286 . . . . 3.6499999999999999 111.193 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.1 158.0 43.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.397 . . . . 2.8300000000000001 111.434 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 m -114.8 140.14 49.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.009 -0.541 . . . . 4.5199999999999996 110.449 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.36 120.22 17.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.999 0.428 . . . . 3.5 111.637 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.675 HG22 ' CG ' ' A' ' 40' ' ' GLU . 43.2 p -102.19 132.47 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.874 -0.603 . . . . 1.46 110.246 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 50' ' ' ILE . 4.1 mp -98.65 106.32 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.246 0.546 . . . . 1.01 111.857 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 p -90.22 -179.31 5.61 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.431 -0.804 . . . . 1.04 109.891 178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.453 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 1.4 t -103.47 -45.22 4.91 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.932 -0.307 . . . . 1.3600000000000001 111.515 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' O ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 70.97 4.52 5.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.252 -0.431 . . . . 4.2300000000000004 110.703 -178.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 3.2 m-85 -177.94 171.9 1.72 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.469 -0.938 . . . . 3.8799999999999999 108.469 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 16.7 p-10 -97.82 120.32 38.0 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.217 -0.593 . . . . 1.52 110.091 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 31' ' ' THR . . . -127.86 164.72 21.14 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.566 -0.826 . . . . 0.17999999999999999 113.381 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.93 122.48 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.877 0.37 . . . . 1.1100000000000001 111.633 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.778 HD12 ' HB ' ' A' ' 26' ' ' VAL . 4.7 mt -99.88 126.28 53.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 116.026 -0.533 . . . . 0.38 110.428 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 3.2 tttp -98.68 -33.29 11.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.425 0.898 . . . . 2.1400000000000001 113.425 -177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.793 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -161.22 146.12 13.74 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.361 0.874 . . . . 1.3500000000000001 113.361 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.725 HD22 ' CZ3' ' A' ' 24' ' ' TRP . 1.1 mt -138.13 129.01 26.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.803 -1.089 . . . . 1.1399999999999999 109.412 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -110.12 -33.23 6.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.189 0.441 . . . . 3.0800000000000001 112.189 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.507 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 21.8 m-85 -87.29 134.35 33.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.966 0.412 . . . . 1.9299999999999999 111.518 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 24' ' ' TRP . 14.2 m120 -117.6 -172.37 2.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.482 0.658 . . . . 1.7 111.748 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 22' ' ' LYS . 2.7 mp -56.75 -22.65 37.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.926 -1.034 . . . . 1.0600000000000001 112.241 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.78 -25.38 14.39 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.056 0.391 . . . . 2.3300000000000001 112.056 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 20' ' ' THR . 31.4 m-20 -76.2 150.18 37.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.436 0.636 . . . . 1.8500000000000001 112.25 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -110.5 143.76 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-N 114.771 -1.104 . . . . 1.3799999999999999 110.778 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . . . -119.95 150.66 40.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.674 -0.694 . . . . 2.1600000000000001 110.411 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.428 ' CB ' ' HG2' ' A' ' 18' ' ' GLU . 28.8 p90 -119.51 141.57 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.074 -0.512 . . . . 5.6500000000000004 110.43 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.971 HG21 ' O ' ' A' ' 12' ' ' ILE . 8.1 t -60.58 137.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 3.6099999999999999 111.795 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.08 6.63 20.34 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.622 -0.799 . . . . 1.8700000000000001 113.763 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.4 OUTLIER -157.07 129.12 4.02 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 117.599 0.699 . . . . 2.96 112.058 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 3.7 Cg_exo -73.51 150.46 45.99 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 122.557 2.172 . . . . 0.91000000000000003 111.423 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -120.46 -17.91 8.01 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.681 -0.408 . . . . 1.8400000000000001 112.077 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 60' ' ' LYS . 9.0 p -140.84 143.61 28.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.007 0.743 . . . . 0.46999999999999997 113.007 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.55 127.35 52.97 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.494 -0.776 . . . . 1.1000000000000001 109.615 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.784 HD11 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -139.62 149.61 22.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.214 -0.448 . . . . 0.85999999999999999 111.233 -178.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.835 ' CG ' HG12 ' A' ' 4' ' ' VAL . 2.5 mt-10 -98.7 113.16 25.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.441 -0.503 . . . . 1.3899999999999999 110.148 179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.59 ' OG1' HG21 ' A' ' 5' ' ' VAL . 3.5 p -142.73 157.08 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 110.782 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.93 122.18 11.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.948 0.404 . . . . 3.1299999999999999 110.485 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -40.81 117.12 0.79 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.989 -0.55 . . . . 3.1000000000000001 112.284 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 83' ' ' LEU . 2.6 tp -105.62 147.99 27.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.959 -0.564 . . . . 4.3099999999999996 110.511 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -17.55 -47.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.264 1.579 . . . . 8.3300000000000001 115.264 -177.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 83' ' ' LEU . 72.6 m-20 -108.7 -57.06 2.19 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 119.383 -0.927 . . . . 6.2300000000000004 113.257 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 86' ' ' LEU . 13.0 tp -141.25 -31.3 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.014 0.746 . . . . 4.3899999999999997 113.014 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.245 -0.883 . . . . 7.79 110.85 -178.979 . . . . . . . . 2 2 . 1 stop_ save_